Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule motor activity (GO:0003777),0.9238289465822521,2.143391545087936,0.0,0.0,0.0,15/51,1.19%,KIF11;CENPE;KIF23;KIF15;KIF20B;KIF18B;KIF4A;KIF14;KIFC1;KIF22;KIF2C;DNAH8;KIF24;KIF18A;KIF20A
prerank,motor activity (GO:0003774),0.9033373347515348,2.123522722747455,0.0,0.0,0.0,15/60,1.19%,KIF11;CENPE;KIF23;KIF15;KIF20B;KIF18B;KIF4A;KIF14;KIFC1;KIF22;KIF2C;DNAH8;KIF24;KIF18A;KIF20A
prerank,DNA secondary structure binding (GO:0000217),0.8721846021067832,1.9454871230324249,0.0,0.00031205961680245633,0.001,17/31,8.32%,NEIL3;RAD51AP1;GEN1;CLSPN;HMGB2;MEN1;HMGA1;BLM;RAD51B;RAD51C;HMGB3;MSH6;RBBP8;XRCC3;LIN54;HMGB1;RAD18
prerank,four-way junction DNA binding (GO:0000400),0.874696603390278,1.8170043977930674,0.0013054830287206266,0.08800081193829269,0.251,10/17,7.33%,GEN1;HMGB2;MEN1;BLM;RAD51B;RAD51C;HMGB3;MSH6;XRCC3;HMGB1
prerank,microtubule binding (GO:0008017),0.7459002101053123,1.8156231244224157,0.0,0.07208577148136742,0.256,48/222,6.11%,CENPE;NUSAP1;KIF23;TPX2;KIF15;DLGAP5;PRC1;KIF20B;KIF18B;KIF14;KIFC1;KIF22;BIRC5;KNSTRN;GTSE1;SKA1;KIF2C;FAM83D;RACGAP1;SKA2;KIF18A;CKAP5;KIF20A;SPAG5;CCSAP;PLK1;CDK5RAP2;TUBGCP6;UXT;CCDC88A;NDE1;REEP4;CCDC69;CEP44;EZR;SUN2;GAS2L3;CEP57L1;HAUS6;FBXW11;S100A9;ABRAXAS1;MAP4;CEP295;TUBGCP4;S100A8;CLASP1;CCDC88C
prerank,damaged DNA binding (GO:0003684),0.7881348170439693,1.7989161214046976,0.001088139281828074,0.09096537829791602,0.362,18/44,9.43%,NEIL3;POLQ;HMGB2;RAD1;ERCC4;RPA2;XRCC1;SMC6;POLD1;RBBP8;FEN1;PCNA;DCLRE1C;DCLRE1B;HMGB1;RAD18;RPA1;ERCC3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6860285122525575,-1.787555424797174,0.012658227848101266,0.8248443879258416,0.433,9/12,17.60%,ACVR1;TGFBR1;BMPR2;LTBP1;BMPR1B;ENG;TGFBR3;ACVRL1;TGFBR2
prerank,single-stranded DNA binding (GO:0003697),0.738144304546284,1.7470680870548165,0.0,0.20702926577580102,0.693,39/93,14.58%,NEIL3;RAD51AP1;RAD51;MCM10;HMGB2;ERCC4;CDC45;RPA2;RADX;POLA1;BLM;BRCA2;RAD51B;DDX11;SMC6;MCM6;NUCKS1;MCM9;PMS2;RBBP8;HMGB1;TDP2;NABP2;RPA1;LONP1;PCBP2;PARK7;RAD23A;RTF1;FAM111A;DHX9;CTC1;TOP3A;TDP1;HNRNPU;REXO4;APTX;RAD52;RPA3
prerank,"DNA binding, bending (GO:0008301)",0.8905349330511797,1.7438297181384335,0.0053475935828877,0.19215070904611248,0.714,4/14,3.80%,TOP2A;HMGB2;LEF1;HMGB3
prerank,BMP binding (GO:0036122),-0.6791834919276558,-1.725320832793807,0.02527075812274368,0.7752493139682752,0.642,3/11,12.54%,BMPR2;ENG;GREM2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7122447770977025,-1.7150280218886684,0.013605442176870748,0.5625125493608192,0.659,7/10,17.48%,NSF;SQSTM1;GNAS;SHISA6;SHANK2;SHANK3;DLG4
prerank,ankyrin binding (GO:0030506),0.8309056118023319,1.7062075368026517,0.0063371356147021544,0.31538825271501586,0.891,2/19,0.51%,SLC4A1;RHAG
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5813894898490117,-1.705079963863808,0.022727272727272728,0.46169098453918744,0.694,9/18,17.60%,ACVR1;TGFBR1;BMPR2;LTBP1;BMPR1B;ENG;TGFBR3;ACVRL1;TGFBR2
prerank,tubulin binding (GO:0015631),0.6983237552559266,1.7030811411484412,0.0,0.29770487442954335,0.899,52/295,6.11%,CENPE;NUSAP1;KIF23;TPX2;KIF15;DLGAP5;PRC1;KIF20B;KIF18B;KIF14;KIFC1;KIF22;BIRC5;GTSE1;SKA1;KIF2C;FAM83D;RACGAP1;SKA2;KIF18A;CKAP5;KIF20A;SPAG5;CCSAP;PLK1;BRCA1;CDK5RAP2;STMN1;TUBGCP6;AGBL1;BRCA2;UXT;CCDC88A;NDE1;FYN;REEP4;CCDC69;CEP44;EZR;SUN2;GAS2L3;CEP57L1;HAUS6;S100A9;ABRAXAS1;MAP4;CEP295;TUBGCP4;S100A8;CLASP1;AGTPBP1;CCDC88C
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.7999851234869457,1.702947964720916,0.00749063670411985,0.2711514379452616,0.9,2/21,1.38%,CHRNB4;P2RX1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.7456505105454329,1.6989764784000474,0.003264417845484222,0.2619740483056621,0.909,10/42,5.38%,CCNF;CCNB2;CKS2;CCNB1;CCNA2;CCNE1;CDKN2C;CCNE2;CCNYL1;CDKN2A
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.8033270903125085,1.6927611358558312,0.00975609756097561,0.26429049084577266,0.925,9/21,7.11%,POLK;POLQ;POLE2;POLA1;POLE;POLD1;POLH;POLN;PRIMPOL
prerank,DNA polymerase activity (GO:0034061),0.8002689381505416,1.6889833546298112,0.008443908323281062,0.2595221513164999,0.936,9/22,7.11%,POLK;POLQ;POLE2;POLA1;POLE;POLD1;POLH;POLN;PRIMPOL
prerank,sterol transfer activity (GO:0120015),-0.5993373380888415,-1.6850666702638006,0.029556650246305417,0.44635566561809786,0.768,7/17,13.35%,OSBPL2;ABCA1;PLTP;MTTP;OSBP;GRAMD1B;NPC2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.5462596726543882,-1.6802002303588757,0.005681818181818182,0.3845793454253396,0.775,10/20,22.56%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,DNA polymerase binding (GO:0070182),0.7960585578952792,1.6789976665721682,0.0175,0.2746124627861616,0.959,9/18,9.58%,RAD51;FANCD2;SMG6;PCNA;RTEL1;HMGB1;SMARCA4;NABP2;LONP1
prerank,single-stranded DNA helicase activity (GO:0017116),0.8064310654893708,1.676180018174113,0.0025188916876574307,0.26839077417616264,0.963,10/19,11.50%,RAD51;PIF1;POLQ;DSCC1;MCM6;RFC5;HELQ;DNA2;RFC2;DHX9
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.8508890777752792,1.6561371351249228,0.014285714285714285,0.3239178822409497,0.984,1/11,0.81%,CHRNB4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.8394374821565839,1.6526819635496552,0.011142061281337047,0.3188209084998429,0.989,6/13,8.74%,GEN1;EXO1;SLX4;FEN1;DNA2;DNASE1L1
prerank,kinesin binding (GO:0019894),0.7673683443176238,1.6515181652809057,0.01740139211136891,0.30775647892865404,0.99,3/27,0.63%,PRC1;KIF18B;FAM83D
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.7986425817677874,1.6419775970761976,0.029525032092426188,0.3265859919646107,0.992,2/18,1.35%,HSD17B3;SRD5A2
prerank,lipoprotein particle binding (GO:0071813),-0.5357223792586052,-1.6311738258468014,0.027624309392265192,0.48867928136384065,0.883,9/20,18.44%,TREM2;LPL;HSPD1;PLTP;CDH13;STAB1;SCARB1;CD36;THBS1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5807304251698997,-1.624026999296459,0.034334763948497854,0.4501079245030453,0.896,9/15,28.10%,HS6ST3;NDST3;HS3ST4;HS3ST1;HS6ST2;HS3ST5;HS6ST1;NDST2;HS3ST3A1
prerank,WW domain binding (GO:0050699),0.7527448741876381,1.61955932777919,0.019024970273483946,0.39845555071147926,0.997,2/26,0.21%,KIF20B;CDC25C
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.7842082439085701,1.6031310263949106,0.02570694087403599,0.45200417041032154,0.998,4/16,7.58%,NEIL3;CD38;SMUG1;NEIL1
prerank,DNA replication origin binding (GO:0003688),0.7492636505469134,1.6005352152806598,0.021739130434782608,0.4429347065275213,0.999,8/23,5.34%,MCM10;CDC45;POLA1;DDX11;MCM6;ORC5;MCM9;ORC3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.8277842847277299,1.5998100491552163,0.027298850574712645,0.4275216750193653,0.999,1/11,0.03%,NEIL3
prerank,protein kinase C binding (GO:0005080),0.699228937262212,1.5991545539447993,0.016611295681063124,0.41360381610997565,0.999,10/43,14.72%,TOP2A;CCDC88A;PICK1;NELL2;ITGAV;PRKCB;NELL1;RACK1;IRS1;PRKCSH
prerank,cholesterol transfer activity (GO:0120020),-0.5745484030347519,-1.5959252544004991,0.037914691943127965,0.4875398790799366,0.948,6/16,13.35%,OSBPL2;ABCA1;PLTP;MTTP;GRAMD1B;NPC2
prerank,ATP hydrolysis activity (GO:0140603),0.6998972823286005,1.5900492307149001,0.016483516483516484,0.43431497283129555,1.0,11/41,11.50%,KIF20B;KIF14;SMCHD1;CHD1L;ABCB10;ABCD1;DNA2;RUVBL2;TOR1A;RUVBL1;DHX9
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.8124208144881074,1.5882557253888367,0.026392961876832845,0.42613474338913204,1.0,6/11,14.25%,PPP1R11;PPP1R8;PPP1R14A;PPP1R14C;PPP1R2;PABIR1
prerank,symporter activity (GO:0015293),0.8221498669610343,1.578149924011276,0.0361794500723589,0.45337804326871156,1.0,1/10,1.14%,SLC5A5
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7852928690821501,1.57174028193093,0.032,0.46434470980205506,1.0,1/15,0.36%,SLC4A1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.8111511638077814,1.5623933365284823,0.048209366391184574,0.48827968241080344,1.0,9/11,18.59%,RPA2;TERF2;HNRNPA2B1;TERF1;NABP2;RPA1;CTC1;RAD50;HNRNPA1
prerank,palmitoyltransferase activity (GO:0016409),-0.4711080367620011,-1.5615210333549379,0.019230769230769232,0.557030988554983,0.975,19/28,35.93%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;GOLGA7;ZDHHC8;YKT6;ZDHHC24;ZDHHC16;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;HHAT;ZDHHC4;ZDHHC23;ZDHHC22;GOLGA7B;ZDHHC1
prerank,lysophospholipase activity (GO:0004622),-0.5141302844520864,-1.5585998160255232,0.041666666666666664,0.5167142274765594,0.976,7/20,15.41%,MGLL;ABHD12;ENPP2;GDE1;ABHD16A;PLA2G6;PNPLA7
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8250953313125949,1.5549910629350097,0.027065527065527065,0.5039058160612051,1.0,1/10,0.70%,SLC6A12
prerank,protein kinase regulator activity (GO:0019887),0.6471557940851345,1.5535371675463703,0.00508130081300813,0.494448710960467,1.0,13/95,6.08%,TPX2;CCNF;CCNB2;CCNB1;CCNA2;CCNE1;CCNE2;CCNYL1;STK11;GPRC5B;GMFG;FAF1;KIDINS220
prerank,diacylglycerol kinase activity (GO:0004143),-0.6117897638258216,-1.5506706384381093,0.05818181818181818,0.4994310956428619,0.98,7/11,13.66%,DGKH;DGKA;DGKI;DGKZ;AGK;DGKQ;DGKB
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5258354768817429,-1.5403399147719672,0.09170305676855896,0.4557712717641772,0.985,8/16,11.40%,PTPRZ1;PTPRG;PTPN6;PTPRE;PTPRD;PTPRK;PTPRO;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5258354768817429,-1.5403399147719672,0.09170305676855896,0.4557712717641772,0.985,8/16,11.40%,PTPRZ1;PTPRG;PTPN6;PTPRE;PTPRD;PTPRK;PTPRO;PTPRT
prerank,nucleosomal DNA binding (GO:0031492),0.7380532884329853,1.535276414467217,0.044472681067344345,0.5592108333100018,1.0,11/21,11.81%,SMARCC2;MBD3;RCC1;SMARCD2;HNRNPC;MBD2;RBBP4;H3-3A;SMARCA4;SMARCC1;MTA2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.6997055174396668,1.5351083889185475,0.03981264637002342,0.5434793573335486,1.0,7/28,8.09%,TTK;AURKB;AURKA;MAP2K6;MAPKAPK3;PRKACA;MAPK14
prerank,solute:anion antiporter activity (GO:0140323),0.7663306071376815,1.5148113841893445,0.05622489959839357,0.6198306428711419,1.0,1/14,0.36%,SLC4A1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7660608750971849,1.5112221029557538,0.06702412868632708,0.6206085629158851,1.0,7/12,16.36%,CDK1;MAPK1;CDK6;BRD4;CDK19;CCNK;CDK8
prerank,histone deacetylase binding (GO:0042826),0.6393031959420116,1.509838778028115,0.009230769230769232,0.6102620998101442,1.0,15/88,8.07%,TOP2A;HEY2;LEF1;IKZF3;USF1;RAD9A;SMG5;HDAC10;MTA3;RBBP4;GMNN;HDAC6;PKN2;CAMTA2;CIR1
prerank,gamma-tubulin binding (GO:0043015),0.6937397463033265,1.5085631941114304,0.0587515299877601,0.6001152793966605,1.0,11/21,20.09%,RACGAP1;CDK5RAP2;TUBGCP6;BRCA2;TUBGCP4;OFD1;TUBGCP3;MARK4;NDRG1;ARHGEF7;DIXDC1
prerank,acylglycerol lipase activity (GO:0047372),-0.6155926598624679,-1.5082753495163042,0.09818181818181818,0.5186600629141288,0.996,6/11,19.23%,MGLL;ABHD12;ABHD16A;ABHD6;ABHD3;ABHD15
prerank,glutamate receptor binding (GO:0035254),-0.5282893706086589,-1.5073085092470215,0.03508771929824561,0.4886909343417442,0.996,8/17,17.48%,NSF;SQSTM1;SYNDIG1;GNAS;SHISA6;SHANK2;SHANK3;DLG4
prerank,endodeoxyribonuclease activity (GO:0004520),0.7065305713228537,1.5062160389099486,0.05334987593052109,0.5952657213436394,1.0,10/20,14.79%,ERCC4;EXO1;RBBP8;FEN1;MBD4;DCLRE1C;ZRANB3;DNA2;APEX1;RAD50
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5213091564465436,-1.502523952893615,0.05508474576271186,0.4739937873281968,0.997,7/16,18.44%,TREM2;PLTP;CDH13;STAB1;SCARB1;CD36;THBS1
prerank,syntaxin binding (GO:0019905),-0.3756625484260495,-1.494614616837657,0.017241379310344827,0.47202329161368045,0.998,19/61,13.69%,NSF;SCFD2;STX6;PTPN2;STX16;ABCA1;NAPA;SNAP47;VAMP1;SYT1;TMED9;STXBP5L;VAMP2;VAMP8;SYT9;GOLGA2;RAB11A;UNC13A;STXBP5
prerank,telomeric DNA binding (GO:0042162),0.6759620851445608,1.494561421922412,0.05632183908045977,0.635080327645099,1.0,12/32,12.38%,PIF1;BLM;SMG6;SMG5;TERF2;UPF2;XRCC6;HNRNPA2B1;TERF1;RPA1;CTC1;APEX1
prerank,magnesium ion binding (GO:0000287),0.6195220598018625,1.4833979868164076,0.002014098690835851,0.6722905827449797,1.0,24/135,8.81%,TOP2A;GEN1;PIF1;PLK1;STK26;OXSR1;MSH6;STK11;FEN1;DUT;IMPA1;SIK2;UBA2;EPHX2;PDE2A;STK38L;MAP3K5;GNAI1;TDP2;RP2;PPA2;STK38;MARK2;MAST2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6865466769539348,1.479373039731758,0.05828571428571429,0.6755644904320606,1.0,2/27,1.14%,SLC4A1;SLC5A5
prerank,microtubule plus-end binding (GO:0051010),0.7061512084700208,1.478584071180671,0.06472081218274112,0.6637072617364801,1.0,6/20,6.93%,KNSTRN;KIF2C;KIF18A;FBXW11;CLASP1;MAPRE3
prerank,telomerase RNA binding (GO:0070034),0.6852919935521186,1.4707928823189746,0.07673860911270983,0.6873254905354466,1.0,13/22,20.46%,SMG6;NOP10;SMG5;HNRNPC;EXOSC10;DCP2;TEP1;HNRNPU;DKC1;WRAP53;XRN1;SNRPB;SMG7
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5398808301783509,-1.4606401234299564,0.06976744186046512,0.5469196382965982,0.998,6/14,10.59%,SPOCK1;TIMP2;SPOCK2;BST2;TIMP3;RECK
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5530230130275008,-1.4589260075773924,0.0784313725490196,0.5253815005689044,0.998,7/13,14.06%,PTPRJ;ERN1;ITGA5;PDGFD;PDGFC;ITGB3;VEGFA
prerank,chloride transmembrane transporter activity (GO:0015108),0.7184641016254203,1.4566943879001564,0.07402597402597402,0.7390819964349377,1.0,1/16,0.36%,SLC4A1
prerank,neuropeptide binding (GO:0042923),-0.49113728946146207,-1.4534996885375018,0.06965174129353234,0.5152791455917084,0.998,8/18,40.92%,GPR149;SORL1;OPRL1;OPRK1;GPR37;OPRD1;SSTR2;NMUR2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.7119717378087955,1.4514610360231799,0.07712082262210797,0.7494722248935168,1.0,5/18,11.37%,BIRC5;DPEP1;BIRC2;TNFAIP8;XIAP
prerank,phospholipase A2 activity (GO:0004623),-0.44980508492600824,-1.4507024873639662,0.05426356589147287,0.499213573388662,0.998,15/26,44.39%,PLA2G15;PLA2G7;ABHD3;PLA2G6;PLA2G4E;PLA2G12A;PLA2G4A;PLA2G3;PLA2G4C;PNPLA3;PNPLA8;PLAAT1;PLA2G5;PLA2G4F;PLA2G2D
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6619773256311179,1.4467629476656438,0.0761789600967352,0.7571695029901133,1.0,8/26,14.25%,PPP1R9B;PPP1R11;PPP1R8;PPP1R14A;PPP1R14C;LMTK2;PPP1R2;PABIR1
prerank,phospholipase activity (GO:0004620),-0.36463899854313175,-1.4431209396264715,0.029411764705882353,0.49878798636957544,0.999,19/67,17.82%,MGLL;PLA2G15;LPL;ABHD12;PLCB2;ENPP2;GDE1;ABHD16A;ABHD6;PLCB4;PLBD2;PDIA3;ABHD3;PLA2G6;SMPDL3A;PNPLA7;LIPH;SEC23IP;GPLD1
prerank,DNA binding (GO:0003677),0.5932373600560114,1.43558488648199,0.0,0.7989311301924388,1.0,170/694,15.06%,TOP2A;NEIL3;RAD51AP1;BRIP1;RAD51;CLSPN;E2F2;POLQ;MCM10;FOXA2;HMGB2;TIPIN;MEN1;RAD1;ERCC4;CDC45;SMC1B;BRCA1;NR4A2;EXO1;RPA2;HMGA1;SOX6;MBD3;RADX;POLA1;BLM;HEY2;GTF3C5;BRCA2;MYRFL;RPL7;LEF1;POLE;E2F1;SMARCA5;RAD51B;IKZF3;DDX11;PBX4;LIN9;RAD51C;BATF;ELK4;BCLAF3;SMC6;LIG4;MCM6;USF1;HMGB3;POLR2A;TIMELESS;TFPT;NUCKS1;POLD1;ERG;MSH6;MCM9;CTCF;PMS2;RBBP8;FEN1;PCNA;SLPI;ETS2;CGAS;ATAD5;MBD4;TAF1;FOXO1;FOXJ3;DCLRE1C;MBD1;TCF7L1;TCF3;SETX;ARID4A;MND1;PHF19;XRCC6;DCLRE1B;HMGB1;CAMTA2;AHR;TDP2;MAX;ILF2;SMARCA4;PHF1;PALB2;RAD18;ZBTB16;ZNF638;DNA2;RLF;DNASE1L1;GTF2A1;TERF1;NABP2;ZBTB7A;SNAPC3;EGFR;FLI1;ZNF148;RPA1;ERCC3;RPS27;MECP2;LONP1;SRRT;EGR1;SPTY2D1;ZBTB32;NR2C2;RFX2;DNMT1;NR2F2;KAT6A;PCBP2;PMS1;CUX1;TSHZ1;NFYC;ARID5B;PARK7;NFE2;RAD23A;RTF1;SMAD4;ATF6;RFC1;FAM111A;TAF6;JUN;DHX9;ATF5;CCNT1;FOXP2;CBFB;CTC1;APEX1;TOP3A;PDS5B;TDP1;ZBTB33;KIN;NFE2L2;HIVEP2;ING2;PRKDC;HNRNPU;PSIP1;REXO4;DDIT3;CEBPZ;BCL6;CREBBP;MYC;CEBPG;APTX;POU6F1;CHTF18;RAD52;CAMTA1;RPA3;E2F3;RAD50;TP53;JUNB;LRRFIP1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.639110241903123,1.4274943186424494,0.08813559322033898,0.8257097460592995,1.0,8/34,7.59%,UBE2C;UBE2T;UBE2I;UBE2O;TAF1;UBE2Z;BIRC6;UBE2K
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.6457308697434562,1.4263763055815397,0.08400460299194476,0.8149436892796148,1.0,7/31,7.59%,UBE2C;UBE2T;UBE2O;TAF1;UBE2Z;BIRC6;UBE2K
prerank,acetylcholine receptor activity (GO:0015464),0.6722952238936931,1.4262484038921248,0.07936507936507936,0.7994967382478931,1.0,1/22,0.81%,CHRNB4
prerank,kinase activator activity (GO:0019209),0.6386475605053743,1.423206033743106,0.09474885844748858,0.7995687520056168,1.0,6/30,13.57%,TPX2;STK11;GPRC5B;MARK2;FGF13;PRKAG2
prerank,histone acetyltransferase binding (GO:0035035),0.662200576666123,1.4179142464461425,0.07848101265822785,0.8117377183107669,1.0,8/21,14.93%,KANSL1;PCNA;TAF7;KANSL1L;ZBTB7A;EGR1;TRIM68;TP53
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.6469802027519307,1.4140207387509018,0.072,0.8164173041367374,1.0,9/30,11.37%,BIRC5;UBE2O;DPEP1;BIRC2;UBE2Z;BIRC6;TNFAIP8;PTTG1;XIAP
prerank,protein kinase activator activity (GO:0030295),0.5988969024638845,1.4139671651505252,0.06932773109243698,0.8017946317898021,1.0,20/60,19.33%,TPX2;INCENP;DBF4;ERBB3;STK11;GPRC5B;MARK2;CAB39L;MLST8;FGF13;PRKAG2;FAM20A;STK4;MAP2K1;PAK2;CD24;IQGAP1;TAOK1;CDKN1A;STK3
prerank,kinase binding (GO:0019900),0.5829488754750798,1.4114871233639217,0.0,0.7996806305220803,1.0,106/434,14.97%,KIF11;TPX2;PRC1;KIF14;CDC25C;AURKB;FOXM1;CIT;FAM83D;RACGAP1;BORA;CKS2;BARD1;CCNB1;CCNA2;KIF20A;PLK1;CDKN2C;CDK5RAP2;CNTLN;CHEK2;POLA1;CDC25A;EXOC2;ATG13;ARHGAP33;RB1;CEP152;AURKA;FBXO5;OXSR1;SGO1;TIAM1;FLNA;USF1;RAD9A;TBL2;MAP2K6;AXIN1;POLR2A;PTPN22;CEP192;RPS19;GPRC5B;TFRC;SP100;RPS7;CAV1;CDKN2A;PPP1CB;PPP2R5A;FAF1;GSN;TRADD;MYOM1;SLC12A7;RND3;KIZ;MAPRE3;CDC25B;MAP3K1;CEP250;CIR1;PRKACA;CLTC;GRB2;IBTK;PLCG2;LRRC14;UBQLN1;JAK2;EGFR;CDKN2D;CAV2;PPP1R15A;MSN;LRBA;PARK7;RAD23A;VRK1;PPP1CC;KAT2B;BECN1;ATF5;CRK;HNRNPA0;FAS;ADIPOR1;TRIM68;CDK5RAP3;PRAM1;SPRED2;RAC2;DGKD;ADD2;PRKAG2;LATS1;SKI;CASP9;TRIM5;PPP1R12A;GSK3B;LIMS1;CCNK;TP53;PDCD10
prerank,leucine zipper domain binding (GO:0043522),0.7418434711130499,1.4104545818212264,0.1111111111111111,0.7909233108810046,1.0,4/10,13.59%,PMF1;ERC1;PAWR;DDIT3
prerank,water transmembrane transporter activity (GO:0005372),0.73172112625932,1.4093954835613591,0.10653409090909091,0.783339582571035,1.0,1/11,1.86%,AQP1
prerank,Wnt-activated receptor activity (GO:0042813),-0.5107824798573048,-1.4087575002243138,0.07692307692307693,0.5754551234857105,1.0,13/15,47.17%,RYK;PKD1;FZD3;TSPAN12;FZD7;FZD4;FZD6;FZD2;FZD5;LRP5;FZD8;FZD1;FZD10
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.6410518975490257,1.4057209816136513,0.10788863109048724,0.7874692201358798,1.0,15/29,22.57%,CIT;CDKN2C;CDKN2A;CIB1;PKIG;CDKN2D;KAT2B;SPRED2;PRKAG2;HEXIM1;CDKN1A;PRKAR2A;YWHAG;PKIA;CDKN1B
prerank,GABA receptor activity (GO:0016917),-0.4527616563773895,-1.4031747870641524,0.0875,0.5679419048256475,1.0,9/21,14.65%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABBR1;GABBR2;GABRG1;GABRA1
prerank,hormone receptor binding (GO:0051427),0.7040144163855352,1.401283425104992,0.12552891396332863,0.7961264943864266,1.0,7/14,21.25%,NPPC;PTHLH;JAK2;SOCS2;ADCYAP1;NCOA6;TYK2
prerank,metallocarboxypeptidase activity (GO:0004181),0.6442060097366273,1.4007427918771076,0.11217183770883055,0.7855154442688586,1.0,7/26,16.34%,AGBL1;CPA6;CPM;AGTPBP1;VASH2;AGBL3;CPD
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.49048479765569075,-1.396085269682358,0.07983193277310924,0.5448690776312756,1.0,7/16,13.94%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V1A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.49048479765569075,-1.396085269682358,0.07983193277310924,0.5448690776312756,1.0,7/16,13.94%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V1A
prerank,anion:anion antiporter activity (GO:0015301),0.6845426746903083,1.3940378372710465,0.11989795918367346,0.8046910209017663,1.0,1/17,0.36%,SLC4A1
prerank,methyl-CpG binding (GO:0008327),0.6508081049621249,1.3940135772769664,0.10947109471094711,0.7919775874811292,1.0,7/22,12.72%,UHRF1;MBD3;MBD2;MBD1;LRWD1;MECP2;ZBTB33
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5935539149994956,1.3853493618473416,0.09701492537313433,0.8203413454639947,1.0,12/51,14.30%,SLC4A1;SLC5A5;SLC35E1;SLC25A16;SLCO4C1;SLC35D2;SLC35A1;SLCO4A1;SLC16A10;SLCO2A1;MCU;SLC35C2
prerank,carbohydrate kinase activity (GO:0019200),-0.546946471957672,-1.3809013531527086,0.13712374581939799,0.5688051574287436,1.0,9/11,28.67%,HK2;HK3;GALK2;NAGK;GNE;POMK;XYLB;GALK1;KHK
prerank,protein kinase binding (GO:0019901),0.5693839599595255,1.3796964084064915,0.001,0.8344810217500394,1.0,107/479,14.97%,TOP2A;KIF11;TPX2;PRC1;KIF14;CDC25C;FOXM1;CIT;FAM83D;RACGAP1;BORA;CKS2;CCNB1;CCNA2;KIF20A;PLK1;CDKN2C;CDK5RAP2;CNTLN;CHEK2;POLA1;CDC25A;EXOC2;ATG13;ARHGAP33;CEP152;AURKA;FBXO5;CCDC88A;OXSR1;EZR;PPM1D;USF1;RAD9A;TBL2;MAP2K6;AXIN1;NEDD9;CEP192;RPS19;GPRC5B;MAPKAPK3;TFRC;RPS7;BANK1;CAV1;CDKN2A;PPP1CB;FAF1;ATF7;TCF3;SLC12A7;RND3;KIZ;MAPRE3;CDC25B;PIN1;MAP3K1;MAP4K2;CEP250;CIR1;PRKACA;CLTC;GRB2;IBTK;PLCG2;STK38;PICK1;NELL2;JAK2;ITGAV;CDKN2D;CAV2;PRR7;PPP1R15A;MAP3K11;MSN;LRBA;VRK1;PPP1CC;KAT2B;BECN1;CRK;PRKCB;HNRNPA0;ADIPOR1;TRIM68;CDK5RAP3;PRAM1;NELL1;SPRED2;RACK1;RAC2;ADD2;PRKAG2;LATS1;SKI;CASP9;IRS1;TRIM5;PPP1R12A;GSK3B;PRKCSH;LIMS1;CCNK;TP53;PDCD10
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.716014296155858,1.3777224394422096,0.13247863247863248,0.8317239859467651,1.0,6/10,12.38%,EXO1;POLD1;FEN1;DCLRE1C;DCLRE1B;APEX1
prerank,protein phosphatase 1 binding (GO:0008157),0.6472458142000737,1.3773372176020406,0.13423645320197045,0.821000906169937,1.0,4/21,9.89%,PHACTR4;PPP1R9B;PPP1R11;PPP1R15A
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.42816886123203224,-1.3738009885705709,0.11242603550295859,0.5685881709436427,1.0,15/24,35.93%,GLUL;ZDHHC17;GOLGA7;ZDHHC8;YKT6;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;GOLGA7B;ZDHHC1
prerank,steroid hydroxylase activity (GO:0008395),0.6583892177086034,1.3671831940283397,0.14701986754966886,0.8587375852082301,1.0,4/16,12.06%,CYP1B1;CYP2A6;CYP27A1;CYP46A1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.6045541710755936,1.3656491367215529,0.13507377979568672,0.8539714930940612,1.0,14/34,19.33%,CKS2;CCNB1;INCENP;DBF4;CAB39L;MLST8;CCNT1;FAM20A;CCNK;STK4;MAP2K1;IQGAP1;TAOK1;STK3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7166392244685754,1.3642160050369405,0.1358695652173913,0.8483786482227351,1.0,1/11,1.86%,AQP1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.72726628170951,1.359509046340567,0.1370851370851371,0.8587529037933961,1.0,7/10,22.57%,CDKN2C;CDKN2A;CDKN2D;KAT2B;HEXIM1;CDKN1A;CDKN1B
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6323955725158433,1.3543878391965318,0.12515337423312883,0.8712834525964915,1.0,1/21,0.81%,CHRNB4
prerank,methylated histone binding (GO:0035064),0.5737508019635433,1.3534932795982924,0.08832807570977919,0.8637596453628428,1.0,24/62,18.34%,UHRF1;SPIN4;NCAPD3;MORC4;CBX5;SUZ12;MSH6;NCAPG2;TAF1;LRWD1;PHF19;TAF7;PHF1;PHF2;ZMYND8;ING3;ING2;ING5;RBBP5;ATRX;GLYR1;MBTD1;MORC3;DPF2
prerank,phospholipid transfer activity (GO:0120014),-0.43756726476701324,-1.349158672552848,0.1134020618556701,0.614543872565424,1.0,9/21,18.03%,OSBPL2;PLTP;PRELID2;MTTP;PITPNB;PLEKHA3;C2CD2L;PITPNM2;PRELID3A
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.6702557433603125,1.3490600374764776,0.15760869565217392,0.8733663099712531,1.0,3/13,10.13%,SLC38A5;SLC7A1;SLC3A1
prerank,neuropeptide receptor binding (GO:0071855),0.6694817354820761,1.348817390488193,0.1695364238410596,0.8627075342273988,1.0,4/14,19.55%,AGRP;NMU;APLN;PPY
prerank,potassium ion leak channel activity (GO:0022841),-0.5048996963975663,-1.3426028575821993,0.14285714285714285,0.6127391395402563,1.0,4/15,5.75%,KCNK13;TMEM175;KCNK6;KCNK10
prerank,ubiquitin-specific protease binding (GO:1990381),0.654621005030651,1.3418847291127893,0.1424968474148802,0.8836666077851766,1.0,12/19,17.81%,CLTC;SART3;DERL2;AMFR;PARK7;SUMO1;RAD23A;PTEN;SPATA2;RHBDD2;CHMP3;SYVN1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6706599516429966,1.3395890282523448,0.15691489361702127,0.8840446307898782,1.0,7/14,17.67%,USP27X;MINDY4;DESI2;USP15;OTUD5;YOD1;USP7
prerank,ubiquitin binding (GO:0043130),0.568129210587546,1.337080337565536,0.11157455683003129,0.8846650090490558,1.0,7/73,8.25%,TOP2A;CKS2;IKBKG;FAF1;NPLOC4;BIRC2;FAF2
prerank,deoxyribonuclease activity (GO:0004536),0.6599703672440281,1.334872609124181,0.16182572614107885,0.8831010646988299,1.0,5/14,12.38%,ERCC4;MBD4;ZRANB3;DNASE1L1;APEX1
prerank,histone methyltransferase activity (GO:0042054),0.5917240499892672,1.3342873684518313,0.14417531718569782,0.8748006245275359,1.0,8/32,11.79%,EZH2;MEN1;SUV39H1;SUZ12;KMT2C;EHMT1;FBL;NSD3
prerank,double-stranded DNA binding (GO:0003690),0.5510371853291528,1.3317847691586409,0.001,0.8756970735656189,1.0,117/531,19.59%,NEIL3;E2F7;RAD51AP1;RAD51;E2F8;E2F2;UHRF1;GFI1;FOXA2;VAX2;HMGB2;SPIB;MEN1;DMRTA1;NR4A2;HEY2;LEF1;E2F1;RAD51B;DDX11;BATF;ELK4;USF1;HMGB3;NUCKS1;ERG;BACH2;MSH6;RBBP8;FEN1;FOXP1;ETS2;CGAS;NR1D1;FOXJ3;ATF7;TERF2;ZBTB26;MBD1;TCF7L1;ZFP41;IRF9;RUNX3;MND1;KLF10;XRCC6;HMGB1;CAMTA2;AHR;MAX;ZNF638;TERF1;ZBTB7A;EGFR;FLI1;MECP2;KLF13;EGR1;ZBTB32;NR2C2;RFX2;CUX1;PARK7;NFE2;ATF6;JUN;DHX9;APEX1;TDP1;ZBTB33;KIN;SP3;ZBTB7B;PRKDC;HNRNPU;PSIP1;REXO4;BCL6;CEBPG;GABPA;APTX;POU6F1;CAMTA1;GMEB2;E2F3;RAD50;ELF1;JUNB;IRF8;HOXB4;TFAP4;TCF4;HIVEP1;ZNF23;RFX7;RFX4;ZNF445;NFATC3;XBP1;RXRB;TDG;POU2F2;RARG;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;SAFB;ZBTB20;RPS3;PAX2;SOX9;NPAS2;SREBF2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4294922734414002,-1.3314881784997907,0.08648648648648649,0.6216106267987418,1.0,6/22,8.63%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1
prerank,glutathione transferase activity (GO:0004364),-0.4158440478426168,-1.329196751451351,0.12258064516129032,0.6086668167519517,1.0,11/23,33.56%,HPGDS;LANCL1;ALOX5AP;GSTT2;GSTO1;GSTA3;MGST1;PTGES;GSTA4;LTC4S;GSTZ1
prerank,methylation-dependent protein binding (GO:0140034),0.5677766113297773,1.3270814638076656,0.11953041622198506,0.8857051101921133,1.0,21/57,18.07%,UHRF1;SPIN4;NCAPD3;MORC4;CBX5;SUZ12;MSH6;NCAPG2;LRWD1;PHF19;PHF1;PHF2;ZMYND8;ING3;ING2;ING5;RBBP5;ATRX;GLYR1;MBTD1;MORC3
prerank,transcription corepressor binding (GO:0001222),0.6160254067635861,1.3267493331320401,0.1336459554513482,0.8766356196688088,1.0,8/27,10.57%,EZH2;SUZ12;NR1D1;HDAC6;PHF1;ZBTB16;ZBTB7A;EHMT1
prerank,protein phosphatase 2A binding (GO:0051721),0.6031518237501151,1.3174902598688254,0.16409036860879905,0.9084724144298367,1.0,6/23,8.99%,MASTL;PTPA;ANKLE2;SMG5;FOXO1;STRN
prerank,C-C chemokine receptor activity (GO:0016493),0.62097814941702,1.3165307887340802,0.16728167281672818,0.9022010650719957,1.0,4/21,10.59%,CXCR5;CCR2;GPR75;CCR6
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3660723224339282,-1.3148445291217905,0.0851063829787234,0.6295349945078091,1.0,6/38,14.30%,APP;SPOCK1;SERPINE2;TFPI;SERPINI1;SERPINE1
prerank,transaminase activity (GO:0008483),-0.5216121518150381,-1.3140862543949325,0.17905405405405406,0.6137110730779161,1.0,3/11,25.17%,GOT2;AGXT;OAT
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6857752487785522,1.3105329116963615,0.1721194879089616,0.9192296588947612,1.0,2/10,2.18%,NAA40;BRCA2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3864813228893589,-1.3097913735044864,0.1079136690647482,0.6086272672511879,1.0,11/27,25.48%,RNF19B;ARIH1;RNF180;AUP1;UBE3D;PRKN;SIAH1;ANKIB1;DCUN1D2;SIAH3;RNF144B
prerank,LRR domain binding (GO:0030275),0.6716743187465221,1.3091735497879342,0.1885245901639344,0.9146897795537653,1.0,6/14,17.21%,PMF1;LRRFIP2;ERC1;PAWR;DDIT3;POLR2J
prerank,transmitter-gated ion channel activity (GO:0022824),-0.37337509798525326,-1.305827300302769,0.09848484848484848,0.6027953192466947,1.0,10/29,14.65%,GABRB3;GABRG2;GRIA4;GABRG3;GABRA2;GABRA3;GLRA2;GRIK2;GABRG1;GABRA1
prerank,SH3 domain binding (GO:0017124),-0.31728481810360704,-1.3046701456105219,0.030303030303030304,0.5894051691037379,1.0,26/62,24.33%,DNM2;SYNJ1;EVL;SYNJ2;ADAM15;RUFY2;VASP;ABI1;LANCL1;AFAP1;WIPF1;PRKN;SOCS7;NCF1;ADAM9;ABI2;SHANK3;SKAP1;GPX1;DAB2IP;ENAH;AFAP1L2;DPYSL3;CNTNAP1;ZNF106;AKAP5
prerank,3'-5' exonuclease activity (GO:0008408),0.5700695036407363,1.303105130271856,0.15334773218142547,0.9323383894414934,1.0,20/45,20.79%,ERI2;RAD1;RAD9A;POLD1;PDE12;EXOSC10;PNLDC1;ERI1;APEX1;REXO4;RAD50;ANGEL2;CNOT6;ERI3;DIS3L;TATDN1;CNOT8;PNPT1;WRN;CNOT7
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.515196503629321,-1.3004436652924394,0.17228464419475656,0.5859380228900342,1.0,6/11,34.26%,AKR1B1;AKR1B10;RDH13;AKR1A1;DHRS13;RDH14
prerank,protein heterodimerization activity (GO:0046982),0.5396825686752852,1.2972264492029353,0.04904904904904905,0.9492432788591213,1.0,37/178,15.45%,TOP2A;IL12A;BARD1;NR4A2;RCC1;AURKA;LSM6;ERBB3;SAE1;USF1;PSMF1;EXT1;TAF1;IKBKG;UBA2;YWHAH;TCF3;PEF1;TAF7;AHR;BOK;GTF2A1;PAFAH1B1;TCOF1;ATF6;LSM5;VAPA;FXR1;DGKD;ADD2;DDIT3;MICU1;TPM4;TLR6;TP53;GCA;CYBB
prerank,FMN binding (GO:0010181),-0.5288319881920329,-1.2962191922101605,0.16906474820143885,0.5816980121812463,1.0,6/11,33.38%,POR;DUS2;MTRR;PPCDC;NDOR1;NOS1
prerank,syntaxin-1 binding (GO:0017075),-0.41877814102273153,-1.294307890239412,0.12432432432432433,0.5713938238371741,1.0,9/22,25.62%,NSF;SYT1;VAMP2;UNC13A;STXBP5;STXBP1;CPLX1;CPLX2;SNAP25
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.5623485506201239,1.2906879372334201,0.11647429171038824,0.9703909863961451,1.0,21/60,20.15%,CDKN3;PHLPP2;PPM1D;PPP3CA;LRRC40;PPP1CB;CTDSPL2;CTDSPL;TAB1;PPP2CB;PPP1CC;MTMR6;PTEN;LRRK1;PPP6C;LRRK2;PPP1CA;ILKAP;PPM1B;PPP2CA;RPAP2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6498847785841069,1.2900372948243857,0.202113606340819,0.9625153103748729,1.0,3/13,4.82%,GPSM2;CCDC88A;ARHGDIB
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.48138381364977717,-1.2883559053753069,0.1415929203539823,0.5725496476617553,1.0,10/15,51.88%,PLA2G4E;PLA2G12A;PLA2G4A;PLA2G3;PLA2G4C;PLA2G5;PLA2G4F;PLA2G2D;PLA2G4B;PLA2G10
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5888226089212831,1.2881417761054255,0.18577981651376146,0.960621259088657,1.0,7/29,14.54%,SLC25A21;SLC25A12;SLC1A5;ABCC2;SLC19A1;SLC25A22;SLC25A13
prerank,retinoic acid receptor binding (GO:0042974),0.6258969586373483,1.2864199648665506,0.17894736842105263,0.9580632893405477,1.0,10/17,23.06%,NR4A2;HMGA1;ASXL1;ACTN4;CNOT1;RARG;MED1;NCOA6;NRIP1;NSD1
prerank,death receptor binding (GO:0005123),0.6442474221640926,1.2858968069097843,0.19590268886043533,0.9504406388518728,1.0,2/15,4.16%,NTF4;PIDD1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.6706543137661772,1.2839945860739619,0.20027624309392264,0.9493838994552204,1.0,4/11,15.19%,NAA40;NAA16;NAA25;NAA20
prerank,amino acid:sodium symporter activity (GO:0005283),0.6568237680794099,1.2745684386389122,0.22116689280868385,0.9828805224344618,1.0,1/11,0.70%,SLC6A12
prerank,lipase activity (GO:0016298),-0.34544751521964717,-1.2695235213198532,0.10666666666666667,0.6054301959801576,1.0,13/43,19.23%,LIPA;MGLL;PLA2G15;DAGLB;LPL;ABHD12;ABHD16A;ABHD6;PLBD2;ABHD3;LIPH;SEC23IP;ABHD15
prerank,protein phosphatase binding (GO:0019903),0.5217972932550154,1.263095686936089,0.10663983903420524,1.0,1.0,23/117,9.89%,NEK2;MASTL;RPA2;ITGA1;PHACTR4;PPP1R9B;PTPA;ANKLE2;STX17;SMG5;PPP1R11;CDC27;SNX3;KCNN4;FOXO1;ANK1;TRAF3;ANAPC7;MAP3K5;MAPK14;STRN;EGFR;PPP1R15A
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5918572354681729,1.2613475356360835,0.20023837902264602,1.0,1.0,9/27,13.77%,PRIM1;POLR1B;POLR2I;POLR2A;PRIMPOL;POLR1A;POLR1F;POLR1D;POLR1C
prerank,ATP binding (GO:0005524),0.5244103985544347,1.2612668778229186,0.024,1.0,1.0,55/266,13.62%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;STK26;TRIP13;BLM;SMARCA5;OXSR1;DAPK2;PTPA;LIG4;MCM6;HASPIN;RRM1;RPS6KA5;MSH6;MAP4K1;STK11;ABCD1;CDK6;TLK1;SIK2;UBA2;RUNX3;STK38L;EIF4A3;MAP3K5;CARS2;RTEL1;AKT3;MAP4K2;TAP1;STK38;MARK2;MYH10;MAST2;ABCA2;P2RY1;PIM1;LONP1;MAP4K5;ATP7A;BTK;ABCF2;DHX9;OLA1;BMPR1A;LMTK2;HNRNPU;PRKAG2;LATS1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.43842553799088346,-1.2601452493816934,0.15789473684210525,0.6154001192569561,1.0,5/18,13.05%,AKR1B1;ALDH6A1;ALDH1A1;AKR1B10;ALDH18A1
prerank,aminopeptidase activity (GO:0004177),-0.37363778884472776,-1.2599963070056295,0.13157894736842105,0.6021596055596458,1.0,7/26,8.10%,XPNPEP3;XPNPEP1;LAP3;METAP1D;NPEPPS;MMP14;ANPEP
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.599221909823334,1.257601662028705,0.22972972972972974,1.0,1.0,3/21,5.10%,CDK1;CDKL1;CDK6
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.599221909823334,1.257601662028705,0.22972972972972974,1.0,1.0,3/21,5.10%,CDK1;CDKL1;CDK6
prerank,GDP binding (GO:0019003),-0.31713267450498495,-1.2570792663792127,0.06976744186046512,0.5965878833556918,1.0,20/63,15.22%,RAP1B;RAB14;RALA;RAB28;DYNC1LI1;RAP2A;RRAGD;RAP2B;GNAI3;KRAS;NRAS;RIT1;RAP1A;MIEF1;RAP2C;RAB31;RERG;RAB12;RRAGC;MRAS
prerank,tropomyosin binding (GO:0005523),0.6098083385193735,1.2551162924003718,0.23067010309278352,1.0,1.0,1/16,0.80%,TMOD4
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5171380011691841,-1.2509148861755774,0.21212121212121213,0.5985286808966331,1.0,3/10,13.29%,CACNB2;CACNA1C;CACNB4
prerank,alanine transmembrane transporter activity (GO:0022858),0.6387982158745366,1.2498892266923025,0.2321187584345479,1.0,1.0,1/12,0.87%,SLC38A5
prerank,disordered domain specific binding (GO:0097718),0.5733371509865518,1.246811766342699,0.20334928229665072,1.0,1.0,14/23,23.07%,RB1;FYN;CLTC;KCNA1;NUMA1;TP53;FKBP8;FN1;PPIL1;SMAD2;MDM2;GAPDH;CALM3;NCOA3
prerank,endonuclease activity (GO:0004519),0.5361164774234224,1.2463713763990398,0.1855447680690399,1.0,1.0,8/49,7.26%,ANKLE1;SLFN14;ERCC4;SMG6;FEN1;MBD4;YBEY;ZRANB3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3607492095745496,-1.2463170511448434,0.17829457364341086,0.5983765310220199,1.0,13/30,22.56%,SLC39A11;TMEM165;SLC11A2;SLC30A4;SLC39A7;TTYH1;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5580917387331078,1.2461376389152343,0.20909090909090908,1.0,1.0,16/35,19.94%,FOXP1;TAF1;KLF10;H3-3A;SMARCA4;GTF2A1;SNAPC3;RUVBL2;PARK7;MYC;TP53;POU2F1;TAF1C;HDAC1;AGO2;MMP12
prerank,mRNA 5'-UTR binding (GO:0048027),0.5728120894893597,1.245073351021867,0.23104693140794225,1.0,1.0,7/24,11.89%,RPS7;UTP23;RPL41;RPS14;MYH10;IGF2BP3;CCT5
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6455258866890866,1.2432472346049341,0.2451523545706371,1.0,1.0,4/11,16.43%,LEF1;MBD2;SRRM2;TAF9
prerank,retinoid X receptor binding (GO:0046965),0.6428362878575697,1.2414739964876436,0.2471264367816092,1.0,1.0,2/11,1.94%,NR4A2;HMGA1
prerank,lysine-acetylated histone binding (GO:0070577),0.5868758788600361,1.2411168269387576,0.2371638141809291,0.9921218622519825,1.0,11/20,20.04%,BRD9;TAF1;BRD4;SMARCA4;YEATS4;ZMYND8;KMT2A;PSME4;DPF2;BRD7;BRD3
prerank,acetylation-dependent protein binding (GO:0140033),0.5868758788600361,1.2411168269387576,0.2371638141809291,0.9921218622519825,1.0,11/20,20.04%,BRD9;TAF1;BRD4;SMARCA4;YEATS4;ZMYND8;KMT2A;PSME4;DPF2;BRD7;BRD3
prerank,transcription cis-regulatory region binding (GO:0000976),0.5129420890222245,1.2371866841164363,0.019,1.0,1.0,100/406,19.61%,E2F7;E2F8;FOXM1;E2F2;UHRF1;GFI1;FOXA2;HMGB2;MEN1;SUV39H1;BRCA1;CDK5RAP2;HMGA1;SOX6;DEAF1;LEF1;E2F1;RB1;TWIST1;CTCF;RBL1;FOXP1;DACH1;NR1D1;NFXL1;HNRNPL;E2F6;TCF3;SETX;ARID4A;ZFP41;RUNX3;TFDP1;KLF10;TAF7;XRCC6;HMGB1;AHR;MAX;PSPC1;DMTF1;GABPB1;GABPB2;ETV6;SNAPC3;FLI1;NONO;LONP1;EGR1;TFDP2;SALL2;NR2C2;CUX1;NFYC;MXI1;ARID5B;PARK7;NFE2;SMAD4;ATF6;JUN;ATF5;ZNF25;SATB2;SP3;NFE2L2;ZBTB7B;ACTN4;DDIT3;TAF2;MYC;NFX1;GABPA;RBBP5;PBX2;E2F3;TP53;RUNX1;PLAGL1;TFAP4;TCF7L2;PURG;FOXK2;TAF9;XBP1;RXRB;MLXIP;ZBED4;SNCA;POU2F2;HDAC4;BRD7;PROX1;HDAC1;ZBTB20;RPS3;TBL1XR1;PAX2;SOX9;AGO2
prerank,transcription coregulator binding (GO:0001221),0.5398907104267077,1.2365222210645392,0.1849096705632306,0.9954398001150142,1.0,13/50,11.11%,CIT;EZH2;SUZ12;UBE2I;CTCF;NR1D1;HDAC6;AHR;PHF1;ZBTB16;ZBTB7A;EHMT1;SMAD4
prerank,GABA-A receptor activity (GO:0004890),-0.41484912867952695,-1.2356664234311154,0.185,0.6112020204641658,1.0,7/18,14.65%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,adenyl ribonucleotide binding (GO:0032559),0.513255164757813,1.2335670849239992,0.031,0.999773315473638,1.0,79/291,19.33%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;STK26;TRIP13;BLM;SMARCA5;OXSR1;DAPK2;PTPA;LIG4;MCM6;HASPIN;RRM1;RPS6KA5;MSH6;MAP4K1;STK11;ABCD1;CDK6;PDE4A;TLK1;SIK2;UBA2;RUNX3;PDE2A;STK38L;EIF4A3;MAP3K5;CARS2;RTEL1;AKT3;MAP4K2;TAP1;STK38;MARK2;MYH10;MAST2;ABCA2;P2RY1;PIM1;LONP1;MAP4K5;ATP7A;BTK;SLC19A1;ABCF2;DHX9;OLA1;BMPR1A;LMTK2;HNRNPU;PRKAG2;LATS1;STK4;MAP3K20;ATP5F1D;PDXK;MARK4;CNBD2;SRPK1;AK6;TRNT1;PGK1;CLP1;TDG;TAOK1;STK17B;YARS2;ABCD4;N4BP2;NIM1K;MTHFD1L;KSR1;STK3
prerank,mRNA 3'-UTR binding (GO:0003730),0.5181010718685087,1.232663189103271,0.18078512396694216,0.9949546008416404,1.0,31/79,18.99%,RPS7;HNRNPC;BOLL;EXOSC8;ZFP36L1;PUM2;ELAVL4;UTP23;HNRNPA2B1;RPL41;AUH;RNPS1;CPEB3;RBMS2;PUM1;IGF2BP3;HNRNPA0;CCT5;FXR1;HNRNPU;DAZAP1;RNF20;TP53;RC3H1;ANGEL2;ZFP36L2;TUT1;LARP4B;CPSF1;ELAVL1;RPL5
prerank,histone acetyltransferase activity (GO:0004402),0.5610642116916594,1.2315057371172746,0.2213209733487833,0.991421473088735,1.0,12/30,16.60%,NAA40;BRCA2;EPC1;TAF1;KAT6A;KAT2B;HAT1;CREBBP;TADA2A;TADA3;TAF9;BAZ1A
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.6371560190222276,1.2270848074024316,0.2597402597402597,1.0,1.0,6/10,22.68%,SUV39H1;EHMT1;SETDB2;ASH1L;SETDB1;SETD5
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5724546595218152,1.2257838714241058,0.2675544794188862,0.9986965566888103,1.0,2/22,7.28%,CDKN3;MTMR2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.4797435610751273,-1.225603425927061,0.1986062717770035,0.6240104410682015,1.0,9/12,28.37%,SLC25A25;SLC17A9;LRRC8A;SLC25A24;SLC35B2;SLC25A17;SLC25A5;SLC25A42;SLC25A23
prerank,calcium-release channel activity (GO:0015278),-0.4136073003735611,-1.2243933568844776,0.21171171171171171,0.6147690720756545,1.0,7/17,16.43%,ITPR2;TPCN2;MCOLN1;RYR2;MCOLN3;TPCN1;ITPR3
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.31158802978894096,-1.2241609237607725,0.1323529411764706,0.6035238605180376,1.0,30/53,35.25%,KDM1A;ACOX3;POR;SQOR;ACADL;MICAL3;DPYD;MTHFR;MTO1;MICAL2;MTRR;NOX4;ILVBL;CYB5R3;CRY1;SDHA;SQLE;NQO2;GCDH;GFER;NDOR1;AIFM2;KDM1B;DDO;AOX1;FOXRED2;NOS1;ACADVL;CRY2;GSR
prerank,U6 snRNA binding (GO:0017070),0.6122721299376938,1.223963778564416,0.2523364485981308,0.9978486487968091,1.0,10/14,24.71%,SART3;LSM2;METTL16;PRPF4;LSM7;TUT1;DDX39B;PRPF8;LSM3;RBM22
prerank,active ion transmembrane transporter activity (GO:0022853),0.5420477636791312,1.2236464321881118,0.22433035714285715,0.9909765191178804,1.0,12/37,22.62%,SLC4A1;SLCO4C1;SLCO4A1;COX10;COX4I1;SLCO2A1;NDUFA4;SLC22A4;UQCRH;SLCO3A1;SLCO5A1;ATP13A3
prerank,single-stranded RNA binding (GO:0003727),0.537078611662893,1.2236337569249167,0.24347826086956523,0.9828485266524704,1.0,16/43,22.17%,DDX11;EIF4B;DHX58;SNRPC;EXOSC10;LONP1;DHX9;RBM7;FXR1;HNRNPU;LACTB2;HNRNPA1;AGO2;ZFR;ENDOV;AGO1
prerank,protein phosphatase activator activity (GO:0072542),0.6189911244160684,1.2220774882827732,0.26822558459422285,0.9812919279610159,1.0,5/13,9.89%,PHACTR4;PTPA;PPP2R5E;PPP2R5A;PPP1R15A
prerank,serine-type endopeptidase activity (GO:0004252),0.5101271192086108,1.2194884080355424,0.20307692307692307,0.9837945812053243,1.0,4/80,3.02%,PRTN3;TMPRSS4;TMPRSS3;FAP
prerank,peptidoglycan binding (GO:0042834),0.6381216149007276,1.2183977245828244,0.2814710042432815,0.9803076034769745,1.0,1/10,1.50%,PGLYRP1
prerank,anion transmembrane transporter activity (GO:0008509),0.6357328560800553,1.2141341711869835,0.2742782152230971,0.989743259512277,1.0,3/12,11.20%,SLC4A1;ABCC2;SLC19A1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.6236553246608519,1.2097706095855023,0.2781065088757396,1.0,1.0,4/10,16.21%,USP27X;DESI2;OTUD5;YOD1
prerank,cation:chloride symporter activity (GO:0015377),0.6380321646701418,1.2087219291093245,0.2714285714285714,0.9967429876904159,1.0,4/10,12.57%,SLC12A3;SLC12A7;SLC12A1;SLC12A6
prerank,cGMP binding (GO:0030553),0.6395831053807866,1.203497285084076,0.28254847645429365,1.0,1.0,2/11,12.26%,PDE2A;PDE5A
prerank,metalloaminopeptidase activity (GO:0070006),-0.41926558655142,-1.2013479308143493,0.18274111675126903,0.6478879820375236,1.0,5/16,8.10%,XPNPEP3;XPNPEP1;NPEPPS;MMP14;ANPEP
prerank,chemoattractant activity (GO:0042056),0.548530830023332,1.1974755973484574,0.26635514018691586,1.0,1.0,3/26,7.33%,HMGB2;PGF;HMGB1
prerank,5'-3' exonuclease activity (GO:0008409),0.609021640382972,1.197093837836871,0.2808683853459973,1.0,1.0,6/14,13.35%,EXO1;FEN1;DCLRE1C;DCLRE1B;DCP2;DXO
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.62549042243825,1.1969593827839204,0.2847124824684432,1.0,1.0,4/11,10.45%,PRPF19;UBE2K;UBE4B;AMFR
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.6089013338856393,1.1956603449241716,0.2773224043715847,1.0,1.0,4/13,9.82%,AGPAT1;AGPAT4;GPAT3;AGPAT3
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.49352383078487705,1.19517235359486,0.028,1.0,1.0,128/597,19.59%,E2F7;E2F8;KIF2C;E2F2;MCM10;GFI1;FOXA2;VAX2;HMGB2;SPIB;MEN1;SUV39H1;CDC45;BRCA1;CDK5RAP2;DMRTA1;NR4A2;SOX6;POLA1;HEY2;LEF1;E2F1;DDX11;BATF;ELK4;MCM6;USF1;ORC5;ERG;BACH2;MCM9;CTCF;FOXP1;ETS2;ORC3;NR1D1;MBD4;MBD2;HNRNPL;FOXJ3;ATF7;ZBTB26;TCF7L1;ARID4A;ZFP41;IRF9;RUNX3;KLF10;TAF7;XRCC6;HMGB1;AHR;MAX;PSPC1;DMTF1;GABPB1;GABPB2;ZW10;ZBTB7A;FLI1;NONO;KLF13;EGR1;ZBTB32;NR2C2;RFX2;CUX1;NFYC;ARID5B;NFE2;SMAD4;ATF6;JUN;DHX9;ATF5;ZBTB33;SP3;NFE2L2;ZBTB7B;HNRNPU;DDIT3;TAF2;BCL6;CEBPG;GABPA;POU6F1;RBBP5;GMEB2;E2F3;ELF1;TP53;RUNX1;JUNB;IRF8;HOXB4;TFAP4;TCF7L2;TCF4;HIVEP1;ZNF23;FOXK2;RFX7;RFX4;MCM3;TAF9;NFATC3;XBP1;RXRB;ZBED4;SNCA;POU2F2;HDAC4;RARG;FOXE1;CREB1;ZNF740;RFX1;GMEB1;BRD7;NKX2-8;PROX1;ZBTB20;TBL1XR1;PAX2;SOX9;CENPC;NPAS2;SREBF2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6136069033309435,1.1951640527029033,0.28591160220994477,0.9996643520017852,1.0,6/11,21.16%,TCF3;MAP4K2;STK38;MAP3K11;TRAF6;SASH1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.525480358096212,1.1950056986346604,0.25934314835787087,0.9929320927165093,1.0,3/34,1.48%,EZH2;MEN1;SUV39H1
prerank,chloride channel inhibitor activity (GO:0019869),-0.5130467352019233,-1.191777761759823,0.29,0.6600108575210644,1.0,5/10,29.02%,VTI1B;VAMP8;STX1A;WNK2;CFTR
prerank,nuclease activity (GO:0004518),0.5159111109722215,1.1916600526214383,0.22826086956521738,0.9991781801053707,1.0,12/52,15.03%,ANKLE1;RNASE6;EXO1;STK31;FEN1;PDE12;DNA2;DNASE1L1;APEX1;RNASE12;REXO4;RNASEH2A
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.49345000953476326,1.1872558481460822,0.162,1.0,1.0,51/188,19.42%,GFI1;FOXA2;HMGB2;MEN1;SUV39H1;BRCA1;CDK5RAP2;SOX6;CTCF;NR1D1;HNRNPL;LIN54;ARID4A;TAF7;XRCC6;HMGB1;AHR;PSPC1;DMTF1;GABPB1;GABPB2;FLI1;NONO;EGR1;NFYC;ARID5B;SMAD4;ATF6;JUN;DHX9;ATF5;NFE2L2;DDIT3;TAF2;GABPA;RBBP5;TP53;RUNX1;TFAP4;TCF7L2;FOXK2;TAF9;ZBED4;SNCA;POU2F2;HDAC4;BRD7;PROX1;ZBTB20;TBL1XR1;PAX2
prerank,sodium channel regulator activity (GO:0017080),0.5147642705482544,1.187017424386698,0.24743443557582667,1.0,1.0,7/37,14.50%,TMPRSS3;GPD1L;YWHAH;FXYD5;NEDD4L;FGF13;SGK3
prerank,chloride channel activity (GO:0005254),-0.29163068774772294,-1.1863519687380752,0.23529411764705882,0.6619162645800756,1.0,13/59,14.65%,TTYH2;GABRB3;PACC1;CLCN7;GABRG2;GABRG3;GABRA2;GABRA3;CLCN4;GLRA2;GABRG1;TTYH1;GABRA1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.5362402249849236,1.1851925635941154,0.2828282828282828,1.0,1.0,14/33,20.79%,ERI2;PDE12;EXOSC10;DCP2;PNLDC1;ERI1;ANGEL2;CNOT6;ERI3;DIS3L;XRN1;CNOT8;PNPT1;CNOT7
prerank,exonuclease activity (GO:0004527),0.5172058352179497,1.1835979340291563,0.2597826086956522,1.0,1.0,15/46,15.89%,RAD1;EXO1;RAD9A;FEN1;EXOSC8;DCLRE1C;PDE12;DCLRE1B;EXOSC10;ERI1;APEX1;DXO;REXO4;RAD50;CNOT6
prerank,nuclear localization sequence binding (GO:0008139),0.5714994008189846,1.181540911929548,0.2728442728442728,1.0,1.0,9/18,22.69%,POM121;TNPO1;KPNA3;NUP214;RANBP6;IPO5;KPNB1;TNPO2;KPNA4
prerank,3'-5' DNA helicase activity (GO:0043138),0.5690493457545873,1.1809259937226786,0.2877604166666667,0.9992192882073355,1.0,6/16,14.23%,BLM;MCM6;HELQ;ERCC3;DHX9;FANCM
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5205531073672318,1.180264938941394,0.25054945054945055,0.9950075437623384,1.0,12/44,14.99%,EZH2;MEN1;SUV39H1;NSD2;KMT2C;EHMT1;KMT5C;NSD3;SETDB2;KMT2A;RBBP5;KMT2B
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3854217221658245,-1.1793796478216116,0.21875,0.667552492183541,1.0,8/19,18.35%,GABRG2;GABRG3;GABRA2;GABRA3;GRIK2;GABRG1;GABRA1;GRIK4
prerank,O-acyltransferase activity (GO:0008374),0.5326550514347507,1.1792535612153188,0.27314814814814814,0.992031020572992,1.0,4/30,7.38%,LRAT;GPAT3;MBOAT2;MOGAT2
prerank,nuclear import signal receptor activity (GO:0061608),0.579949768047901,1.1775674589106058,0.2987012987012987,0.9919363714564591,1.0,8/15,22.69%,TNPO1;KPNA3;RANBP6;IPO5;KPNB1;TNPO2;TNPO3;KPNA4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5440060283222705,1.173955671948253,0.2780373831775701,0.9994671055684701,1.0,3/26,7.50%,SLC6A12;SLC16A12;SLC16A1
prerank,rRNA binding (GO:0019843),0.5140266109867742,1.1721585740232214,0.2835164835164835,0.999565163999917,1.0,17/42,21.14%,FASTKD5;MRPL18;MRPL16;UTP23;RPS14;EMG1;MRPS7;RPS5;RPLP0;ERI1;RPS9;RPL12;RPL5;RPS3;PTCD3;RPL23;MDM2
prerank,pre-mRNA binding (GO:0036002),0.5338685009191255,1.166894685048264,0.2972972972972973,1.0,1.0,12/28,18.59%,SLBP;SNRPC;HNRNPL;U2AF1;RNPC3;U2AF1L4;ERI1;RBM7;HNRNPU;TARBP2;PRPF8;HNRNPA1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4026886059463009,-1.1667259875608829,0.23,0.687439014509703,1.0,7/17,20.16%,ABCA1;ATP8B1;PLTP;MTTP;PITPNB;PITPNM2;ATP10B
prerank,ligand-gated anion channel activity (GO:0099095),-0.408999237450972,-1.1662254947314457,0.24413145539906103,0.6768017420243763,1.0,8/17,14.65%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GLRA2;GABRG1;GABRA1
prerank,CoA hydrolase activity (GO:0016289),0.5573668026267259,1.166053246225704,0.2992021276595745,1.0,1.0,4/16,8.72%,ABCD1;ACOT11;ACOT13;ACOT2
prerank,C-C chemokine binding (GO:0019957),0.5470925505665201,1.1657966431528322,0.3151515151515151,1.0,1.0,3/22,10.59%,CXCR5;CCR2;CCR6
prerank,nuclear export signal receptor activity (GO:0005049),0.6006980584812192,1.1644449787792062,0.3127690100430416,1.0,1.0,5/11,18.62%,XPO1;NUP42;NUP214;XPO4;EIF4ENIF1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5282484493763361,1.164368550968188,0.29767441860465116,0.9965685453300286,1.0,4/27,3.00%,SLC12A3;AQP1;MAGT1;ITPR1
prerank,protein serine/threonine kinase activity (GO:0004674),0.4805361610712348,1.161393040823603,0.1,1.0,1.0,86/334,16.36%,TTK;CDK1;AURKB;CIT;PBK;NEK2;MASTL;PLK1;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;SLK;PRKCE;RPS6KA5;MAP4K1;STK11;MAPKAPK3;CHEK1;CDK6;GRK6;TLK1;TAF1;SIK2;ATM;PRKD3;CSNK1A1;STK38L;MAP3K5;BRD4;PIM2;PKN2;AKT3;CSNK1G2;PIM3;MAP3K1;MAP4K2;PRKCA;PRKACA;MAPK14;STK38;MARK2;MAST2;CLK4;STK24;EGFR;PIM1;PDPK1;MAP4K5;RIOK3;CDK19;HIPK2;MAP3K11;TESK2;MELK;DYRK1A;VRK1;PRKCB;RPS6KA6;BMPR1A;LMTK2;PDIK1L;ROCK2;GRK2;PRKDC;LATS1;CDK16;STK39;NRBP1;FAM20A;HTATIP2;CDC7;SGK3;GSK3B;CCNK;STK4;MAP3K20;BCR;PAK5;MAP2K1;MARK4;PAK2;LIMK2;CDK8
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4340562986538239,-1.160824080364883,0.2788844621513944,0.6792888185053301,1.0,7/13,14.65%,GABRG2;GABRG3;GABRA2;GABRA3;GLRA2;GABRG1;GABRA1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.47157593424290845,-1.1607487245548895,0.26239067055393583,0.6681196037748477,1.0,5/10,16.35%,SLC24A3;SLC8A3;SLC8B1;SLC3A2;SLC8A1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5765076459663626,1.1602507946626348,0.32545931758530183,0.9995472162297484,1.0,4/15,9.82%,AGPAT1;AGPAT4;GPAT3;AGPAT3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.501918669293671,1.1573374403124879,0.2913553895410886,1.0,1.0,7/55,11.20%,SLC6A12;SLC38A5;SLC7A1;SLC16A12;SLC16A1;SLC3A1;SLC19A1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5924877877431431,1.1556297682986898,0.3241106719367589,1.0,1.0,6/12,19.03%,TAF1;H3-3A;GTF2A1;RUVBL2;POU2F1;HDAC1
prerank,chemokine receptor activity (GO:0004950),0.5394313397528064,1.1554311439394052,0.31100478468899523,0.9993440896581032,1.0,6/24,17.70%,CXCR5;CCR2;GPR75;CCR6;GPR35;CXCR4
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5860495614116272,1.1538838108464329,0.3310344827586207,0.9986480505329697,1.0,4/12,17.56%,NAPSA;CTSE;PSEN1;SPPL3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.4641331344114205,-1.153843962071786,0.26621160409556316,0.6737270422130325,1.0,8/11,28.37%,SLC25A25;SLC17A9;LRRC8A;SLC25A24;SLC35B2;SLC25A17;SLC25A42;SLC25A23
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.44919649988191057,-1.1538182010772087,0.3023255813953488,0.6629236286382352,1.0,7/12,14.65%,GABRB3;GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,hexose transmembrane transporter activity (GO:0015149),0.6004988059584052,1.1523198689561847,0.3283173734610123,0.9981079645494113,1.0,4/12,18.63%,SLC2A4;SLC2A8;SLC2A3;SLC2A1
prerank,cAMP binding (GO:0030552),0.605894337233581,1.1521576597149932,0.3129251700680272,0.9924549015524821,1.0,3/11,16.72%,PDE4A;PDE2A;CNBD2
prerank,cytokine receptor activity (GO:0004896),0.4861237164807241,1.1516264272734713,0.25846153846153846,0.9883548306850418,1.0,16/83,12.56%,IL2RG;IL2RA;IL7R;IL18RAP;CD74;CD44;CCR2;GFRA2;IL21R;IL20RA;IL17RA;CCR6;IL1R1;IL10RA;FLT3;F3
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.2870003036793879,-1.1503088908076677,0.2037037037037037,0.6599832356475152,1.0,21/55,24.48%,ITPR2;SLC24A3;CACNB2;TRPC5;CUL5;ATP2B2;TRPC1;TMEM165;RYR2;PKD1;SEC61A1;ATP2B3;TRPV4;TRPC3;ORAI1;ANXA2;PKD2L1;PKD1L2;ANXA6;PKD2L2;ANXA9
prerank,1-phosphatidylinositol binding (GO:0005545),-0.4137729779546089,-1.1497684568732387,0.2964426877470356,0.6508945602703969,1.0,6/15,10.86%,WDFY3;SNAP91;EEA1;ZFYVE9;ZFYVE1;SCARB1
prerank,transforming growth factor beta binding (GO:0050431),-0.3644923347806427,-1.1497187558963302,0.281437125748503,0.641081587577806,1.0,9/23,18.44%,ACVR1;TGFBR1;LTBP1;ENG;TGFBR3;ACVRL1;CD36;TGFBR2;THBS1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.507781817245056,1.148926745127942,0.3099352051835853,0.9922340037959584,1.0,6/48,7.88%,RHAG;P2RX1;AQP1;RHD;SLC12A7;TRPM7
prerank,chemokine binding (GO:0019956),0.5182383510949697,1.1476576739136257,0.315668202764977,0.9908448031569234,1.0,5/30,10.59%,CXCR5;CCR2;HMGB1;ITGAV;CCR6
prerank,MHC class II protein complex binding (GO:0023026),0.599297453703268,1.1437614904226932,0.3435672514619883,0.9992738798802511,1.0,2/11,3.69%,MS4A1;CD74
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5881669687612774,1.1405728740895862,0.3252840909090909,1.0,1.0,3/12,6.74%,PDE7B;PDE4A;PDE2A
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.4728930070448091,1.1404729138834309,0.104,0.9991058601233054,1.0,112/431,19.33%,KIF14;KIFC1;SMC4;RAD51;PIF1;EPB42;PLK1;RRAD;ARHGEF5;STK26;TRIP13;BLM;SMARCA5;GBP4;OXSR1;DAPK2;TUBA1C;PTPA;LIG4;MCM6;HASPIN;NOA1;ATL2;RRM1;RPS6KA5;ARL5C;MSH6;MAP4K1;TUBB4B;STK11;ABCD1;CDK6;REM1;TLK1;SIK2;ARL11;UBA2;RAB1B;RAB22A;TUBA1B;ARF4;RUNX3;RND3;GBP2;STK38L;EIF4A3;MAP3K5;CARS2;RTEL1;AKT3;GNAI1;MAP4K2;RAB8A;TAP1;STK38;MARK2;MTG2;MYH10;MAST2;ABCA2;SEPHS1;P2RY1;PIM1;LONP1;MAP4K5;RABL6;RIT2;RHOU;ATP7A;BTK;ABCF2;TUBB;DHX9;ARF3;OLA1;BMPR1A;RAB11B;LMTK2;RAC2;HNRNPU;PRKAG2;LATS1;RAB35;RAB2A;TUBD1;STK4;MAP3K20;ATP5F1D;ARL4C;PDXK;MARK4;RAB5A;MMAA;RAC1;SRPK1;AK6;TRNT1;PGK1;CLP1;TDG;LRRK2;DRG1;TAOK1;STK17B;RAB6A;YARS2;ABCD4;N4BP2;NIM1K;MTHFD1L;KSR1;STK3
prerank,RNA polymerase binding (GO:0070063),0.5592981963575229,1.1387998883297863,0.32697201017811706,0.9996708363936795,1.0,7/18,17.07%,BRCA1;ANP32B;PKN2;DHX9;CCNT1;TCERG1;SCAF8
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.28518011263014115,-1.1379341002909604,0.17391304347826086,0.6593297272301355,1.0,13/85,7.77%,LIPA;MGLL;PLA2G15;DAGLB;NDST3;LPL;ABHD12;PLA2G7;ENPP2;GDE1;ABHD16A;ABHD6;CA2
prerank,copper ion binding (GO:0005507),0.4909319294410233,1.1375757772741555,0.3170995670995671,0.9980056619863557,1.0,10/42,17.96%,CUTA;CUTC;HEPH;COA6;ATP7A;PARK7;SUMF1;TP53;ATOX1;SNCA
prerank,protein homodimerization activity (GO:0042803),0.4680952661352613,1.1363668091601575,0.087,0.9964100494634598,1.0,119/589,17.97%,TOP2A;CENPF;KIF20B;GEN1;SLC4A1;KNSTRN;ECT2;CIP2A;MAD2L1;BARD1;STK26;SOX6;CHEK2;BLM;SMCHD1;PECAM1;GBP4;CCDC88A;IKZF3;FAP;FLNA;SLK;S100A11;PTPA;RBM44;USF1;PML;AXIN1;MSH6;PSMF1;ABCB10;ABCD1;TFRC;EXT1;SNRPC;IMPA1;IKBKG;TERF2;MYOM1;TCF3;CDADC1;EPHX2;PDE2A;DPY30;GBP2;MAP3K5;DCLRE1B;MGAT2;AHR;BOK;SNX9;ST3GAL2;TPST1;TAP1;ZBTB16;PEX11B;TERF1;NRF1;CAV2;TIMM9;NADK2;TXN;MAP3K11;NR2F2;UXS1;CARD9;PARK7;SMAD4;B2M;RNF8;DPP4;TRIM68;FOXP2;BMPR1A;EFEMP2;KMT2A;FXR1;GALM;SMIM1;PON3;RACK1;ZBTB7B;DGKD;ACTN4;ADD2;DDIT3;TPM4;NRBP1;NECTIN1;TRIM5;TYROBP;STK4;PDCD10;LRRFIP1;CEP57;GCA;APPL1;RPE;PDXK;TARBP2;TFAP4;STARD3NL;FGFR1;GSTM1;TGFB2;RDH5;MMAA;SYNE1;TARS2;PIP4K2A;CANT1;ADCY8;CRYL1;TRIM37;SPPL3;EPRS1;TDG;LRRK2;CYP2R1
prerank,microtubule minus-end binding (GO:0051011),0.5680288767847683,1.136156324800403,0.33426573426573425,0.9913307985651914,1.0,6/13,13.42%,TUBGCP6;TUBGCP4;HAUS4;HAUS7;TUBGCP3;NUMA1
prerank,carboxypeptidase activity (GO:0004180),0.5091216378554135,1.1358296599513737,0.3303769401330377,0.986683235758293,1.0,8/35,17.23%,AGBL1;CPA6;CPM;AGTPBP1;VASH2;AGBL3;CPD;NAALAD2
prerank,acetyltransferase activity (GO:0016407),0.5165640695430797,1.135349948989232,0.31524249422632794,0.9826721047107395,1.0,8/31,19.31%,ESCO2;PAFAH2;KAT6A;KAT2B;NAA16;CREBBP;NAT10;ELP3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4672634961017533,-1.134074297341575,0.34545454545454546,0.6596768183711654,1.0,6/10,14.65%,GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,nucleotidyltransferase activity (GO:0016779),0.5475885830555425,1.1321443962025555,0.34167709637046306,0.9889620209673313,1.0,8/19,22.23%,DNTT;CGAS;TUT4;PAPSS2;TUT1;TENT2;PNPT1;TENT4A
prerank,RNA stem-loop binding (GO:0035613),0.5784864315568162,1.1310853791914126,0.3506666666666667,0.9871198926812597,1.0,7/12,17.73%,CSDE1;MYH10;CPEB3;DHX9;METTL16;RC3H1;EPRS1
prerank,fibroblast growth factor binding (GO:0017134),0.5365777275329613,1.1299954629723241,0.3398294762484775,0.9854218579387968,1.0,7/21,16.17%,FGFBP3;RPS19;ITGAV;GLG1;CEP57;FGFR1;FIBP
prerank,glucose transmembrane transporter activity (GO:0005355),0.5587831981876817,1.129499104893153,0.3333333333333333,0.9815516094640444,1.0,4/17,18.63%,SLC2A4;SLC2A8;SLC2A3;SLC2A1
prerank,sequence-specific DNA binding (GO:0043565),0.46726030150494763,1.1280868824036105,0.093,0.9813693142372028,1.0,122/590,20.51%,E2F7;PIF1;E2F8;E2F2;UHRF1;GFI1;FOXA2;VAX2;SPIB;DMRTA1;NR4A2;MBD3;HEY2;MYRFL;LEF1;E2F1;SMG6;IKZF3;PBX4;BATF;ELK4;USF1;SMG5;ERG;BACH2;CTCF;FOXP1;ETS2;NR1D1;TAF1;MBD2;FOXO1;FOXJ3;ATF7;TERF2;ZBTB26;UPF2;MBD1;TCF7L1;ZFP41;IRF9;RUNX3;LRWD1;KLF10;XRCC6;AHR;MAX;TERF1;ZBTB7A;FLI1;ZNF148;MECP2;LONP1;KLF13;EGR1;ZBTB32;NR2C2;RFX2;NR2F2;CUX1;NFE2;SMAD4;ATF6;JUN;ATF5;FOXP2;CBFB;CTC1;ZBTB33;KMT2A;SP3;NFE2L2;ZBTB7B;HNRNPU;BCL6;CEBPG;GABPA;POU6F1;GMEB2;E2F3;ELF1;KMT2B;JUNB;IRF8;HOXB4;POU2F1;TFAP4;TCF7L2;TCF4;HIVEP1;ZNF23;FOXK2;RFX7;RFX4;NFATC3;XBP1;RXRB;POU2F2;HDAC4;RARG;KDM2B;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;SAFB;ZBTB20;PAX2;SOX9;NPAS2;SREBF2;ZBTB18;MMP12;SLTM;ZCWPW1;KDM2A;SMG7;PRDM4;RBPJ
prerank,TBP-class protein binding (GO:0017025),0.5294957246370764,1.1276995810161154,0.3448275862068966,0.9772444934634407,1.0,9/21,21.66%,TAF1;PSMC1;AHR;GTF2A1;RUVBL2;RUVBL1;YEATS2;GTF2A2;TAF11
prerank,triglyceride lipase activity (GO:0004806),-0.38099269349763953,-1.1268287755570283,0.2857142857142857,0.6675374118591952,1.0,3/20,2.74%,PLA2G15;DAGLB;LPL
prerank,CoA-ligase activity (GO:0016405),0.5621735109005249,1.126417997132799,0.3468286099865047,0.9765757523098635,1.0,2/14,10.20%,ACSS3;SLC27A2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.48189400013903894,1.1255140876408716,0.3158974358974359,0.9742813296189491,1.0,16/71,16.26%,CDC25C;CDKN3;CDC25A;PTPRA;PTPN22;CDC25B;EYA3;PTPDC1;PTPN7;PTPN14;MTMR6;PTEN;EYA1;PTPN5;PTPRU;DUSP22
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4778225765431867,1.1252235915501907,0.31917098445595854,0.9699485283869806,1.0,21/75,19.58%,H6PD;DHDH;DCXR;CBR4;HPGD;GFUS;IMPDH2;ME3;BDH1;ABCC4;DHRS4;RDH10;NSDHL;HADHA;RDH5;GLYR1;CRYL1;PHGDH;MDH2;HADHB;PGD
prerank,cyclic nucleotide binding (GO:0030551),0.5392148734424055,1.124185897472221,0.331353919239905,0.9682095410748782,1.0,5/21,16.72%,PDE4A;PDE2A;SLC19A1;PDE5A;CNBD2
prerank,calcium channel regulator activity (GO:0005246),0.4968261780350999,1.1239487495367662,0.327313769751693,0.9636452124174082,1.0,13/37,23.93%,RRAD;ITPR1;REM1;INAFM2;SGK3;NRXN2;STIMATE;YWHAE;CACNG8;NRXN1;CACNG4;FKBP1A;INAFM1
prerank,serine-type peptidase activity (GO:0008236),0.46395183654905964,1.1197296092032896,0.3157894736842105,0.9727763203583484,1.0,4/96,3.02%,PRTN3;TMPRSS4;TMPRSS3;FAP
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4213827337912054,-1.1192572166269907,0.2938775510204082,0.6758511012882555,1.0,5/14,29.17%,SLC26A11;SLC25A11;SLC26A8;SLC26A6;SLC25A10
prerank,RNA binding (GO:0003723),0.4606474615318226,1.1175671461226127,0.04,0.9746836335033133,1.0,410/1321,20.46%,TOP2A;MKI67;NUSAP1;RAD51AP1;MBNL3;ADAD1;HMGB2;BARD1;LBR;BRCA1;PTCD2;RADX;RBM15;SUGP2;ZC3H4;RPL7;RPL18A;FASTKD5;SMG6;NOL7;LSM6;CTNNA1;DDX11;RPS20;DHX38;KRI1;PRPF38B;FLNA;EIF4B;EZR;EIF2S1;EIF2A;DHX58;RBM3;RCAN3;NOP10;UTP3;DEK;NPM3;HMGB3;NOA1;TBL2;DDX18;SMG5;POLR2A;RPL36;RPL14;MKRN1;PA2G4;NUCKS1;UBE2I;SCAF11;SLBP;UBE2O;TUBB4B;COA6;RPS19;MAP4;DDX49;ANKHD1;DUT;SLPI;TFRC;ZC3H7A;TNPO1;PPP1R8;SNRPF;EIF3E;RPS7;CDKN2A;HNRNPC;SNRPC;NKAP;RBM27;ZC3H18;RANGAP1;CRKL;HNRNPM;R3HDM1;EDF1;NUP42;MRPL40;RPS4X;HNRNPL;MRPL16;HEATR6;RPS18;MRPL10;LRRC47;NAP1L4;HNRNPA3;PEF1;SETX;CPSF2;CRNKL1;U2AF1;TUBA1B;ZFP36L1;RPL23A;HMGN2;CSDE1;JAKMIP1;PSMC1;MTHFSD;TNRC6B;SNRNP200;EIF4A3;PUM2;TCP1;TAF15;DCP1B;MRPL22;XRCC6;CCDC137;HMGB1;METAP2;NOL10;PKN2;SRSF3;RPL28;EXOSC10;SAP18;SPEN;KMT2C;ZNF326;DYNC1H1;UTP23;ILF2;EWSR1;HNRNPA2B1;DCP2;PSPC1;MRPL37;DCN;NOVA2;TFB1M;CLTC;GRB2;RPL41;RPS14;TFB2M;ZNF638;DNA2;URB1;NOL11;MYEF2;MARK2;MYH10;SART3;PRPF38A;NCOA5;NUDT4;SRSF4;CCDC9;NCBP1;HNRNPUL2;LSM2;SNRNP35;CSRP1;RBM47;RNPS1;RALY;LLPH;DHX40;EDC3;NONO;CASC3;EMG1;RPS27;MECP2;LONP1;RPS19BP1;CSTF3;SRRT;MRPS7;BTF3;MRPL43;RBM19;RPS5;TXN;CPEB3;NIFK;PUM3;SLC4A1AP;RBMS2;UTP6;PCBP2;RBM38;RBFOX3;MSN;PNLDC1;SPATS2L;PARK7;RPLP0;TCOF1;SUMO1;LTA4H;TUT4;RPS11;PUM1;RTF1;PRPF31;PPP1CC;JUN;UBAP2;CCAR2;DHX9;RDX;MSI2;IGF2BP3;FBL;PELP1;CNOT4;HNRNPA0;RPL27A;FASN;ERI1;LSM5;TEP1;DHX29;DCP1A;NUP98;TEFM;APEX1;U2SURP;METTL16;UCHL5;CANX;UPF3B;RBM7;SRFBP1;KIN;FXR1;RTCA;VIRMA;HNRNPR;PPIG;RPS15A;ROCK2;THOC5;RACK1;RPS9;CWC15;DXO;PRKDC;HNRNPU;SF3B5;PSIP1;ACTN4;REXO4;HELZ2;DAZAP1;CEBPZ;LSM14A;DNAJC21;NOL8;NAP1L1;NFX1;SUMO2;CLNS1A;APTX;PRRC2C;PPIA;HNRNPAB;DIAPH1;NSA2;PCBP3;RSRC2;RPL12;CS;TPT1;ANXA11;FDPS;KYAT3;LARP1B;CNOT1;LSM7;SRRM2;LUC7L2;DNAJC2;MAP3K20;RPL22L1;LRRFIP1;RC3H1;DDX43;METTL14;NOP58;DHX57;DIMT1;NTPCR;STAU1;SART1;THOC2;IPO5;SRSF10;AHNAK;TARBP2;PYM1;SAMD4A;ASS1;NOSIP;ZFP36L2;EEF2;ZC3H15;TASOR;PURG;DARS1;UBAP2L;TRIM28;SNRNP40;VIM;TRUB2;SYNE1;KPNB1;SRSF7;ZGRF1;CDC40;POP4;TUT1;SRPK1;SCG3;LARP4B;TCERG1;PSMD4;NAT10;SCAF8;TRNT1;DDX39B;RPL3;ZCCHC24;TDRD7;POLDIP3;PNO1;SNRPG;RPL18;SEC63;PCF11;HSP90B1;GSPT1;YWHAE;PRPF8;MEX3C;ERI3;EPRS1;HEXIM1;ZBED4;MDH2;PTCD1;LACTB2;FLNB;DKC1;FAM32A;RBM25;REPIN1;PPIE;ALKBH5;POLR1G;CAST;RBBP6;HNRNPA1;EIF4ENIF1;CKAP4;PES1;YARS2;GNL3L;HADHB;ELAVL1;RTCB;RPS17;RPS6;HNRNPLL;RPL5;WRAP53;GPATCH8;NCBP2;SAFB;RPS3;TES;DDX54;RPL21;CCT6A;THRAP3;XRN1;AGO2;HELB;NCBP3;ZCCHC8;HELZ;AFF2;SRSF2;SF3A2;G3BP1;PTCD3;CDK11B;SRBD1;FAM120A;ZYX;ZFR;RPL23;RPL17;SLTM;CPSF7;SNRPB;PNPT1;TPR;FYTTD1;RNMT;RBM4B;SYNCRIP;SMG7
prerank,RNA methyltransferase activity (GO:0008173),0.5327464567936548,1.1163111298082748,0.3598014888337469,0.9734498417367592,1.0,6/19,11.72%,TRDMT1;METTL4;TRMT5;METTL8;TYW3;FBL
prerank,aspartic-type peptidase activity (GO:0070001),0.585534144632189,1.1158391161120371,0.36194563662374823,0.969771150333751,1.0,3/10,14.04%,NAPSA;CTSE;PSEN1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5839511071433496,1.1158181161854261,0.3755334281650071,0.9646725492479593,1.0,6/10,25.19%,SLCO4C1;SLCO4A1;SLCO2A1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5246359957464166,1.1137862839857966,0.34067357512953367,0.9664189132737023,1.0,4/17,8.72%,ABCD1;ACOT11;ACOT13;ACOT2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.4582690580161824,1.109530207807644,0.245,0.976119196520012,1.0,35/248,12.53%,KIF15;KIF20B;KIF18B;KIF14;RAB33B;SMCHD1;CHD1L;GBP4;ATL2;ARHGDIB;ABCB10;ABCD1;RAB1B;RAB22A;RND3;GBP2;PIN1;GNAI1;RAB8A;DNA2;MTG2;GNAO1;RIT2;KIF2A;RHOU;RUVBL2;TOR1A;RUVBL1;DHX9;RAB8B;GPN2;DHX29;GFM2;RAB43;RAB11B
prerank,antiporter activity (GO:0015297),0.5231218253802378,1.108952471659169,0.3684210526315789,0.9730868438291884,1.0,5/20,14.30%,SLC35E1;SLC25A16;SLC35D2;SLC35A1;SLC35C2
prerank,cation transmembrane transporter activity (GO:0008324),0.4798743563377291,1.1085687505420019,0.36706135629709363,0.9693351846926301,1.0,3/48,2.84%,SLC38A5;SLC1A5;SLC7A1
prerank,peptide hormone receptor binding (GO:0051428),0.5769735927848522,1.108490288064127,0.36671368124118475,0.9645601066443303,1.0,2/11,13.68%,PTHLH;ADCYAP1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.455771771640843,1.1072582164237448,0.3112449799196787,0.9636947875466619,1.0,20/134,12.43%,SLC4A1;SLC38A5;SLC25A21;SLC25A12;SLC1A5;SLC7A1;SLC16A12;SLC2A8;SLC16A1;SLCO4C1;SLC35D2;SLC35A1;SLCO4A1;ABCC2;SLC3A1;SLC52A1;SLC19A1;ABCC4;SLC25A22;SLCO2A1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.42482102026933294,-1.105532958297086,0.3277591973244147,0.7002787153279088,1.0,6/12,14.97%,FRS2;PIK3R1;SH2B2;BLNK;SH2B3;GAB2
prerank,NADPH binding (GO:0070402),0.5480399222551675,1.1050348566045307,0.3734087694483734,0.9661077681173154,1.0,2/13,7.15%,LBR;CBR4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.5218020988219886,1.1042157524587852,0.36059479553903345,0.9639919598253389,1.0,7/21,21.30%,PDE7B;PDE4A;PDE2A;PDE5A;PDE8A;PDE7A;PDE1C
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5144575970624138,1.103894662426962,0.36395759717314485,0.9600442828273985,1.0,11/27,22.44%,POLR1B;POLR2I;POLR2A;POLR1A;POLR1F;POLR1D;POLR1C;POLR2J;TENT2;POLR3B;POLR2B
prerank,MHC protein binding (GO:0042287),0.525498537298915,1.1034746620309654,0.375,0.9567275033562095,1.0,5/20,11.30%,CD74;TUBB4B;TAP1;PILRA;TUBB
prerank,vitamin D receptor binding (GO:0042809),0.5529514736973739,1.1028196188672343,0.3735255570117955,0.9539897706467775,1.0,12/14,29.56%,MED30;TAF7;MED14;MED1;THRAP3;MED13;TAF11;MED16;RXRA;MED12;MED4;SNW1
prerank,solute:proton symporter activity (GO:0015295),-0.3846128831452298,-1.1014595568153387,0.27510917030567683,0.699661862480687,1.0,6/16,22.59%,CTNS;SLC25A3;SLC11A2;SLC2A9;SLC39A8;SLC36A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.49767144122042906,1.1010040679767306,0.3755656108597285,0.9552347709074112,1.0,2/32,2.20%,SLC38A5;SLC1A5
prerank,PDZ domain binding (GO:0030165),0.47153433281184476,1.1008237279780826,0.34953464322647365,0.9511390815890032,1.0,6/61,8.40%,KIF14;CIT;PLEKHA2;KIDINS220;CCDC88C;ERC1
prerank,MHC class I protein binding (GO:0042288),0.5502668472303578,1.0986790513561087,0.38461538461538464,0.9533081426405653,1.0,5/13,17.90%,TUBB4B;TAP1;PILRA;TUBB;ATP5F1B
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5716003383085483,1.0983456268157679,0.3839541547277937,0.9497788081898879,1.0,5/11,17.74%,MAP3K5;MAP3K1;EGFR;MAP3K20;MAP3K7
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.53559378301701,1.0978743813819847,0.38412291933418696,0.9466512040182984,1.0,4/16,14.54%,SLC25A12;SLC1A5;SLC25A22;SLC25A13
prerank,beta-tubulin binding (GO:0048487),0.49656369876940076,1.0958038861997808,0.389988358556461,0.9488104147987193,1.0,10/31,18.33%,RACGAP1;UXT;EMD;CCT5;FGF13;BBS4;APPL1;PEX14;TAOK1;TBCD
prerank,growth factor activity (GO:0008083),0.467259406218989,1.0939117759461787,0.3702171664943123,0.9502897015263733,1.0,4/74,6.87%,IL12A;NTF4;PGF;TGFA
prerank,phosphatase binding (GO:0019902),0.4546183598001219,1.093365415238345,0.3538928210313448,0.9474989260719567,1.0,25/105,17.91%,NEK2;RPA2;ITGA1;MAPK1;RCAN3;STX17;CEP192;CDC27;SNX3;KCNN4;ANK1;TRAF3;ANAPC7;MAP3K5;MAPK14;MAST2;EGFR;CNST;PPP6R3;RACK1;TP53;KIFAP3;JAK3;HSP90B1;IQGAP1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.46548484816957547,1.0879847621385317,0.37327677624602335,0.9605285022376762,1.0,11/53,18.76%,SLC38A5;SLC25A12;SLC1A5;SLC7A1;SLC43A2;SLC3A1;SLC25A22;SLC25A13;SFXN1;SLC38A6;SLC66A1
prerank,N-methyltransferase activity (GO:0008170),0.5137349654070175,1.0870406172640135,0.40197287299630086,0.9589427782435902,1.0,6/20,15.25%,ZCCHC4;TRMO;TFB1M;TFB2M;METTL15;DIMT1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.561874776137838,1.0849142266231633,0.37677053824362605,0.9612461536256579,1.0,7/12,21.87%,DCPS;CYFIP2;NCBP1;NCBP2;AGO2;NCBP3;EIF4E2
prerank,histone methyltransferase binding (GO:1990226),0.5586415231883615,1.080991454414766,0.39574468085106385,0.9692601276994891,1.0,2/11,7.99%,LCORL;PHF1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.42372984565358934,-1.0776339054275015,0.36964980544747084,0.749454799991076,1.0,5/12,6.91%,KDM1A;KDM7A;KDM4A;PHF8;KDM4B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.36224297281572826,-1.075724986818807,0.33004926108374383,0.7438545951977321,1.0,7/18,24.42%,PIK3R5;WDR91;PIK3R1;SOCS7;AGAP2;PIK3R2;SOCS5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.523652672871937,1.073991404993655,0.4137022397891963,0.987452306219067,1.0,3/15,14.63%,SNX3;PHLDA3;RUBCNL
prerank,phosphatase inhibitor activity (GO:0019212),0.5132495584904485,1.0723269058130114,0.3951715374841169,0.9881565550313951,1.0,5/20,15.98%,PPP1R9B;LMTK2;ANP32E;PPP1R2;STYX
prerank,nuclear receptor binding (GO:0016922),0.44962865988254547,1.0697345048694897,0.3707070707070707,0.9918071226586779,1.0,43/111,23.07%,NR4A2;HMGA1;LEF1;BRD8;FOXP1;MED30;TAF1;YWHAH;TAF7;SMARCA4;NCOA7;TACC2;STRN;ZBTB7A;ASXL1;PARK7;PRKCB;TRIM68;STAT5B;ACTN4;LATS1;MED14;KDM4C;CNOT1;TADA3;TCF7L2;SIRT1;TMF1;MED1;PROX1;DDX54;THRAP3;NCOA6;NCOA2;MED13;MMS19;TAF11;NRIP1;RNF6;PHB2;BCAS3;NSD1;NCOA3
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.4269955754454821,-1.0695939716127965,0.3745583038869258,0.7486704460969905,1.0,5/10,32.31%,B4GALT5;B4GALT7;B3GALT5;B3GALT2;B3GALT6
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.40096244074536397,-1.0683386772922105,0.3644067796610169,0.7418552975035138,1.0,6/14,16.68%,ACO2;SDHB;NFU1;ACO1;ISCU;RSAD1
prerank,signal sequence binding (GO:0005048),0.4788769277821508,1.0667819939283691,0.41638225255972694,0.9967169646269675,1.0,11/35,16.64%,POM121;TNPO1;KPNA3;NUP214;PEX5L;RANBP6;TOMM70;AP2B1;KDELR2;IPO5;KPNB1
prerank,ribosomal small subunit binding (GO:0043024),0.5129758230736174,1.064826023796474,0.4045226130653266,0.9984000706687033,1.0,7/17,25.32%,EIF4B;PIM1;DHX29;PTCD3;ABCE1;NPM1;MTIF2
prerank,I-SMAD binding (GO:0070411),-0.39975650538705526,-1.063402471903437,0.3590733590733591,0.7441321830780016,1.0,6/13,12.36%,TGFBR1;SMAD1;CTNNB1;SMAD3;SMAD6;SMAD7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5483577614099431,1.062782023626809,0.42740841248303935,1.0,1.0,3/11,8.86%,DCPS;DCP2;NUDT4
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5348478301881898,1.059422563478395,0.4207650273224044,1.0,1.0,6/14,15.26%,MTMR12;MTMR2;MTMR14;MTMR6;PTEN;MTM1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.46054961266389477,1.0576095681740005,0.4069264069264069,1.0,1.0,5/47,10.13%,SLC38A5;SLC1A5;SLC7A1;SLC43A2;SLC3A1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5378722796207347,1.0556700475106298,0.4324693042291951,1.0,1.0,3/12,13.67%,SULF2;GALNS;ARSB
prerank,ubiquitin-protein transferase activity (GO:0004842),0.43554839230881154,1.0552590477188404,0.335,1.0,1.0,91/346,19.75%,UBE2C;UBE2T;UHRF1;TRIM58;BARD1;NEURL1B;RFWD3;RNF26;BRCA1;MEFV;DTL;TRIM59;PML;PRPF19;PPP1R11;CDC23;FBXW11;MKRN1;FBXO3;UBE2O;TAF1;TRAIP;FBXO44;MSL2;TRAF3;BIRC2;UBE2Z;BIRC6;UBE2K;UBE3B;NEDD4L;TRIM11;FBXO17;RNF157;KLHL9;RNF141;KCMF1;TNFAIP1;ASB1;CUL3;CBLL1;TRIM47;IRF2BPL;UBE3C;AMFR;TRIM44;UBR2;RNF168;MIB1;XIAP;RNF8;TRIM3;CNOT4;TRIM68;RNF2;RNF152;FBXO11;NFX1;ARIH2;RNF20;FANCL;TRIM5;RNF111;RBCK1;RC3H1;MYLIP;TRIM28;RNF115;TRAF3IP2;UBE2R2;RNF103-CHMP3;SH3RF1;RNF4;RNF19A;TRIM37;MEX3C;UBE2M;DDB2;SYVN1;UBE2G1;MALT1;RNF214;FBXW8;RBBP6;RNF43;AKTIP;BSPRY;TRAF6;RNFT2;DTX3;FBXO21
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.47549233592709894,1.0540025600078842,0.42531356898517675,1.0,1.0,6/31,12.57%,SLC12A3;AQP1;SLC12A7;SLC12A1;KCNA1;SLC12A6
prerank,lipid phosphatase activity (GO:0042577),0.5336717044116028,1.0528113169747275,0.4174496644295302,1.0,1.0,2/14,6.72%,PLPPR3;EPHX2
prerank,mRNA binding (GO:0003729),0.43487816994859685,1.0513880353180105,0.36936936936936937,1.0,1.0,95/249,22.22%,RBM15;RPL7;EIF2A;SLBP;SLPI;PPP1R8;RPS7;HNRNPC;HNRNPM;HNRNPL;BOLL;ZFP36L1;EIF4A3;PUM2;DCP1B;ELAVL4;UTP23;HNRNPA2B1;NOVA2;RPL41;RPS14;AUH;MYEF2;MYH10;SRSF4;NCBP1;SNRNP35;RBM47;RNPS1;EDC3;CSTF3;MRPS7;RPS5;CPEB3;PUM3;SLC4A1AP;RBMS2;PCBP2;RBFOX3;PARK7;PUM1;TYMS;DHX9;IGF2BP3;HNRNPA0;CCT5;DCP1A;NUP98;UPF3B;FXR1;HNRNPR;THOC5;DXO;HNRNPU;DAZAP1;LSM14A;HNRNPAB;RNF20;PCBP3;TP53;SRRM2;LUC7L2;RC3H1;METTL14;THOC2;ANGEL2;SAMD4A;TUT1;LARP4B;SCAF8;TDRD7;PCF11;RBM25;PPIE;EIF4ENIF1;ELAVL1;HNRNPLL;RPL5;NCBP2;RPS3;AGO2;NCBP3;G3BP1;SRBD1;TPR;FYTTD1;RBM4B;SYNCRIP;PTBP2;CELF1;RPL13A;RBFOX2;ELAVL2;PURB;KHNYN
prerank,chloride channel regulator activity (GO:0017081),-0.40079593019329063,-1.0511835467728914,0.3836734693877551,0.7650624925573055,1.0,7/14,29.02%,VTI1B;VAMP8;STX1A;WNK2;CHRNA7;SGK1;CFTR
prerank,cytokine receptor binding (GO:0005126),0.4400760452377833,1.0507855934957049,0.41735537190082644,1.0,1.0,22/83,23.16%,IL12A;INHBC;PGF;JAK2;SOCS2;IL22;SPRED2;TLR5;PIBF1;IL27;USP15;TGFB2;CCL25;KITLG;ERAP1;TRAF6;SMAD2;TYK2;SYK;PXDN;FKBP1A;ADAM17
prerank,double-stranded RNA binding (GO:0003725),0.4453580470882179,1.050250473920715,0.4381443298969072,1.0,1.0,20/70,20.05%,ADAD1;EIF4B;DHX58;TUBB4B;TFRC;TUBA1B;ILF2;CLTC;MSN;DHX9;FXR1;HNRNPU;APTX;LRRFIP1;RC3H1;TARBP2;VIM;ELAVL1;AGO2;ZFR
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5026752735323745,1.0482815620558936,0.42945544554455445,1.0,1.0,5/20,9.82%,AGPAT1;AGPAT4;GPAT3;MOGAT2;AGPAT3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4311243267696092,1.0457829644253187,0.309,1.0,1.0,141/732,19.64%,E2F7;PAX5;E2F8;E2F2;UHRF1;GFI1;FOXA2;NKX6-1;VAX2;MYB;HMGB2;SPIB;MYBL1;DMRTA1;NR4A2;HMGA1;SOX6;HEY2;LEF1;E2F1;TEAD4;IKZF3;PBX4;BATF;ELK4;USF1;PBX3;ERG;BACH2;CTCF;FOXP1;ETS2;DACH1;NR1D1;FOXO1;FOXJ3;ATF7;E2F6;BCL11A;ZBTB26;EBF1;TCF7L1;TCF3;IRF9;RUNX3;HDAC6;EBF3;KLF10;H3-3A;AHR;DMTF1;ZBTB16;E2F5;PLAG1;NFE2L1;NRF1;ZBTB7A;SNAPC3;ZNF148;KLF13;EGR1;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;NFYC;MXI1;RUVBL2;NFE2;SMAD4;ATF6;MED8;JUN;DHX9;FOXP2;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HIVEP2;HNRNPU;CC2D1A;DDIT3;BCL6;SKI;MYC;CEBPG;GABPA;ZNF112;POU6F1;PBX2;GMEB2;E2F3;ELF1;TP53;RUNX1;JUNB;LRRFIP1;IRF8;HOXB4;POU2F1;PLAGL1;TFAP4;TCF7L2;TCF4;HIVEP1;ZNF23;FOXK2;RFX7;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;ZBTB34;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;PAX2;SOX9;THRAP3;NPAS2;SREBF2;PRRX1
prerank,clathrin adaptor activity (GO:0035615),0.5132045549055325,1.0457121386581716,0.44113667117726657,1.0,1.0,5/15,17.38%,AP1G2;STON1;AP2B1;STON2;LDLRAP1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.49928625666537957,1.0450185474944225,0.4294954721862872,0.998841778242245,1.0,5/18,18.84%,STXBP6;S100A11;PDLIM5;PPP1CA;CDC42EP1
prerank,protein tyrosine kinase activity (GO:0004713),0.43165015205296714,1.0444748676436697,0.41236068895643363,0.9962037203354364,1.0,15/108,12.69%,TTK;BLK;WEE1;ERBB3;FYN;BAZ1B;JAK2;EGFR;EPHA3;HIPK2;MELK;DYRK1A;BTK;FLT3;LMTK2
prerank,actin binding (GO:0003779),0.43223048113661716,1.0417222613966464,0.4134808853118712,1.0,1.0,43/170,17.96%,KIF18A;ANLN;MEFV;ALKBH4;PHACTR4;CCDC88A;SYNE2;SLC6A2;EZR;GAS2L3;PRKCE;PHACTR2;GSN;SORBS1;SYNPO2;FXYD5;SHROOM2;DBNL;MYH10;PDLIM7;FLII;LIMA1;PAWR;VPS16;VASH2;EMD;MTSS1;RDX;HNRNPU;ACTN4;ADD2;DAG1;PARVB;SYNE1;PARVA;ADCY8;CALD1;UTRN;CXCR4;PDLIM5;LRRK2;FLNB;SNCA
prerank,SUMO transferase activity (GO:0019789),0.5063908515144485,1.0415048692104831,0.4375804375804376,0.9969902963340452,1.0,8/16,21.14%,UBE2I;PIAS3;NSMCE2;RANBP2;PIAS1;TRIM28;HDAC4;MDM2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.4639869559782147,1.0391243037527065,0.4306987399770905,0.9998590160566599,1.0,5/35,10.94%,BLK;FYN;MELK;DYRK1A;BTK
prerank,acid-thiol ligase activity (GO:0016878),0.5312952982526694,1.03818190088115,0.44972067039106145,0.9984964919261881,1.0,2/13,10.20%,ACSS3;SLC27A2
prerank,protein kinase inhibitor activity (GO:0004860),0.4544129112201524,1.03797089927793,0.449671772428884,0.9948764709560038,1.0,13/42,23.71%,CIT;GMFG;CIB1;IBTK;SPRED2;RACK1;PARVA;HEXIM1;SNCA;CDKN1A;DNAJC3;CDKN1B;NPM1
prerank,gated channel activity (GO:0022836),-0.377022170942124,-1.0375496915298739,0.4089068825910931,0.7897229101131116,1.0,4/14,10.41%,PACC1;TMEM63A;TMEM63B;TMEM266
prerank,snRNA binding (GO:0017069),0.45485318203269315,1.0355196060357708,0.440567066521265,0.9979192530734754,1.0,16/42,19.16%,SNRPC;RNPC3;SART3;LSM2;SNRNP35;PRPF31;CCNT1;RBM7;HNRNPU;PRPF4;LSM7;TUT1;DDX39B;PRPF8;HEXIM1;NCBP2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5102586965511362,1.0334833709230975,0.4577836411609499,0.9997288735467869,1.0,4/15,14.54%,SLC25A12;SLC1A5;SLC25A22;SLC25A13
prerank,mRNA methyltransferase activity (GO:0008174),0.5318793937652003,1.0330057341762173,0.4606896551724138,0.9970226415512086,1.0,6/12,22.26%,CMTR2;METTL8;METTL16;METTL14;RNMT;TRMT10C
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.46342538203479233,1.0304399561085074,0.4407158836689038,1.0,1.0,13/34,20.79%,ERI2;PDE12;EXOSC10;PNLDC1;ERI1;CNOT1;ANGEL2;CNOT6;ERI3;DIS3L;CNOT8;PNPT1;CNOT7
prerank,pyrophosphatase activity (GO:0016462),0.45163101486174045,1.0286713555719467,0.4645161290322581,1.0,1.0,11/50,13.35%,ALPL;DCPS;DCP2;ENTPD3;PPA2;ENTPD5;NUDT4;NUDT9;DHX9;DHX29;DXO
prerank,purinergic nucleotide receptor activity (GO:0001614),0.49548393786222855,1.0285873342470881,0.4410596026490066,0.9976997275066599,1.0,2/15,9.52%,P2RX1;P2RY1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24856062126241063,-1.0278183063718873,0.3333333333333333,0.8047882853993641,1.0,21/74,13.66%,DGKH;HK2;HK3;FAM20C;PIK3CD;GALK2;DGKA;PI4KA;ETNK1;DGKI;PIK3C2B;DGKZ;AGK;PKM;PANK4;DGKQ;PANK3;NMRK1;PIK3CB;GNE;DGKB
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.42607159052982285,1.027639069401165,0.432,0.9964217668016901,1.0,48/254,17.42%,E2F2;MYB;SPIB;MYBL1;NR4A2;LEF1;SMARCD2;ELK4;ERG;FOXO1;MDM4;FOXJ3;TCF3;TFDP1;KLF10;ZBTB16;RLF;PLAG1;NRF1;EGR1;TFDP2;SALL2;NR2C2;NFYC;SMAD4;ATF6;JUN;ATF5;SATB2;DDIT3;MYC;CEBPG;GABPA;ZNF112;PBX2;E2F3;ELF1;TP53;RUNX1;PLAGL1;TFAP4;TCF4;FOXK2;RFX4;ZNF445;NFATC3;RXRB;MLXIP
prerank,manganese ion binding (GO:0030145),-0.2807202560363138,-1.0263464774558149,0.4117647058823529,0.7982359781808447,1.0,16/48,13.32%,XPNPEP3;XPNPEP1;FAM20C;ADCY2;GALNT3;EXD2;LARGE1;GYG1;GALNT1;ADPRM;MGAT1;MPPE1;HMGCL;XYLT2;ME1;B4GALT7
prerank,leak channel activity (GO:0022840),0.49365100801058986,1.0258858893626135,0.4646074646074646,0.9976942418359811,1.0,1/18,0.51%,RHAG
prerank,tau-protein kinase activity (GO:0050321),0.49115578719432623,1.0256714222107315,0.4401972872996301,0.9943060041722543,1.0,10/20,21.70%,FYN;MARK2;DYRK1A;ROCK2;GSK3B;MARK4;TAOK1;MARK1;ROCK1;BRSK1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3267458046640212,-1.0243945934577467,0.3837837837837838,0.7938756640316107,1.0,14/24,30.99%,EEF2K;CAMK1;PHKG2;CAMK4;CAMK2G;MAPKAPK2;CAMK2B;MKNK2;PHKA1;PTK2B;CAMK2D;MAPKAPK5;CAMKK1;MKNK1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.42232904542473926,1.0204338205701455,0.47,1.0,1.0,76/269,19.45%,UBE2C;UBE2T;CCNB1;BRCA1;RPA2;CHEK2;RB1;ERBB3;GLMN;SMC6;PML;AXIN1;SMG5;POLR2A;PA2G4;TANK;PTPN22;IKBKG;FOXO1;FAF1;NPLOC4;TUBA1B;HDAC6;TRAF3;CCT2;TCP1;DDRGK1;UBE2K;SNX9;PRKACA;FAF2;RAD18;BLZF1;EGFR;CASC3;CUL3;PRR7;PCBP2;SUMO1;TUBB;JUN;RNF8;BECN1;AMBRA1;CDK5RAP3;ARRB2;SPOP;SKI;SUMO2;BAG1;RNF20;FANCL;GSK3B;TP53;HGS;CCDC50;TRIOBP;YOD1;TRIM28;USP25;UBXN1;CAMLG;TRIM37;YWHAE;UBA52;USP7;CXCR4;UBE2G1;STAM;RPL5;WRAP53;CDKN1A;SLF1;PRKAR2A;TRAF6;CASP8
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.420812689625061,1.0198084518362114,0.411,1.0,1.0,157/831,19.64%,E2F7;PAX5;E2F8;FOXM1;E2F2;GFI1;FOXA2;NKX6-1;VAX2;MYB;SPIB;MYBL1;DMRTA1;NR4A2;SOX6;HEY2;DEAF1;LEF1;E2F1;RB1;TEAD4;IKZF3;PBX4;BATF;ELK4;TWIST1;USF1;PBX3;ERG;BACH2;CTCF;RBL1;FOXP1;ETS2;DACH1;NR1D1;TAF1;NFXL1;FOXO1;FOXJ3;ATF7;E2F6;BCL11A;ZBTB26;EBF1;TCF7L1;TCF3;ZFP41;IRF9;RUNX3;HDAC6;TFDP1;EBF3;KLF10;H3-3A;MAX;DMTF1;ZBTB16;E2F5;GTF2A1;PLAG1;ETV6;NFE2L1;NRF1;ZBTB7A;SNAPC3;ZNF148;KLF13;EGR1;TFDP2;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;CUX1;NFYC;MXI1;RUVBL2;NFE2;SMAD4;ATF6;MED8;JUN;DHX9;ATF5;ZNF25;FOXP2;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HIVEP2;HNRNPU;CC2D1A;ACTN4;DDIT3;BCL6;SKI;MYC;CEBPG;NFX1;GABPA;ZNF112;POU6F1;PBX2;GMEB2;E2F3;ELF1;TP53;RUNX1;JUNB;LRRFIP1;IRF8;HOXB4;POU2F1;PLAGL1;TFAP4;TCF7L2;TCF4;HIVEP1;ZNF23;PURG;FOXK2;RFX7;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;ZBTB34;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;RPS3;PAX2;SOX9;THRAP3;NPAS2;SREBF2;PRRX1
prerank,neurexin family protein binding (GO:0042043),0.5442843113647367,1.0179496526100509,0.4871060171919771,1.0,1.0,1/10,3.01%,CEL
prerank,sequence-specific mRNA binding (GO:1990825),0.5360302540289416,1.0173606289159047,0.4656160458452722,1.0,1.0,2/10,11.50%,TYMS;DHX9
prerank,RNA cap binding (GO:0000339),0.4986179690317415,1.0158194397115454,0.4655612244897959,1.0,1.0,7/16,21.87%,DCPS;CYFIP2;NCBP1;NCBP2;AGO2;NCBP3;EIF4E2
prerank,R-SMAD binding (GO:0070412),0.4996129263079484,1.0154219905059592,0.47058823529411764,0.9994734922058274,1.0,5/18,11.33%,MEN1;PMEPA1;TRIM33;SMAD4;JUN
prerank,filamin binding (GO:0031005),0.520818952246312,1.0109924417053102,0.47474747474747475,1.0,1.0,2/11,6.71%,RFLNB;SYNPO2
prerank,MAP kinase phosphatase activity (GO:0033549),-0.38917081007210486,-1.0098585262636888,0.4054982817869416,0.8206424946252006,1.0,3/12,12.78%,DUSP3;DUSP10;DUSP7
prerank,carboxy-lyase activity (GO:0016831),0.475791691843252,1.0096812834553108,0.47475961538461536,1.0,1.0,4/23,12.03%,PISD;AZIN1;UXS1;CSAD
prerank,proton transmembrane transporter activity (GO:0015078),-0.275617866714406,-1.0088989064857088,0.4392523364485981,0.8133969517048181,1.0,11/39,19.25%,ATP6V1B2;CTNS;SLC9A1;COX6B1;CLCN4;SLC11A2;COX5A;ATP6V1F;UQCRQ;UQCRFS1;NNT
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4160810314142546,1.0088504516712398,0.473,1.0,1.0,140/731,19.64%,E2F7;PAX5;E2F8;E2F2;GFI1;FOXA2;NKX6-1;VAX2;MYB;SPIB;MYBL1;DMRTA1;NR4A2;SOX6;HEY2;LEF1;E2F1;TEAD4;IKZF3;PBX4;BATF;ELK4;TWIST1;USF1;PBX3;ERG;BACH2;CTCF;FOXP1;ETS2;DACH1;NR1D1;FOXO1;FOXJ3;ATF7;E2F6;BCL11A;ZBTB26;EBF1;TCF7L1;TCF3;IRF9;RUNX3;HDAC6;EBF3;KLF10;H3-3A;AHR;MAX;DMTF1;ZBTB16;E2F5;PLAG1;NFE2L1;NRF1;ZBTB7A;SNAPC3;ZNF148;KLF13;EGR1;SALL2;ZBTB32;MYNN;NR2C2;RFX2;NR2F2;ZEB1;NFYC;MXI1;RUVBL2;NFE2;SMAD4;ATF6;MED8;JUN;DHX9;FOXP2;SATB2;ZBTB33;STAT5B;SP3;NFE2L2;ZBTB7B;HIVEP2;HNRNPU;CC2D1A;DDIT3;BCL6;SKI;MYC;CEBPG;GABPA;ZNF112;POU6F1;PBX2;GMEB2;E2F3;ELF1;TP53;RUNX1;JUNB;LRRFIP1;IRF8;HOXB4;POU2F1;PLAGL1;TFAP4;TCF7L2;TCF4;HIVEP1;ZNF23;FOXK2;RFX7;RFX4;ZNF445;NFATC3;XBP1;RXRB;MLXIP;ZNF467;POU2F2;HDAC4;RARG;ZBTB34;FOXE1;CREB1;ZNF740;RFX1;GMEB1;NKX2-8;PROX1;HDAC1;SAFB;ZBTB20;PAX2;SOX9;THRAP3;NPAS2;SREBF2;PRRX1
prerank,heme binding (GO:0020037),0.4210447089415001,1.0076967690086274,0.4774396642182581,1.0,1.0,10/65,15.45%,CYP1B1;SDHD;NR1D1;CYP2A6;JAK2;PGRMC2;CYP27A1;CYP46A1;HEBP1;CYBB
prerank,nuclear receptor coactivator activity (GO:0030374),0.43293922546633035,1.0071621078052357,0.4844587352625938,1.0,1.0,23/52,23.81%,PSMC3IP;HMGA1;BRD8;MED30;NCOA7;CCAR2;PRKCB;ACTN4;HELZ2;MED14;SS18;CNOT6;TMF1;RNF4;MED1;THRAP3;NCOA6;NCOA2;MED13;CALCOCO1;ACTN1;NCOA3;WDR77
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.524461945867684,1.00600993117216,0.4853963838664812,1.0,1.0,3/12,13.00%,DCXR;CBR4;DHRS4
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.42006992713276503,1.0060057318734124,0.4964964964964965,0.9989717767883749,1.0,35/173,16.70%,E2F8;GFI1;HEY2;DEAF1;CTCF;FOXP1;ETS2;DACH1;NR1D1;E2F6;BCL11A;ZBTB26;TCF3;MAX;ZBTB16;ETV6;ZNF148;ZBTB32;ZEB1;MXI1;JUN;ZNF25;FOXP2;ZBTB33;CC2D1A;BCL6;SKI;MYC;NFX1;POU6F1;LRRFIP1;IRF8;PLAGL1;FOXK2;NFATC3
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.24962173447212815,-1.005271434536351,0.4473684210526316,0.812367932917093,1.0,6/60,4.00%,MERTK;ACVR1;IGF1R;CSF1R;ERBB4;FLT1
prerank,store-operated calcium channel activity (GO:0015279),-0.4230823467094249,-1.0052176973111606,0.4642857142857143,0.8029795627507412,1.0,8/10,30.65%,TRPC5;TRPC4;TRPC1;TRPC3;ORAI1;STIM2;TRPC7;ORAI3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4099287112453103,-1.0036660931534662,0.46153846153846156,0.7976642234650089,1.0,6/11,17.04%,ITPR2;TRPC5;TRPC4;TRPC1;ITPR3;TRPC3
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.47287410446209605,1.0025434276023983,0.4963054187192118,1.0,1.0,8/22,18.80%,EXOSC8;ZFP36L1;ELAVL4;CPEB3;HNRNPA0;ZFP36L2;CPSF1;ELAVL1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.525170815753448,0.9993074717205488,0.47796143250688705,1.0,1.0,7/10,31.55%,PML;ANKRD13A;DNAJB2;LAPTM5;ANKRD13B;FAAP20;ANKRD13D
prerank,metal ion binding (GO:0046872),0.41082349186769684,0.9981402147109901,0.525,1.0,1.0,83/477,17.96%,TOP2A;EFCAB11;GEN1;PIF1;PLK1;STK26;SLC25A12;C2CD5;OXSR1;ITPR1;S100A11;PPP3CA;RCN3;S100A9;MSH6;STK11;FEN1;DUT;SYT8;RASGRP1;IMPA1;SIK2;S100A8;UBA2;GSN;EPHX2;PDE2A;STK38L;MAP3K5;GNAI1;TDP2;CIB1;RP2;PPA2;STK38;MARK2;CDH18;CDH24;MAST2;SMOC2;CAPN1;CEMIP2;MELK;DNER;MICU3;SYT3;SLIT3;SLIT1;CRACR2A;APEX1;CANX;NT5C3A;DXO;BAIAP3;LATS1;MICU1;TPM4;ADGRL3;SLC25A13;TPT1;ANXA11;ADGRV1;STK4;IDH2;MAP3K20;GCA;RPE;PDXK;NDUFAB1;CDH4;FOXK2;PIR;ACER3;SRPK1;TRPM4;CANT1;ADPRH;HSP90B1;MCTP1;TDG;LRRK2;IQGAP1;SNCA
prerank,tRNA binding (GO:0000049),-0.26960383271237887,-0.9972050109138362,0.4375,0.8052373819783101,1.0,15/43,21.40%,NEMF;CARS1;SARS1;TRNAU1AP;AIMP1;NSUN2;ELP5;TYW5;ALKBH1;TRMT10B;IGHMBP2;RPUSD4;YRDC;DARS2;TRMT10A
prerank,Toll-like receptor binding (GO:0035325),0.5125664609921557,0.9967343483690645,0.48579545454545453,1.0,1.0,4/11,14.21%,S100A9;S100A8;MYD88;TLR6
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4751864254170045,0.9947578811084921,0.4877450980392157,1.0,1.0,10/20,21.41%,SENP1;DESI2;OTUD5;USP50;YOD1;USP25;USP21;USP7;USP47;COPS2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.4259439294055818,0.9938488330042331,0.48770053475935826,1.0,1.0,20/49,23.03%,ABRAXAS1;IKBKG;HDAC6;ZRANB3;RAD18;UBQLN1;TAB3;RNF169;RAD23A;RNF168;ZFAND2B;PSMD4;UBXN1;PRPF8;ATRIP;OTUD7A;UBQLN2;MINDY2;ZBTB1;UIMC1
prerank,phospholipase inhibitor activity (GO:0004859),-0.4239554002452512,-0.9921449198161929,0.49158249158249157,0.8090344749955887,1.0,8/10,39.49%,ANXA4;APOC1;ANXA2;ANXA9;ANXA1;ANGPTL3;ANXA5;SNCB
prerank,protein phosphatase regulator activity (GO:0019888),0.4249095845986979,0.9914804740247343,0.505933117583603,1.0,1.0,11/53,13.75%,PHACTR4;PPP1R9B;PTPA;RCAN3;ANKLE2;PPP2R5E;PPP2R5A;PPP1R15A;LMTK2;PPP6R3;PPP1R2
prerank,cadherin binding (GO:0045296),0.41152885165285163,0.9910553356660747,0.544,1.0,1.0,80/315,17.95%,DIAPH3;CIP2A;CCNB2;TMPO;CKAP5;ANLN;CTNNA1;STXBP6;FLNA;SLK;EZR;S100A11;EIF2A;VASN;RPL14;SWAP70;EIF3E;CNN2;RANGAP1;CRKL;STX5;RPL23A;FXYD5;PKN2;SNX9;DBNL;ERC1;STK38;MARK2;CDH18;CDH24;UNC45A;STK24;EGFR;CLIC1;LIMA1;CEMIP2;PARK7;EMD;RUVBL1;AHSA1;UBAP2;BSG;RDX;FASN;VAPA;DHX29;HCFC1;PACSIN2;OLA1;RAB11B;PLCB3;RACK1;TXNDC9;CC2D1A;BAG3;PSEN1;PPL;LRRFIP1;SPTAN1;PPFIBP1;AHNAK;CTNND2;CDH4;EEF2;PAK2;ZC3H15;DNAJB1;PARVA;LASP1;SEPTIN9;CHMP2B;CALD1;YWHAE;PDLIM5;NDRG1;PPP1CA;NUDC;IQGAP1;FLNB
prerank,phosphatase activator activity (GO:0019211),0.49416636241009915,0.9896990384560264,0.5054054054054054,1.0,1.0,4/14,9.89%,PHACTR4;PPP2R5E;PPP2R5A;PPP1R15A
prerank,ubiquitin protein ligase activity (GO:0061630),0.40964256585531994,0.9882457999481619,0.53,1.0,1.0,56/228,19.66%,UHRF1;TRIM58;NEURL1B;RFWD3;RNF26;MEFV;TRIM59;PRPF19;PPP1R11;MKRN1;UBE2O;FBXO44;MSL2;BIRC2;UBE2K;UBE4B;UBE3B;NEDD4L;TRIM11;FBXO17;RNF157;KCMF1;ASB1;CUL3;CBLL1;IRF2BPL;UBE3C;AMFR;TRIM44;UBR2;XIAP;RNF8;TRIM3;TRIM68;RNF2;RNF152;NFX1;ARIH2;FANCL;TRIM5;RNF111;RC3H1;MYLIP;RNF115;TRAF3IP2;SH3RF1;RNF19A;TRIM37;MEX3C;SYVN1;RBBP6;RNF43;BSPRY;TRAF6;RNFT2;DTX3
prerank,glutamate receptor activity (GO:0008066),-0.3295783826122847,-0.987695866613187,0.4791666666666667,0.8103852681972312,1.0,6/19,18.35%,GRIA1;GRIA4;GRM5;GRIK2;GRM8;GRIK4
prerank,E-box binding (GO:0070888),0.4416907308700677,0.9865735305266398,0.4948921679909194,1.0,1.0,8/34,15.91%,TWIST1;TCF3;AHR;MAX;ZEB1;MYC;TFAP4;TCF4
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5012688095051611,0.9853384361528996,0.5035360678925035,1.0,1.0,5/12,26.53%,TRAF3;TRIM37;TRAF6;BABAM2;TRAP1
prerank,receptor antagonist activity (GO:0048019),-0.3499239113656003,-0.9849678808291334,0.4372093023255814,0.8082981951230396,1.0,9/17,49.30%,DKK2;IL18BP;CCL5;DKK3;ESR2;FST;IGSF1;WFIKKN1;AGTR2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.5149733805942245,0.9843081244042697,0.5097222222222222,1.0,1.0,1/11,2.63%,DDAH2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.48391103225819315,0.9827335015600157,0.5144736842105263,1.0,1.0,7/16,19.72%,MTMR12;MTMR2;MTMR14;MTMR6;PTEN;MTM1;INPP5F
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.43940609194201335,0.9802905217322855,0.49067599067599066,1.0,1.0,10/28,26.53%,PIDD1;TRAF3;MYD88;TRIM37;TRAF6;RIPK1;MADD;BABAM2;CASP8AP2;TRAP1
prerank,androgen receptor binding (GO:0050681),0.4534267568047335,0.98025622732834,0.4952038369304556,1.0,1.0,8/25,17.19%,FOXP1;SMARCA4;ZBTB7A;PARK7;PRKCB;TRIM68;KDM4C;TMF1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.45154065409713773,0.979406719740034,0.5059808612440191,1.0,1.0,7/23,21.30%,PDE7B;PDE4A;PDE2A;PDE5A;PDE8A;PDE7A;PDE1C
prerank,voltage-gated ion channel activity (GO:0005244),0.4817689933291991,0.9775476129083024,0.5077720207253886,1.0,1.0,4/14,19.93%,VDAC2;HVCN1;ANO6;PKD2
prerank,phosphatidate phosphatase activity (GO:0008195),0.49496800787759343,0.9736205338941432,0.5033200531208499,1.0,1.0,1/13,1.24%,PLPPR3
prerank,ribosome binding (GO:0043022),0.42796415131122423,0.9733056831378675,0.5369774919614148,1.0,1.0,14/46,22.95%,SLFN14;EIF2S1;EIF2A;CPEB3;ERI1;NAA16;RACK1;PYM1;EEF2;EIF6;NCLN;CCDC47;EFL1;SRP68
prerank,ATPase regulator activity (GO:0060590),-0.26625514929405825,-0.9677557738212157,0.5416666666666666,0.8430732308986776,1.0,12/38,15.67%,PFN1;DNAJC19;DNAJB6;HSPH1;DNAJA2;ATP1B2;FNIP1;TSC1;ATP1B1;HSPBP1;DNAJC1;SIL1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.40097989151576796,0.9672676023444265,0.579,1.0,1.0,57/232,19.66%,UHRF1;TRIM58;NEURL1B;RFWD3;RNF26;MEFV;TRIM59;PRPF19;PPP1R11;MKRN1;UBE2O;FBXO44;MSL2;BIRC2;UBE3B;NEDD4L;TRIM11;FBXO17;RNF157;KCMF1;ASB1;CUL3;PIAS3;CBLL1;IRF2BPL;UBE3C;AMFR;TRIM44;NSMCE2;UBR2;XIAP;RNF8;TRIM3;TRIM68;RNF2;RNF152;NFX1;ARIH2;FANCL;TRIM5;RNF111;RC3H1;PIAS1;MYLIP;RNF115;TRAF3IP2;SH3RF1;RNF19A;TRIM37;MEX3C;SYVN1;RBBP6;RNF43;BSPRY;TRAF6;RNFT2;DTX3
prerank,growth factor receptor binding (GO:0070851),0.4042213359132102,0.9658233744620432,0.5649948822927329,1.0,1.0,15/95,15.40%,IL12A;CCDC88A;GLMN;FYN;PGF;ARF4;TGFA;GRB2;JAK2;IL1R1;FGF9;TLR5;PIBF1;PSEN1;EGF
prerank,protein kinase C activity (GO:0004697),0.48545550161222045,0.9641535431514958,0.5348189415041783,1.0,1.0,4/14,11.77%,PRKCE;PRKD3;PRKCA;PRKCB
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.36974848688124146,-0.9619598248370844,0.5037593984962406,0.8486630747607256,1.0,8/13,25.79%,TRMT1;WDR4;METTL1;FTSJ1;TRMT10B;TRMT10A;TRMT11;THUMPD2
prerank,hydro-lyase activity (GO:0016836),-0.250377018449258,-0.959986062993335,0.56,0.8444213908038285,1.0,10/41,12.58%,TBXAS1;HACD3;ACO2;ECHS1;ENO1;ECHDC1;NAXD;CA2;ACO1;TGDS
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.4928348530702878,0.9585758195289924,0.5273224043715847,1.0,1.0,3/11,13.84%,SGMS2;PIGF;SGMS1
prerank,neuropeptide hormone activity (GO:0005184),0.45172383966297214,0.9583300400993868,0.5379975874547648,1.0,1.0,4/22,19.89%,AGRP;ADCYAP1;PPY;HCRT
prerank,transcription coactivator binding (GO:0001223),0.46303826296110573,0.9580727403285455,0.5405742821473158,1.0,1.0,3/20,11.11%,CIT;AHR;SMAD4
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.43549551591326136,0.9548959970632029,0.5432525951557093,1.0,1.0,3/28,10.29%,CHRNB4;GABRA4;GABRA5
prerank,glycine binding (GO:0016594),-0.38823371896792325,-0.9544504718254574,0.5084745762711864,0.8489477049444126,1.0,9/11,44.20%,GRIN3A;GLRA2;GRIN2B;GLRA3;GRIN1;SRR;GNMT;GRIN3B;GLDC
prerank,cAMP response element binding (GO:0035497),0.5050474392996497,0.954128392619672,0.5331491712707183,1.0,1.0,4/10,23.97%,ATF7;JUN;CREB1;HMGA2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.5001284406560124,0.9537509328669445,0.5342657342657343,1.0,1.0,3/10,15.19%,NAA16;NAA25;NAA20
prerank,galactosyltransferase activity (GO:0008378),-0.37793280465567247,-0.952629646817083,0.516728624535316,0.8446274645183337,1.0,7/11,40.78%,B4GALT5;B4GALT7;B3GALT6;B4GALT4;B4GALT2;A4GALT;B3GNT6
prerank,methyltransferase activity (GO:0008168),0.40877697217682574,0.9524666958763726,0.5605234460196292,1.0,1.0,14/46,20.56%,SUV39H1;ARMT1;LCMT1;METTL4;DNMT1;EHMT1;NDUFAF7;NSUN3;COQ5;LRTOMT;PRMT3;GCSH;DNMT3B;PRMT7
prerank,semaphorin receptor binding (GO:0030215),-0.3008695437823725,-0.9518970342647426,0.5375,0.837542249514758,1.0,14/23,36.83%,SEMA3D;SEMA3E;SEMA4C;SH3BP1;SEMA4G;SEMA3A;SEMA7A;SEMA4D;SEMA4F;PLXNB1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.43818552050707943,0.9518229738190703,0.5586527293844367,1.0,1.0,10/28,22.78%,EXO1;FEN1;EDC3;APEX1;PRORP;RNASEH2A;POP4;AGO2;ENDOV;RPP30
prerank,endopeptidase activity (GO:0004175),0.3890524879782469,0.9497267509561713,0.644,1.0,1.0,35/257,14.90%,PRTN3;TMPRSS4;TMPRSS3;ADAMTS7;KEL;ESPL1;NAPSA;USP1;SENP1;NRDC;FAP;PSMB7;PIDD1;MBTPS2;CASP2;USP38;CTSE;PREP;PITRM1;USP48;ATG4B;PSMA4;DPP4;CTSO;CTSK;F3;USP14;MMP19;PSEN1;USP24;CASP9;USP15;PSMB1;PCSK1;ADAMTS1
prerank,epidermal growth factor receptor binding (GO:0005154),0.43712867506550085,0.9491941712123557,0.5269461077844312,1.0,1.0,4/25,8.24%,CCDC88A;ARF4;TGFA;GRB2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4151834219931247,0.9491303365501748,0.5463467829880043,1.0,1.0,14/40,21.28%,SUV39H1;ARMT1;LCMT1;METTL4;DNMT1;METTL8;METTL9;FBL;LRTOMT;ICMT;DNMT3B;THUMPD3;PRMT7;PCMTD1
prerank,calcium channel activity (GO:0005262),-0.22538879400392176,-0.9474341789324151,0.5217391304347826,0.8397121461252749,1.0,38/84,30.65%,SLC24A3;CACNB2;CACNA1C;TRPC5;TPCN2;CUL5;MCOLN1;TRPC4;TRPC1;CACNA2D3;CACNG2;CACNG7;RYR2;PKD1;SEC61A1;CACNB4;CACNA2D2;TRPV4;TRPC3;NCS1;ORAI1;P2RX4;ANXA2;CACNA1E;PKD2L1;PKD1L2;ANXA6;PKD2L2;ANXA9;CACNB1;CHRNA7;STIM2;CACNA2D4;CATSPER3;TRPC7;TRPM2;SLC24A5;ORAI3
prerank,ribonuclease activity (GO:0004540),0.4095828855507917,0.9462804542514986,0.5882990249187432,1.0,1.0,7/56,7.57%,SLFN14;RNASE6;SMG6;PPP1R8;EXOSC8;YBEY;EXOSC10
prerank,SUMO binding (GO:0032183),0.47792209262933893,0.9460518746373917,0.5392953929539296,1.0,1.0,6/13,17.83%,PML;UBA2;RNF111;USP25;RNF4;TDG
prerank,phosphatidylinositol binding (GO:0035091),-0.23169193533084834,-0.9457222944650353,0.5217391304347826,0.8350723731029123,1.0,26/91,17.85%,SNX24;ITPR2;WDFY3;APPL2;SNAP91;SNX5;EEA1;ZFYVE9;TULP3;PHF12;SNX16;SNX11;ZFYVE1;SNX27;FES;SCARB1;PITPNB;MPPE1;NCF1;GAP43;MCF2L;ITPR3;SH3YL1;C2CD2L;PITPNM2;THY1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.27164508141312543,-0.9450945104611956,0.5,0.8282851944922758,1.0,11/35,17.82%,GPCPD1;PLCB2;ENPP2;GDE1;APEX2;PLCB4;PDIA3;MPPE1;PLCXD2;SMPDL3A;GPLD1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5039210001714045,0.9424414316751736,0.5424200278164116,1.0,1.0,6/10,25.94%,NSD2;NSD3;ASH1L;SETD5;NSD1;SETD2
prerank,death domain binding (GO:0070513),0.4887562504779566,0.9423099845461025,0.5238095238095238,1.0,1.0,3/11,13.14%,DAP;TRADD;RACK1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.48276424496207265,0.942044901061459,0.5464788732394367,1.0,1.0,5/11,20.56%,NDUFAF7;FBXO11;PRMT9;PRMT3;PRMT7
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4832611926896445,0.9407375114072939,0.5599455040871935,1.0,1.0,2/12,4.68%,CCDC88A;PGF
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5006408528581489,0.9398800246823639,0.5522174535050072,1.0,1.0,8/10,31.55%,USP15;DNAJC2;ANKRD13A;DNAJB2;LAPTM5;ANKRD13B;FAAP20;ANKRD13D
prerank,metalloendopeptidase activity (GO:0004222),0.3866672621375597,0.9355806886500379,0.5932028836251287,1.0,1.0,18/76,24.48%,ADAMTS7;KEL;NRDC;MBTPS2;PITRM1;MMP19;ADAMTS1;ADAMTSL3;ADAMTS5;ADAM10;MMP12;MME;ADAMTS2;ADAMTS3;ADAM17;ADAMTS10;ADAMTS9;ZMPSTE24
prerank,phosphotyrosine residue binding (GO:0001784),-0.2615047944515192,-0.9346465344582234,0.5675675675675675,0.845034803560672,1.0,6/37,4.60%,BCAR3;YES1;PTPN6;PFN1;PIK3R1;VAV2
prerank,protein tyrosine kinase binding (GO:1990782),-0.22697766840766753,-0.9321407178400607,0.5789473684210527,0.8428578149964115,1.0,13/71,10.14%,ACVR1;SIRPA;TREM2;PTPN2;SQSTM1;HSP90AA1;BMPR2;GRM5;ANGPT1;TJP2;DUSP3;BLNK;SH2B3
prerank,ubiquitin protein ligase binding (GO:0031625),0.3843052766198238,0.9297340622664625,0.682,1.0,1.0,75/254,21.14%,UBE2T;BRCA1;RPA2;CHEK2;RB1;ERBB3;GLMN;SMC6;PML;AXIN1;SMG5;POLR2A;PA2G4;TANK;PTPN22;IKBKG;FOXO1;FAF1;NPLOC4;TUBA1B;HDAC6;TRAF3;CCT2;TCP1;UBE2K;SNX9;PRKACA;FAF2;RAD18;BLZF1;EGFR;CASC3;CUL3;PCBP2;SUMO1;TUBB;JUN;RNF8;BECN1;AMBRA1;ARRB2;SPOP;SKI;SUMO2;BAG1;RNF20;FANCL;GSK3B;TP53;CCDC50;TRIOBP;YOD1;TRIM28;USP25;UBXN1;CAMLG;TRIM37;YWHAE;UBA52;USP7;CXCR4;UBE2G1;RPL5;WRAP53;CDKN1A;SLF1;PRKAR2A;TRAF6;CASP8;RPL23;PRR5L;UBE2N;SMAD2;RIPK1;MDM2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.43788553367850147,0.9277223515418503,0.5924112607099143,1.0,1.0,11/22,23.03%,IKBKG;ZRANB3;TAB3;RNF169;RNF168;PRPF8;ATRIP;OTUD7A;MINDY2;ZBTB1;UIMC1
prerank,hexosaminidase activity (GO:0015929),-0.3660656844823611,-0.9271429151352856,0.5591397849462365,0.8464942499320859,1.0,2/12,10.91%,HEXB;HEXD
prerank,calcium channel inhibitor activity (GO:0019855),0.47839362885249453,0.9271382321736265,0.5687679083094556,1.0,1.0,1/11,3.00%,ITPR1
prerank,hyaluronic acid binding (GO:0005540),0.4994227311424023,0.927024357396312,0.5790960451977402,1.0,1.0,1/10,3.88%,CD44
prerank,thioesterase binding (GO:0031996),0.4731915964332129,0.9259693048644889,0.5572625698324022,1.0,1.0,4/11,19.45%,TRAF3;HAUS7;RAC1;TRAF6
prerank,chemokine receptor binding (GO:0042379),-0.2681775082264244,-0.9252010932482276,0.5533980582524272,0.8429388604887965,1.0,16/35,47.28%,CX3CR1;CCL15;CCL4;CCL3;CCL14;PF4;CCL13;CCL2;CCL5;CCRL2;CCL28;CCL7;CXCL10;CXCL12;CKLF;CCL24
prerank,alpha-tubulin binding (GO:0043014),0.4180852573395465,0.9244727108335012,0.5714285714285714,1.0,1.0,8/31,18.02%,RACGAP1;FYN;HDAC6;OFD1;BBS4;ARL4C;SNCA;TAOK1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.48519552960469253,0.9228058378017288,0.5775623268698061,1.0,1.0,1/11,3.00%,ITPR1
prerank,chemokine activity (GO:0008009),-0.27415072417819863,-0.9221037727783478,0.5934959349593496,0.8418487718358878,1.0,17/31,52.15%,CCL15;CCL4;CCL3;CCL14;PF4;CCL13;CCL2;CCL5;CCL28;CCL7;CXCL10;CXCL12;CKLF;CCL24;CCL19;CCL8;CXCL9
prerank,miRNA binding (GO:0035198),0.4157937574860019,0.9207974388830055,0.5969976905311778,1.0,1.0,13/30,24.69%,ZC3H7A;PUM2;HNRNPA2B1;TUT4;PUM1;RC3H1;HNRNPA1;ELAVL1;AGO2;PNPT1;AGO1;YBX1;ZNF346
prerank,protease binding (GO:0002020),0.3897009686100425,0.9201741377181224,0.652834008097166,1.0,1.0,27/99,17.81%,CD177;BRCA2;FAP;COL1A2;CLTC;INSL3;SART3;ITGAV;RIOK3;DERL2;AMFR;PARK7;SUMO1;RAD23A;DPP4;PTEN;F3;SPATA2;FLOT1;RHBDD2;CFLAR;GSK3B;CCBE1;TP53;CHMP3;FN1;SYVN1
prerank,pyridoxal phosphate binding (GO:0030170),-0.2982242102638172,-0.9166276802879351,0.5639810426540285,0.8465096044441469,1.0,14/20,45.30%,PYGB;PYGL;PLPBP;AGXT;OAT;SHMT2;SHMT1;SRR;PYGM;CBS;THNSL2;CTH;GLDC;ACCS
prerank,general transcription initiation factor binding (GO:0140296),0.42696337241917615,0.9153128746862628,0.5721153846153846,1.0,1.0,7/25,14.80%,TAF1;PSMC1;AHR;GTF2A1;RUVBL2;RUVBL1;YEATS2
prerank,metalloexopeptidase activity (GO:0008235),0.3952046384331354,0.9150025066504853,0.5922330097087378,1.0,1.0,12/51,18.45%,AGBL1;CPA6;CPM;AGTPBP1;DPEP1;METAP2;VASH2;LTA4H;AGBL3;CPD;ERAP1;RNPEP
prerank,hormone activity (GO:0005179),0.3932000776134551,0.9138063920745484,0.6131078224101479,1.0,1.0,9/54,19.89%,AGRP;NPPC;PTHLH;ADCYAP1;CCL25;INSL6;APLN;PPY;HCRT
prerank,zinc ion binding (GO:0008270),0.37549194079576376,0.9126226453633929,0.738,1.0,1.0,67/293,18.45%,UHRF1;RNF26;TK1;MEFV;BLM;ZCCHC4;DHX58;HDAC10;S100A9;TNFSF10;CTCF;RASGRP1;SNRPC;S100A8;MDM4;DPEP1;MBD1;CDADC1;PDE2A;GDA;BIRC2;PRIMPOL;BAZ1B;PHF2;SEC24B;SEC24A;PITRM1;TAB3;CSRP1;RPS27;TIMM9;EGR1;ZBTB32;TMEM163;KAT6A;ZEB1;ZMYND8;NAPEPLD;RPS29;LTA4H;RNF8;RNF2;KMT2A;HHIP;GLO1;SKI;ARIH2;KDM4C;LIMS1;TP53;KMT2B;RC3H1;PDXK;TRIM28;CRIP1;ACER3;KPNB1;DUSP12;SLC30A5;EPRS1;LACTB2;SNCA;RASSF1;HDAC4;KDM2B;ERAP1;RNPEP
prerank,endopeptidase activator activity (GO:0061133),-0.3758046687899831,-0.9094340062945097,0.5584415584415584,0.8564507818804278,1.0,2/10,2.18%,PSMD14;VSIR
prerank,alkali metal ion binding (GO:0031420),0.45851060095384,0.9085536361584364,0.5902306648575305,1.0,1.0,6/13,18.01%,IMPA1;PDXK;ADPRH;TDG;DRG1;HDAC4
prerank,ligand-gated ion channel activity (GO:0015276),0.40755896920203016,0.9077033696305299,0.6009122006841505,1.0,1.0,1/30,0.81%,CHRNB4
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.47126714778240697,0.9071781985289955,0.5786593707250342,1.0,1.0,3/12,13.14%,APAF1;BCL2L13;RACK1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.41390002410502474,0.9071525457951857,0.6135040745052387,1.0,1.0,9/29,21.42%,PPM1D;MAPKAPK3;ATF7;MAPK14;CDK5RAP3;SIRT1;TPR;DUSP16;NBR1
prerank,AMP binding (GO:0016208),-0.36727879302107863,-0.9069596968656064,0.5986394557823129,0.8540574233730556,1.0,5/11,20.82%,PFKL;PYGL;APRT;PFKP;PFKM
prerank,ephrin receptor binding (GO:0046875),0.42464393688547125,0.9043141816074141,0.589711417816813,1.0,1.0,5/21,15.67%,FYN;GRB2;ANKS1A;CRK;ANKS1B
prerank,ADP binding (GO:0043531),0.42199181243748923,0.9033346404351363,0.6,1.0,1.0,11/25,23.63%,MSH6;ABCD1;TAP1;MYH10;LONP1;PRKAG2;ATP5F1D;PGK1;PRKAG1;GCLC;MYH9
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.25647354344068873,-0.9021517984940738,0.6,0.8568443284325756,1.0,13/37,16.48%,IARS2;CARS1;WARS2;SARS1;NARS1;FARSA;IARS1;HARS2;HARS1;NARS2;TARS1;QARS1;TARS3
prerank,ligand-gated channel activity (GO:0022834),0.4075594747159708,0.9015199237162594,0.6112385321100917,1.0,1.0,1/29,0.81%,CHRNB4
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4383696625059421,0.9010158173298476,0.6042983565107459,1.0,1.0,1/17,1.18%,LBR
prerank,regulatory RNA binding (GO:0061980),0.39594236663658816,0.898846981858777,0.6328125,1.0,1.0,15/38,24.69%,ZC3H7A;PUM2;HNRNPA2B1;TUT4;PUM1;DHX9;RC3H1;TARBP2;HNRNPA1;ELAVL1;AGO2;PNPT1;AGO1;YBX1;ZNF346
prerank,transforming growth factor beta receptor binding (GO:0005160),0.43508597055415316,0.8984959249578243,0.5898389095415117,1.0,1.0,1/18,0.90%,INHBC
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4768617375848738,0.8980437459630298,0.5932203389830508,1.0,1.0,5/10,24.63%,GFUS;GALM;RPE;GALE;GLCE
prerank,sulfotransferase activity (GO:0008146),0.40996470310605954,0.8979815304587248,0.6203389830508474,1.0,1.0,4/33,13.24%,CHST3;TPST1;CHST12;SULT6B1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3964277004565332,0.8970963180071637,0.6356502242152466,1.0,1.0,9/38,17.85%,CARD10;AXIN1;TRADD;SORBS1;SPATA2;IRS1;SPAG9;LDLRAP1;LRRK2
prerank,tau protein binding (GO:0048156),0.3937414301868024,0.8970516456948058,0.6124454148471615,1.0,1.0,17/40,21.89%,FYN;HDAC6;PIN1;MARK2;PPP2CB;DYRK1A;ROCK2;GSK3B;MARK4;SNCA;TAOK1;PPP2CA;MARK1;SMAD2;ROCK1;BRSK1;DCTN1
prerank,cytokine activity (GO:0005125),0.3694617902430963,0.8948421747757145,0.6905241935483871,1.0,1.0,4/131,7.33%,IL12A;INHBC;IL16;HMGB1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.47603356866377944,0.8948182893737523,0.6111111111111112,1.0,1.0,5/10,20.62%,FAP;DPP4;NAALAD2;DPP9;PRCP
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.324913121306239,-0.893551273665803,0.6098484848484849,0.8678898468532804,1.0,4/13,12.75%,PIK3CD;PIP4K2B;PIK3C2B;PIK3CB
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.2303976804612389,-0.8908434990829979,0.6923076923076923,0.8656594727138867,1.0,6/60,4.00%,MERTK;IGF1R;CSF1R;ERBB4;NRP2;FLT1
prerank,lipase activator activity (GO:0060229),0.47237238696547124,0.8906924628330334,0.5985401459854015,1.0,1.0,3/10,10.94%,FYN;PDPK1;BTK
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.34434402677900655,-0.8901937477834977,0.594306049822064,0.8594363053234615,1.0,4/12,5.58%,PIK3R1;IGF1;ARRB1;GNAS
prerank,phospholipase binding (GO:0043274),0.4435107898282761,0.8899720118052141,0.5895316804407713,1.0,1.0,4/13,10.94%,FYN;PDPK1;PAFAH1B1;BTK
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4290212278165185,0.8879244900905817,0.6141025641025641,1.0,1.0,6/17,18.99%,AK9;NME4;AK3;AK5;CLP1;CMPK2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3976981107754629,0.8858390630190077,0.621301775147929,1.0,1.0,4/25,12.06%,KMO;FMO5;CYP27A1;CYP46A1
prerank,DNA-binding transcription factor binding (GO:0140297),0.367290288205167,0.8851474850091275,0.764,1.0,1.0,63/189,24.02%,HEY2;RB1;CBX5;TWIST1;ZFPM1;USF1;MTA3;RBBP8;RBL1;TAF1;PTMA;TCF3;DDRGK1;HMGB1;SPEN;TLE4;ZBTB7A;PIAS3;HIRA;HIPK2;ZMYND8;PARK7;JUN;DHX9;MTA2;HCFC1;NFE2L2;BBS4;BEX1;DDIT3;CREBBP;SKI;MYC;GABPA;RERE;GSK3B;TP53;PIAS1;SIN3A;TCF7L2;TAF9;TCERG1;SIRT1;HCLS1;HDAC4;CREB1;TLE3;HDAC1;PRRX1;RBPJ;FIZ1;PPARD;SMAD2;MEF2D;CIITA;PURB;HDAC9;ATN1;BBS7;BHLHE40;NPM1;DAPK3;MIER1
prerank,vinculin binding (GO:0017166),0.45552751859479557,0.878728824836429,0.616361071932299,1.0,1.0,6/11,22.51%,CTNNA1;DAG1;UTRN;RTCB;PXN;ACTN1
prerank,pentosyltransferase activity (GO:0016763),-0.2405481216293794,-0.8758994470108142,0.7358490566037735,0.8844843288362798,1.0,14/36,25.15%,LACC1;UPP2;PARP6;LARGE1;QTRT1;SIRT3;PPAT;PARP16;UMPS;PARP2;SIRT5;TNKS2;PARP3;TNKS
prerank,receptor ligand activity (GO:0048018),0.36289894454100435,0.8738770242471725,0.783,1.0,1.0,11/245,7.33%,IL12A;INHBC;NTF4;HMGB2;TNFSF13B;NPPC;IL16;PGF;PTHLH;TGFA;HMGB1
prerank,deubiquitinase activity (GO:0101005),0.36411845242497065,0.8724745781774594,0.6894790602655771,1.0,1.0,21/88,17.67%,USP27X;MINDY4;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP25;USP21;USP40;USP7
prerank,MAP kinase activity (GO:0004707),0.4424798537918935,0.8705611916921537,0.6308724832214765,1.0,1.0,2/14,8.09%,MAPK1;MAPK14
prerank,endoribonuclease activity (GO:0004521),0.38952222659440006,0.8690732320211553,0.6341463414634146,1.0,1.0,3/32,6.67%,SLFN14;SMG6;YBEY
prerank,CCR chemokine receptor binding (GO:0048020),-0.2618245252467586,-0.8671284019987159,0.7152317880794702,0.8963495353108658,1.0,11/28,33.47%,CNIH4;NARS1;CCL15;CCL4;CCL3;CCL14;NES;CCL13;CCL2;CCL5;DEFB130A
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.2956699047332747,-0.8645976918850442,0.6318181818181818,0.8938790822850582,1.0,4/17,10.73%,GRIA1;GRIA4;GRIN3A;GRIK2
prerank,MAP kinase kinase activity (GO:0004708),0.42442632013456344,0.8640261630292491,0.6106870229007634,1.0,1.0,5/15,17.85%,MAP2K6;MAPKAPK3;MAPK14;MAP2K1;LRRK2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.24448754521152838,-0.8633527167593759,0.6608695652173913,0.8888640245836521,1.0,8/33,14.31%,RNF19B;ARIH1;RNF180;RNF185;AUP1;UBE3D;PRKN;SIAH1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4494533262875398,0.8626027191958253,0.6138032305433186,1.0,1.0,2/10,6.95%,CDADC1;GDA
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4296671809423913,0.8622154108938627,0.6121621621621621,1.0,1.0,2/14,13.04%,KCNJ3;KCNJ2
prerank,exopeptidase activity (GO:0008238),0.37777948116250976,0.8565023214379104,0.7098501070663812,1.0,1.0,14/50,20.62%,DPEP3;FAP;DPEP2;CPM;DPEP1;METAP2;LTA4H;DPP4;NAALAD2;ERAP1;RNPEP;MME;DPP9;PRCP
prerank,ribosomal large subunit binding (GO:0043023),-0.3319479417146664,-0.8548347231731619,0.6392857142857142,0.8987644505168605,1.0,4/11,9.77%,NEMF;DHX33;MRRF;NMD3
prerank,ligand-gated cation channel activity (GO:0099094),0.3588959988892414,0.8476480559857185,0.7260556127703398,1.0,1.0,13/75,22.22%,CHRNB4;P2RX1;SHROOM2;KCNJ3;GRIA3;KCNJ2;GRIA2;TRPM4;KCNJ10;GRIK5;GRIK3;GRIN2D;KCNN3
prerank,GTP binding (GO:0005525),0.3520730793172802,0.846191428027027,0.812625250501002,1.0,1.0,37/172,18.30%,RRAD;ARHGEF5;GBP4;TUBA1C;NOA1;ATL2;ARL5C;TUBB4B;REM1;ARL11;RAB1B;RAB22A;TUBA1B;ARF4;RND3;GBP2;GNAI1;RAB8A;MTG2;SEPHS1;RABL6;RIT2;RHOU;TUBB;ARF3;RAB11B;RAC2;RAB35;RAB2A;TUBD1;ARL4C;RAB5A;MMAA;RAC1;LRRK2;DRG1;RAB6A
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3529069333580405,0.845494234720442,0.7229660144181257,1.0,1.0,20/83,17.67%,USP27X;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP25;USP21;USP40;USP7
prerank,cytochrome-c oxidase activity (GO:0004129),0.4162478742297627,0.8450473579215764,0.6605263157894737,1.0,1.0,3/15,13.49%,COX10;COX4I1;NDUFA4
prerank,cell-cell adhesion mediator activity (GO:0098632),0.36501413444780323,0.8447517618038165,0.686059275521405,1.0,1.0,12/42,23.30%,CD47;STXBP6;S100A11;BSG;PALLD;EMB;PDLIM5;PPP1CA;CDC42EP1;CNTN4;RAB10;DSCAM
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.35206910790297896,-0.842847747753141,0.6713286713286714,0.9156125203578519,1.0,4/10,6.91%,KDM7A;KDM4A;PHF8;KDM4B
prerank,guanyl ribonucleotide binding (GO:0032561),0.35002268427700284,0.8417278919532588,0.8328328328328328,1.0,1.0,41/196,18.30%,RRAD;ARHGEF5;GBP4;TUBA1C;NOA1;ATL2;ARL5C;TUBB4B;REM1;ARL11;RAB1B;RAB22A;TUBA1B;ARF4;RND3;PDE2A;GBP2;GNAI1;RAB8A;MTG2;SEPHS1;RABL6;RIT2;RHOU;SLC19A1;TUBB;RAB8B;ARF3;PDE5A;RAB11B;RAC2;RAB35;RAB2A;TUBD1;ARL4C;RAB5A;MMAA;RAC1;LRRK2;DRG1;RAB6A
prerank,phospholipase activator activity (GO:0016004),0.43980470647027836,0.8410350107053941,0.65149359886202,1.0,1.0,3/10,10.94%,FYN;PDPK1;BTK
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2511883814043989,-0.8404240715130776,0.7533333333333333,0.9127971149799381,1.0,3/24,5.37%,KCNN2;KCNK6;KCNJ6
prerank,actinin binding (GO:0042805),0.39882999429780835,0.8398123105294818,0.6725219573400251,1.0,1.0,7/21,19.93%,CSRP3;SYNPO2;CSRP1;MAGI1;DAG1;PDLIM5;PKD2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4225489609108925,0.8388302557974169,0.6657608695652174,1.0,1.0,5/14,23.74%,KMO;CYBB;CYBA;NCF4;AIFM1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.33865578506519856,-0.8362354190954773,0.6621160409556314,0.9142624856649039,1.0,2/11,2.08%,KCNMA1;KCNN2
prerank,RNA polymerase II complex binding (GO:0000993),0.37382137179500274,0.8354177197268422,0.6916201117318436,1.0,1.0,14/32,23.07%,BRD4;ZNF326;RPRD1B;CCAR2;DHX9;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,Hsp70 protein binding (GO:0030544),0.3752261354300331,0.835326562666501,0.7005714285714286,1.0,1.0,12/31,25.86%,SPN;DNAJC18;DNAJC2;DNAJC8;DNAJB1;SNCA;RPS3;HDAC8;DNAJB12;DNAJB14;DNAJC10;DNAJB2
prerank,transition metal ion binding (GO:0046914),0.3427696687153282,0.8338155183704699,0.918,1.0,1.0,82/397,18.45%,UHRF1;RNF26;TK1;MEFV;BLM;CUTA;CUTC;ZCCHC4;RIOX1;HEPH;DHX58;HDAC10;S100A9;TNFSF10;CTCF;COA6;FEN1;RASGRP1;SNRPC;IMPA1;S100A8;MDM4;DPEP1;MBD1;CDADC1;PDE2A;GDA;BIRC2;PRIMPOL;MGAT2;TDP2;BAZ1B;PHF2;SEC24B;SEC24A;PITRM1;TAB3;CSRP1;RPS27;PIM1;TIMM9;EGR1;ZBTB32;TMEM163;KAT6A;ZEB1;ZMYND8;NAPEPLD;ATP7A;RPS29;PARK7;LTA4H;RNF8;ISCA2;RNF2;KMT2A;HHIP;GLO1;SKI;ARIH2;KDM4C;LIMS1;TP53;KMT2B;RC3H1;PDXK;TRIM28;CRIP1;ACER3;KPNB1;DUSP12;ATOX1;SLC30A5;EPRS1;LACTB2;SNCA;RASSF1;CYP2R1;HDAC4;KDM2B;ERAP1;RNPEP
prerank,NADP binding (GO:0050661),0.36856667092046697,0.8330826827245589,0.6850574712643678,1.0,1.0,7/32,19.58%,LBR;CBR4;ME3;DHCR7;GMDS;DECR1;PGD
prerank,potassium:proton antiporter activity (GO:0015386),0.4339698203859023,0.8298678640642277,0.6564245810055865,1.0,1.0,4/10,19.15%,SLC9A8;SLC9A9;SLC9A6;SLC9A7
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.41325594569038154,0.8291666836663004,0.6680384087791496,1.0,1.0,1/14,2.57%,PYCR3
prerank,frizzled binding (GO:0005109),-0.2363930261793432,-0.8273843651817284,0.8050847457627118,0.924708854828994,1.0,23/34,47.20%,RYK;DVL3;DVL2;WNT5B;DVL1;FZD7;WNT4;WNT5A;LRP6;BAMBI;WNT2B;MYOC;WNT7B;WNT7A;NDP;WNT3;WNT9A;SFRP1;ZNRF3;SDCBP;FZD1;WNT6;WNT8B
prerank,voltage-gated sodium channel activity (GO:0005248),0.38403369820927424,0.8255198977438646,0.6804374240583232,1.0,1.0,2/22,3.54%,CACNA1I;HCN3
prerank,glycerophospholipid flippase activity (GO:0140333),0.4337916895699503,0.8250608962421357,0.6762688614540466,1.0,1.0,4/11,20.72%,ATP11C;ATP8A1;ATP11A;ATP8B2
prerank,small GTPase binding (GO:0031267),0.34327664157724364,0.825033889933406,0.8303212851405622,1.0,1.0,41/169,19.82%,BIRC5;RCC1;EXOC2;FLNA;ARHGDIB;EXOC4;CAV1;RANGAP1;RIN3;EVI5;CIB1;RAB8A;ERC1;CYRIB;FGD6;LSM2;TNFAIP1;PEX5L;PDE6D;WHAMM;GGA1;FGD3;RANBP2;RNF152;EXOC5;BRK1;CHML;TRIOBP;PAK2;FMNL1;ATP6AP1;LRRK2;GGA2;NDRG1;IQGAP1;AP3M1;MAPKAP1;ARHGAP1;SGSM3;OCRL;HPS4
prerank,carboxylic acid binding (GO:0031406),-0.23317653244890088,-0.8249651056072239,0.7628865979381443,0.9219959388470684,1.0,22/38,42.32%,PSAP;GRIN3A;MAG;GLRA2;GLUD1;SESN3;SESN2;GRIN2B;SHMT2;SHMT1;NOS1;GLRA3;CAD;GRIN1;CASTOR1;CASTOR2;SRR;GNMT;UBR1;RTN4R;THNSL2;GRIN3B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3864216758908585,0.8235233717943523,0.7032181168057211,1.0,1.0,6/23,16.60%,PLCG2;PLCB1;PLCB3;CHRM3;PLCD1;PLCG1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.38136431862692,0.8222024403358502,0.6926889714993805,1.0,1.0,3/21,8.09%,EZR;AKAP7;PRKACA
prerank,adrenergic receptor binding (GO:0031690),-0.2838401524069037,-0.8200037343520251,0.7272727272727273,0.9244410528406267,1.0,6/16,25.57%,GNAS;ARRDC3;ADRB1;DLG4;AKAP5;C1QBP
prerank,translation elongation factor activity (GO:0003746),0.41628219544260425,0.8192803724181932,0.6966442953020134,1.0,1.0,4/14,16.05%,EEF1B2;GFM2;EIF5A2;EEF2
prerank,sialyltransferase activity (GO:0008373),-0.2683490677016968,-0.8174967163627781,0.7348066298342542,0.9219654217156588,1.0,9/20,20.58%,ST8SIA1;ST3GAL6;ST6GALNAC4;ST6GAL2;ST6GALNAC6;ST3GAL4;ST8SIA5;ST6GALNAC3;ST8SIA3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3401758488558726,0.8159470075016836,0.8568568568568569,1.0,1.0,50/181,20.70%,HEY2;RB1;ZFPM1;MTA3;RBBP8;RBL1;CDKN2A;TAF1;FAF1;TCF3;DDRGK1;SPEN;SMARCA4;MAPK14;NCOA7;TACC2;PIAS3;HIRA;HIPK2;TAF6;JUN;DHX9;MTA2;CDK5RAP3;NFE2L2;BBS4;ACTN4;BEX1;CREBBP;RERE;GSK3B;TADA3;TP53;PIAS1;SIN3A;TCF7L2;COMMD6;TCERG1;SIRT1;HCLS1;HDAC4;MED1;CREB1;PROX1;HDAC1;PRRX1;NCOA2;RBPJ;FIZ1;PPARD
prerank,exoribonuclease activity (GO:0004532),0.42005807972589554,0.8146373262979542,0.6826923076923077,1.0,1.0,4/12,20.79%,EXOSC8;EXOSC10;CNOT6;CNOT7
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3395740175709692,0.8135773579072237,0.8355196770938446,1.0,1.0,23/147,15.40%,ECT2;ARHGEF5;PSD;RCC1;CCDC88A;TIAM1;ARHGEF18;RASGRP1;RIN3;CCDC88C;DENND4C;EEF1B2;FGD6;SOS1;ARHGEF28;FGD3;DENND1B;DENND1A;LAMTOR4;DENND6A;LAMTOR3;BCR;EGF
prerank,MAP-kinase scaffold activity (GO:0005078),0.41952323003696274,0.8113003550839993,0.6754002911208151,1.0,1.0,7/11,27.72%,SPAG9;MAP2K1;SH3RF1;IQGAP1;KSR1;AKAP13;MAPK8IP1
prerank,endopeptidase regulator activity (GO:0061135),0.3605906495983484,0.8112856042875981,0.7346491228070176,1.0,1.0,7/40,13.51%,PSMF1;SLPI;ABCA2;PCSK1N;UCHL5;USP14;PSME1
prerank,chemorepellent activity (GO:0045499),-0.24461214006252846,-0.8099076925714875,0.8137931034482758,0.9284130483126103,1.0,13/25,36.83%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;SEMA3A;SEMA7A;SEMA4D;NRG3;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.42278501750058284,0.8094143405949062,0.7018544935805991,1.0,1.0,1/10,2.56%,CD47
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.42568027245554385,0.8093435257271205,0.6832386363636364,1.0,1.0,5/10,22.37%,PKIG;PRKAG2;PRKAR2A;PRKAG1;PKIA
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.31429627902956314,-0.8089969194373774,0.693950177935943,0.9224996988153403,1.0,6/12,31.77%,SDHB;ISCA1;ISCU;CIAPIN1;FDX1;AOX1
prerank,muscle alpha-actinin binding (GO:0051371),0.3992384326273458,0.8068053034953365,0.7178082191780822,1.0,1.0,5/15,19.93%,SYNPO2;PDLIM7;PALLD;PDLIM5;PKD2
prerank,voltage-gated anion channel activity (GO:0008308),0.3972082919107404,0.806282276625237,0.6879150066401063,1.0,1.0,1/15,3.04%,VDAC2
prerank,omega peptidase activity (GO:0008242),0.3359997074749405,0.8055762748701457,0.7829218106995884,1.0,1.0,20/89,17.67%,USP27X;USP1;TANK;USP38;DESI2;USP48;USP31;BAP1;UCHL5;USP14;USP24;USP15;VCPIP1;OTUD5;USP50;YOD1;USP25;USP21;USP40;USP7
prerank,actin monomer binding (GO:0003785),0.37571652869174754,0.8040286701720233,0.7216867469879518,1.0,1.0,3/22,11.25%,PRKCE;LIMA1;MTSS1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3572255592488172,0.8010359967213931,0.7229050279329609,1.0,1.0,14/33,23.07%,ZNF326;SPTY2D1;RPRD1B;CCAR2;DHX9;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3541355940428419,0.799548061944845,0.7240990990990991,1.0,1.0,7/35,12.73%,DUS1L;GATC;TRDMT1;FTO;TRMT5;TYW3;NT5C3A
prerank,CARD domain binding (GO:0050700),0.3995373082261287,0.7991845348889444,0.7085492227979274,1.0,1.0,2/14,10.76%,CARD10;CARD9
prerank,insulin-like growth factor I binding (GO:0031994),-0.2984028947745168,-0.7989970514329953,0.7068273092369478,0.9332119033276921,1.0,7/13,32.60%,IGF1R;ITGB3;IGFBP4;INSR;ITGB4;IGFBP6;IGFBP3
prerank,outward rectifier potassium channel activity (GO:0015271),-0.313718519008371,-0.7984002460577577,0.7317880794701986,0.9270147620008781,1.0,3/11,16.46%,KCND2;KCND1;KCND3
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3630690314853764,0.7977832284712763,0.7348130841121495,1.0,1.0,1/27,1.13%,SLC12A3
prerank,ferrous iron binding (GO:0008198),0.3725286450769031,0.7959091366975273,0.7022058823529411,1.0,1.0,3/21,6.50%,HAAO;HEPH;FTO
prerank,myosin II binding (GO:0045159),0.4177890519814301,0.7950452360433272,0.7068965517241379,1.0,1.0,4/10,22.12%,GSN;SHROOM4;TRIOBP;SHROOM1
prerank,insulin-like growth factor binding (GO:0005520),-0.2813577296647199,-0.792174540221675,0.7391304347826086,0.9307131488019544,1.0,11/15,42.17%,IGF1R;ITGB3;IGFBP4;INSR;ITGB4;IGFBP6;IGFBP3;IGF2R;LRP2;IGFBP5;IGFALS
prerank,mannosyltransferase activity (GO:0000030),0.3685430539421973,0.7845599989109323,0.7123947051744886,1.0,1.0,10/21,28.55%,ALG8;TMTC2;POMT1;PIGM;POMT2;TMTC4;PIGV;DPY19L1;TMTC1;TMTC3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.34878249073400736,0.782463453336298,0.7621744054360136,1.0,1.0,7/34,19.40%,RACGAP1;PHLDA3;BTK;ARHGAP9;IQGAP1;KIF16B;MAPKAP1
prerank,thyroid hormone receptor binding (GO:0046966),0.36257363662102826,0.7815185186849569,0.7446808510638298,1.0,1.0,10/28,23.07%,BRD8;MED30;TAF7;MED1;THRAP3;NCOA6;MED13;TAF11;NSD1;NCOA3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.38348137067940735,0.7793683242891337,0.7064220183486238,1.0,1.0,4/14,18.99%,AK9;NME4;AK5;CMPK2
prerank,GTPase regulator activity (GO:0030695),0.3228665719530541,0.7760599838186715,0.9219219219219219,1.0,1.0,42/212,15.66%,ECT2;RACGAP1;GPSM2;ARHGAP15;ARHGAP11A;TBC1D1;RGS12;ARHGAP33;CCDC88A;SEC23B;TBC1D8B;TBC1D22B;RANGAP1;EVI5;ARHGAP35;ARFGAP3;ARFGAP1;RP2;RAP1GAP2;SOS1;ARHGAP19;LARS1;GMIP;PDE6D;IPO7;STARD8;ARHGAP39;ASAP2;ARHGAP30;JUN;PLCB1;RANBP2;ARHGAP9;NRP1;ARHGAP45;ADAP1;ARHGAP26;TBC1D25;ARHGAP31;BCR;IPO5;NPRL3
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.19956473060557176,-0.7725795509657861,0.9333333333333333,0.957411555217966,1.0,29/49,37.96%,PCLO;ANXA3;SYT1;SYT4;ANXA4;SYT7;SYT9;SYT6;CPNE4;CPNE2;PLA2G4E;ANXA2;ANXA6;ANXA9;DYSF;ANXA1;PLA2G4A;SYT12;SYT11;CPNE9;SYT13;CPNE5;PLA2G4C;ESYT3;ESYT1;SYT5;ANXA5;SYT17;RPH3A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3911002849666505,0.7719668954353924,0.7180192572214581,1.0,1.0,2/11,18.23%,SLC25A47;SLC22A4
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.3896490694917037,0.7715950091312737,0.727390180878553,1.0,1.0,3/14,13.14%,APAF1;BCL2L13;RACK1
prerank,GTPase binding (GO:0051020),0.3186482447948861,0.7708570639459003,0.9059059059059059,1.0,1.0,62/194,24.93%,BIRC5;RCC1;EXOC2;FLNA;ARHGDIB;EXOC4;CAV1;RANGAP1;RIN3;EVI5;CIB1;RAB8A;ERC1;CYRIB;FGD6;LSM2;TNFAIP1;PEX5L;PDE6D;WHAMM;GGA1;BECN1;AMBRA1;FGD3;RANBP2;RNF152;EXOC5;BRK1;CHML;TRIOBP;PAK2;FMNL1;ATP6AP1;EPRS1;LRRK2;GGA2;NDRG1;IQGAP1;GNB2;AP3M1;MAPKAP1;ARHGAP1;SGSM3;OCRL;HPS4;RRAGB;BNIP3;TNPO3;RAB34;EVI5L;GNB1;FGD4;CHM;YBX1;EHD1;CDC42EP4;DAPK3;AKAP13;RNF41;RADIL;SRGAP2;TBC1D20
prerank,metallopeptidase activity (GO:0008237),0.3181849049121778,0.7705202428017225,0.848730964467005,1.0,1.0,17/113,19.95%,ADAMTS7;KEL;NRDC;MBTPS2;DPEP1;METAP2;PITRM1;MMP19;ADAMTS1;ADAMTSL3;ADAMTS5;PRPF8;ADAM10;ERAP1;RNPEP;MMP12;MME
prerank,G protein-coupled receptor activity (GO:0004930),0.3179986673300882,0.7684012060480085,0.934,1.0,1.0,22/239,16.32%,ADGRD1;S1PR4;CXCR5;VIPR2;MRGPRE;GPR141;LPAR4;GPR75;P2RY1;CALCRL;GPR63;TAPT1;S1PR2;GPR22;TM2D1;ADGRL3;ADGRV1;F2R;LPAR1;GPR35;LGR4;ELOVL4
prerank,channel activity (GO:0015267),0.33774511475157404,0.7680457211136195,0.7697368421052632,1.0,1.0,1/41,1.86%,AQP1
prerank,sodium:proton antiporter activity (GO:0015385),0.39785846172110284,0.767598733452917,0.7246175243393602,1.0,1.0,4/11,19.15%,SLC9A8;SLC9A9;SLC9A6;SLC9A7
prerank,ATPase activator activity (GO:0001671),-0.24745405801670942,-0.7662739607634612,0.8378378378378378,0.9600461816478147,1.0,6/20,15.60%,DNAJC19;DNAJB6;DNAJA2;ATP1B2;ATP1B1;DNAJC1
prerank,ATPase binding (GO:0051117),0.3223234284321764,0.7656145182902081,0.8068181818181818,1.0,1.0,18/71,20.13%,PEX26;EZR;PPP3CA;CAV1;ANK1;EGFR;RDX;FBL;ZNHIT6;PSEN1;NOP58;TAF9;DNAJB1;USP25;UBXN1;SYVN1;PKD2;SVIP
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3445878217798641,0.7654733852264205,0.7761363636363636,1.0,1.0,14/33,23.07%,ZNF326;LLPH;RPRD1B;CCAR2;DHX9;HNRNPU;ELOF1;SCAF8;PCF11;AGO2;RPRD2;AGO1;ELP4;NCOA3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.38069278033806886,0.7623130126885906,0.7557046979865771,1.0,1.0,3/14,14.54%,SLC25A12;SLC25A22;SLC25A13
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3743269034253517,0.7606707511656846,0.7480314960629921,1.0,1.0,4/16,22.04%,HAAO;PIR;ETHE1;IDO2
prerank,phosphatase activity (GO:0016791),0.3197971457725152,0.7586424873023228,0.8374233128834356,1.0,1.0,12/73,17.89%,PLPPR3;ALPL;PTPN22;PPP1CB;ARMT1;EPHX2;PPP1CC;BPNT2;APTX;PLPPR4;DUSP12;PPP1CA
prerank,transferrin receptor binding (GO:1990459),0.397950754701327,0.7579214147366721,0.7394366197183099,1.0,1.0,1/10,5.75%,IKBKG
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.2736938747461837,-0.7574556376647467,0.7990867579908676,0.965968177120082,1.0,5/15,24.42%,PIK3R5;PIK3R1;SOCS7;PIK3R2;SOCS5
prerank,poly-pyrimidine tract binding (GO:0008187),0.3525203585280009,0.7572530948630505,0.7663438256658596,1.0,1.0,4/23,13.54%,HNRNPC;RBMS2;HNRNPU;DAZAP1
prerank,myosin V binding (GO:0031489),-0.27325256093094763,-0.7556527020879414,0.7865612648221344,0.9613989266873947,1.0,6/15,21.39%,RAB14;RAB6B;RAB11A;RAB3C;RAB3A;RAB3B
prerank,cholesterol binding (GO:0015485),0.32713454539962,0.7546964989533713,0.7962962962962963,1.0,1.0,7/47,11.35%,VDAC2;OSBP2;CAV1;OSBPL5;TSPO;OSBPL3;STARD5
prerank,bHLH transcription factor binding (GO:0043425),0.3637840089699449,0.7542777731320512,0.775840597758406,1.0,1.0,3/19,6.33%,TWIST1;USF1;TCF3
prerank,semaphorin receptor activity (GO:0017154),-0.30268579657974065,-0.7534539919180472,0.8105263157894737,0.957477355794949,1.0,2/11,2.38%,NRP2;PLXNA4
prerank,kinase activity (GO:0016301),0.3133884447978869,0.748610175493891,0.8789101917255298,1.0,1.0,26/109,21.36%,MASTL;FN3KRP;PANK2;CHKB;TAF1;PRKD3;PKN2;RFK;SEPHS1;NADK2;PAPSS2;DCAKD;DGKD;STK39;CDC7;GSK3B;PDXK;PIK3CA;PGK1;LRRK2;TAOK1;PANK1;NADK;PKMYT1;CHKA;DGKE
prerank,GTPase activator activity (GO:0005096),0.310191603534631,0.748461240283308,0.966,1.0,1.0,56/313,15.66%,ECT2;RACGAP1;ARHGEF5;PSD;ARHGAP15;ARHGAP11A;RCC1;TBC1D1;ARHGAP33;CCDC88A;SEC23B;TIAM1;TBC1D8B;TBC1D22B;ARHGEF18;RASGRP1;RANGAP1;RIN3;EVI5;CCDC88C;DENND4C;EEF1B2;ARHGAP35;ARFGAP3;ARFGAP1;RP2;RAP1GAP2;FGD6;SOS1;ARHGAP19;LARS1;GMIP;STARD8;ARHGAP39;ASAP2;ARHGAP30;JUN;PLCB1;ARHGEF28;FGD3;RANBP2;DENND1B;ARHGAP9;NRP1;DENND1A;ARHGAP45;ADAP1;LAMTOR4;DENND6A;LAMTOR3;ARHGAP26;TBC1D25;ARHGAP31;BCR;EGF;NPRL3
prerank,GABA receptor binding (GO:0050811),-0.296530432163964,-0.7471101397690615,0.8247422680412371,0.9600718048203533,1.0,5/11,25.12%,ARFGEF2;PLCL2;LHFPL4;AKAP5;SHISA7
prerank,potassium ion antiporter activity (GO:0022821),0.364288285410275,0.741654838427197,0.767833981841764,1.0,1.0,6/15,19.15%,SLC9A8;SLC24A4;SLC24A2;SLC9A9;SLC9A6;SLC9A7
prerank,histone deacetylase activity (GO:0004407),0.35501559459434406,0.7409249249254514,0.7729528535980149,1.0,1.0,10/19,25.59%,HDAC10;HDAC6;SIRT7;SIRT1;HDAC4;HDAC1;HDAC8;HDAC9;MIER1;HDAC11
prerank,poly(U) RNA binding (GO:0008266),0.35206984898752414,0.7406730697117585,0.782716049382716,1.0,1.0,3/20,13.54%,HNRNPC;RBMS2;DAZAP1
prerank,nucleotide diphosphatase activity (GO:0004551),0.3678991626209679,0.7403195872648136,0.7710526315789473,1.0,1.0,2/14,8.86%,NUDT13;NUDT4
prerank,peptidase inhibitor activity (GO:0030414),0.33534690595815164,0.7387541393735494,0.7915717539863326,1.0,1.0,5/33,12.90%,PSMF1;SLPI;PCSK1N;UCHL5;USP14
prerank,peptidase activator activity (GO:0016504),0.3474711148171012,0.7308891813740477,0.7858910891089109,1.0,1.0,10/22,25.82%,TANK;CAV1;PSME1;PCOLCE2;PSME4;PSME2;PSME3;CASP8AP2;NLRC4;VCP
prerank,phospholipase C activity (GO:0004629),0.33606236844466836,0.7303781163675279,0.8028169014084507,1.0,1.0,6/25,16.60%,PLCG2;PLCB1;PLCB3;CHRM3;PLCD1;PLCG1
prerank,sodium channel activity (GO:0005272),0.32169989634438434,0.726648478964047,0.8153503893214683,1.0,1.0,3/37,7.35%,CACNA1I;HCN3;SHROOM2
prerank,mannose binding (GO:0005537),-0.28203894675770064,-0.7237321051576799,0.8256227758007118,0.985240464344942,1.0,4/12,31.68%,CLN5;CLEC4D;LMAN2;CLEC6A
prerank,NAD+ binding (GO:0070403),0.36614020025249927,0.7208237257629989,0.775886524822695,1.0,1.0,6/12,26.13%,HPGD;UXS1;SIRT1;CRYL1;ZC3HAV1;PARP9
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.32432165965148496,0.7179302512812551,0.8173719376391982,1.0,1.0,4/32,6.50%,ALKBH4;RIOX1;JMJD4;FTO
prerank,ion channel activity (GO:0005216),0.3031938156008733,0.7121517050038086,0.8721881390593047,1.0,1.0,4/80,7.88%,CHRNB4;P2RX1;TMC4;TRPM7
prerank,tRNA methyltransferase activity (GO:0008175),0.3475523511157901,0.7119397087723682,0.803594351732991,1.0,1.0,3/16,11.40%,TRDMT1;TRMT5;TYW3
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.2925264413981544,-0.7098130243124271,0.8456591639871383,0.9887386738201891,1.0,2/10,12.78%,DUSP10;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.2925264413981544,-0.7098130243124271,0.8456591639871383,0.9887386738201891,1.0,2/10,12.78%,DUSP10;DUSP7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.36988631391169546,0.7089348775795026,0.7917261055634808,1.0,1.0,1/11,9.21%,KCNJ3
prerank,solute:sodium symporter activity (GO:0015370),-0.2058435438265787,-0.7080079133700306,0.9259259259259259,0.9834937711520386,1.0,27/27,79.46%,SLC5A7;SLC4A8;SLC5A11;SLC5A6;SLC28A2;SLC4A9;SLC13A5;SLC4A10;SLC28A1;SLC4A5;SLC5A1;SLC5A10;SLC20A1;SLC5A2;SLC17A7;SLC34A3;SLC34A2;SLC17A2;SLC17A1;SLC5A8;SLC34A1;SLC5A9;SLC28A3;SLC4A4;SLC4A7;SLC5A3;SLC20A2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.37578272752643194,0.7076858333530582,0.7803468208092486,1.0,1.0,4/10,19.45%,CASP2;CFLAR;CASP9;CASP8
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2997741670269979,0.7064698092054843,0.8663212435233161,1.0,1.0,15/69,23.43%,ESCO2;MOGAT2;KAT6A;KAT2B;NAA16;CERS4;ZDHHC7;CREBBP;CERS6;CERS2;ELP3;ZDHHC6;SOAT1;LPCAT3;ZDHHC21
prerank,nucleoside-diphosphatase activity (GO:0017110),0.36653424035850546,0.7055321078446853,0.7981029810298103,1.0,1.0,3/12,17.22%,ENTPD3;ENTPD5;CANT1
prerank,fatty acid synthase activity (GO:0004312),0.37109231465336545,0.7003585698410644,0.7941176470588235,1.0,1.0,3/10,16.32%,CBR4;ELOVL5;ELOVL4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2932009299540093,0.6986582070421669,0.8886597938144329,1.0,1.0,23/78,21.37%,ESPL1;USP1;CASP2;USP38;CAPN1;USP48;CTSO;CTSK;USP14;CFLAR;USP24;CASP9;USP15;CAPN10;USP25;USP40;USP7;MALT1;CASP8;USP34;CAPN15;USP46;USP47
prerank,poly(A) binding (GO:0008143),0.3262331277106352,0.6963535260606125,0.8157894736842105,1.0,1.0,5/21,18.46%,EIF4A3;ELAVL4;RBMS2;HNRNPU;PPIE
prerank,platelet-derived growth factor binding (GO:0048407),0.3610503658148742,0.6948048639736939,0.8067700987306065,1.0,1.0,2/11,17.17%,COL1A2;COL4A1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2924649686015328,0.6924932612470718,0.8853633572159673,1.0,1.0,7/73,16.02%,VIPR2;NPSR1;SORCS2;CALCRL;S1PR2;F2R;LGR4
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.34231879291341427,0.6905440202493794,0.8179384203480589,1.0,1.0,2/14,16.24%,RDH10;RDH5
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.22275728131514916,-0.6893576237636785,0.9116022099447514,0.9978825586876726,1.0,1/21,1.64%,FRS2
prerank,cardiolipin binding (GO:1901612),0.3660367982645529,0.688869049569875,0.811046511627907,1.0,1.0,2/10,19.95%,NME4;MME
prerank,endopeptidase inhibitor activity (GO:0004866),0.29265185453102277,0.6876421587819075,0.9177800616649537,1.0,1.0,10/82,12.90%,UBE2O;PSMF1;LXN;SLPI;UBE2Z;BIRC6;PCSK1N;PTTG1;UCHL5;USP14
prerank,ligand-gated calcium channel activity (GO:0099604),0.3276281586789448,0.6859184348520929,0.8301886792452831,1.0,1.0,1/19,3.00%,ITPR1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.3191176725090041,0.685430601759197,0.8442028985507246,1.0,1.0,4/22,17.49%,HSPG2;CLTC;LDLRAP1;HSP90B1
prerank,cysteine-type peptidase activity (GO:0008234),0.28823828148713493,0.6846234765114723,0.8882051282051282,1.0,1.0,22/73,21.37%,ESPL1;USP1;CASP2;USP38;USP48;ATG4B;CTSO;CTSK;USP14;USP24;CASP9;USP15;USP50;USP25;USP21;USP40;USP7;MALT1;CASP8;USP34;USP46;USP47
prerank,pseudouridine synthase activity (GO:0009982),-0.26002584573510146,-0.6824055429957826,0.884,0.9979610276611816,1.0,2/13,3.29%,PUS10;PUS7
prerank,glucuronosyltransferase activity (GO:0015020),0.3273446779288881,0.6823315521939561,0.838036809815951,1.0,1.0,4/19,20.60%,EXT1;CHSY1;B3GAT2;B3GAT1
prerank,alpha-actinin binding (GO:0051393),0.31501591761880976,0.6811236523779529,0.8419117647058824,1.0,1.0,7/24,19.93%,SYNPO2;PDLIM7;MAGI1;PALLD;DAG1;PDLIM5;PKD2
prerank,titin binding (GO:0031432),0.33730276899073275,0.6790756780377066,0.8282694848084544,1.0,1.0,2/13,10.23%,MYBPC1;ACTN2
prerank,GTPase inhibitor activity (GO:0005095),-0.25957739357389426,-0.6774021396051223,0.87890625,0.9961223365094194,1.0,5/13,17.53%,TNK2;GPS2;RHOH;CDC42SE1;ARL2
prerank,lipoprotein particle receptor binding (GO:0070325),0.30787597691414137,0.6745097311388375,0.86,1.0,1.0,5/27,17.49%,HSPG2;CLTC;RELN;LDLRAP1;HSP90B1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2871124721823935,0.6742594587366169,0.8753993610223643,1.0,1.0,16/49,24.37%,PTPN22;PPP1CB;ARMT1;EPHX2;PPP1CC;APEX1;DUSP12;PPP1CA;ENPP6;MPPED2;DUSP16;SMPD1;SACM1L;PGP;PGAM5;SAMHD1
prerank,poly-purine tract binding (GO:0070717),0.3056305093109427,0.6739388856874116,0.8392857142857143,1.0,1.0,7/27,20.25%,EIF4A3;ELAVL4;RBMS2;HNRNPU;DAZAP1;PPIE;PNPT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3475553702396011,0.6727819213637836,0.8240223463687151,1.0,1.0,1/10,6.22%,DPEP1
prerank,neuropeptide receptor activity (GO:0008188),0.3051625148059561,0.67237381456347,0.8661327231121282,1.0,1.0,2/29,8.70%,NPSR1;SORCS2
prerank,adenylate cyclase binding (GO:0008179),0.353739806704097,0.670927801649248,0.8138528138528138,1.0,1.0,1/10,3.36%,AKAP12
prerank,Notch binding (GO:0005112),-0.20760325384091774,-0.6700485198230037,0.9473684210526315,0.9959731281067032,1.0,10/22,30.56%,GALNT11;JAG1;SNED1;MEGF10;AAK1;KCTD10;TCIM;JAG2;DLK2;NOTCH4
prerank,O-methyltransferase activity (GO:0008171),0.34955373011514723,0.6693212346284361,0.8194640338504936,1.0,1.0,2/10,16.09%,CMTR2;LRTOMT
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.28867179565983747,0.6631665974522194,0.8716216216216216,1.0,1.0,10/38,20.94%,SNX3;PHLDA3;DENND1A;RUBCNL;ZFYVE26;ATG2B;KIF16B;NCF4;WDR45B;SNX13
prerank,nucleotidase activity (GO:0008252),0.31977434550098627,0.6607964386795705,0.84251968503937,1.0,1.0,3/15,12.73%,NT5C2;BPNT2;NT5C3A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3087324138375844,0.6607271934212585,0.8343409915356711,1.0,1.0,2/22,13.37%,HTR2A;CHRM3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3087324138375844,0.6607271934212585,0.8343409915356711,1.0,1.0,2/22,13.37%,HTR2A;CHRM3
prerank,serotonin receptor activity (GO:0099589),0.3087324138375844,0.6607271934212585,0.8343409915356711,1.0,1.0,2/22,13.37%,HTR2A;CHRM3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.32936523283650687,0.660275661630541,0.8306878306878307,1.0,1.0,2/15,10.59%,CCR2;CCR6
prerank,Tat protein binding (GO:0030957),-0.27677718431664033,-0.6582187576446932,0.88,1.0,1.0,3/10,20.43%,MDFIC;ACTB;TRIM32
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2758845268839563,0.6580764047534917,0.8957055214723927,1.0,1.0,15/72,20.78%,STXBP6;PHLDA3;CGAS;GSN;FLII;ACTN2;PLCB1;KCNJ2;RAB35;PLCD1;LDLRAP1;AMER2;MAPKAP1;MARK1;SVIL
prerank,intracellular chloride channel activity (GO:0061778),0.3255301073780983,0.6574482870638979,0.8646232439335888,1.0,1.0,3/16,17.56%,ANO10;ANO3;ANO6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3255301073780983,0.6574482870638979,0.8646232439335888,1.0,1.0,3/16,17.56%,ANO10;ANO3;ANO6
prerank,calcium activated cation channel activity (GO:0005227),0.31952685781513124,0.6560390740166089,0.8610747051114024,1.0,1.0,2/17,4.93%,ANO10;KCNN4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3347540187858245,0.6556581712057212,0.8228882833787466,1.0,1.0,5/12,22.23%,TUT1;TENT2;TENT5D;PAPOLA;TENT4A
prerank,sterol binding (GO:0032934),0.27837693313850115,0.6536507962068202,0.8854718981972428,1.0,1.0,7/56,11.35%,VDAC2;OSBP2;CAV1;OSBPL5;TSPO;OSBPL3;STARD5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.28102109937479797,0.650412485186316,0.9003147953830011,1.0,1.0,23/54,28.78%,GLS2;HDAC10;HDAC6;SIRT7;NTAQ1;DARS1;ACER3;SIRT1;HDAC4;HDAC1;HDAC8;NAAA;SIRT4;NADSYN1;HDAC9;NIT2;MIER1;HDAC11;HINT1;ASRGL1;NIT1;ASAH1;PIGL
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.33810420590081575,0.6496446049512179,0.8372413793103448,1.0,1.0,12/12,66.22%,ELOVL4;GNAT2;OPN1SW;RHO;OPN4;OPN5;OPN1MW;OPN1MW3;GPR52;RRH;GPR88;OPN3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.30172118177410157,0.64865299990595,0.872366790582404,1.0,1.0,4/24,19.67%,SNX3;OSBPL5;RUBCNL;GOLPH3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.3411583518939249,0.6471504524746158,0.8419540229885057,1.0,1.0,3/10,19.32%,CYBB;CYBA;NCF4
prerank,retinoid binding (GO:0005501),-0.2083546649734617,-0.645652044986545,0.935,1.0,1.0,15/22,49.65%,PTGDS;RARA;RBP4;ALDH1A2;CYP26B1;RBP1;ABCA4;CYP26C1;CRABP2;CRABP1;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1
prerank,snoRNA binding (GO:0030515),0.2912087672825833,0.6448861106008523,0.871264367816092,1.0,1.0,6/30,18.03%,NOP10;NUDT4;UTP6;PRKDC;NOP58;DKC1
prerank,metal ion:proton antiporter activity (GO:0051139),0.32625655127054354,0.6443727877094427,0.8563758389261745,1.0,1.0,4/13,19.15%,SLC9A8;SLC9A9;SLC9A6;SLC9A7
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3284522881870209,0.6428016399985347,0.8534246575342466,1.0,1.0,4/12,19.15%,SLC9A8;SLC9A9;SLC9A6;SLC9A7
prerank,iron ion binding (GO:0005506),0.2766373814604759,0.6388126124902975,0.9016216216216216,1.0,1.0,5/48,7.99%,HAAO;RIOX1;HEPH;FTO;PHF2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.29715848306877035,0.638053288386593,0.88,1.0,1.0,8/25,26.13%,ART3;PARP14;SIRT1;SIRT4;PARP11;ZC3HAV1;PARP1;PARP9
prerank,Hsp90 protein binding (GO:0051879),0.29022950972493616,0.6377622582855936,0.8942528735632184,1.0,1.0,10/33,25.14%,HDAC6;AHR;UNC45A;AHSA1;RPS3;NPAS2;HDAC8;MAPT;TELO2;STIP1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3242983294033466,0.6367644228085166,0.873015873015873,1.0,1.0,5/12,20.79%,PNLDC1;CNOT1;CNOT6;CNOT8;CNOT7
prerank,ribonuclease P RNA binding (GO:0033204),-0.2624682825607302,-0.6366649829941263,0.8941605839416058,1.0,1.0,6/10,35.26%,RPP14;RPP21;RPP38;RPP40;POP5;POP7
prerank,death receptor activity (GO:0005035),0.3297318823132617,0.6360466770573384,0.8666666666666667,1.0,1.0,2/11,15.49%,FAS;TNFRSF11A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3077306117559386,0.6292842564354577,0.8791773778920309,1.0,1.0,4/15,14.99%,KMT2C;KMT2A;RBBP5;KMT2B
prerank,anion channel activity (GO:0005253),0.27075343931809237,0.6249860008543348,0.9279749478079332,1.0,1.0,7/61,10.85%,VDAC2;GABRA4;LRRC8B;CLIC1;LRRC8C;GABRA5;ANO3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.30028487457144337,0.6247224746201785,0.8883248730964467,1.0,1.0,4/19,16.41%,ERBB3;EGF;PAK2;CD24
prerank,estrogen receptor binding (GO:0030331),0.2830724507977142,0.6239340121623798,0.9012775842044135,1.0,1.0,11/32,23.06%,LEF1;STRN;LATS1;CNOT1;MED1;DDX54;NCOA6;MMS19;NRIP1;PHB2;NSD1
prerank,wide pore channel activity (GO:0022829),-0.19127280499948096,-0.6232785039003482,0.9613259668508287,1.0,1.0,11/23,47.20%,GJA1;GJC2;GJB1;GJC1;GJD3;PANX2;PANX1;GJB2;GJD2;PRF1;GJA5
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.29212403695828354,0.6224196562098931,0.8834586466165414,1.0,1.0,7/20,21.40%,AK9;MAGI3;AK3;AK6;CMPK2;AK2;CASK
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3042999784880459,0.6206216317174031,0.8586810228802153,1.0,1.0,3/15,16.81%,ATM;PI4K2B;PIK3CA
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.31637508110483376,0.6105583288201225,0.8727524204702628,1.0,1.0,4/11,19.45%,CASP2;CFLAR;CASP9;CASP8
prerank,protein phosphorylated amino acid binding (GO:0045309),0.26645109730497946,0.6088616185176027,0.9248618784530387,1.0,1.0,13/42,23.03%,CRKL;PIN1;GRB2;PLCG2;CRK;IRS1;PTPN5;LDLRAP1;YWHAE;SYK;FGR;PTPN11;NEDD4
prerank,calcium ion binding (GO:0005509),0.25006955470183706,0.6059980995655794,0.999,1.0,1.0,53/323,20.96%,EFCAB11;SLC25A12;C2CD5;ITPR1;S100A11;PPP3CA;RCN3;S100A9;SYT8;RASGRP1;S100A8;GSN;CIB1;CDH18;CDH24;SMOC2;CAPN1;CEMIP2;MELK;DNER;MICU3;SYT3;SLIT3;SLIT1;CRACR2A;CANX;BAIAP3;MICU1;TPM4;ADGRL3;SLC25A13;TPT1;ANXA11;ADGRV1;GCA;NDUFAB1;CDH4;ACER3;TRPM4;CANT1;HSP90B1;MCTP1;IQGAP1;SNCA;NRXN1;S100A10;PKD2;MMP12;CDH19;CDH20;CDH7;CCDC47;SYT2
prerank,SH2 domain binding (GO:0042169),0.27006063201604,0.6054053666226397,0.9068684516880093,1.0,1.0,6/31,14.46%,CCDC88A;JAK2;CRK;RACK1;IRS1;DAG1
prerank,retinoic acid binding (GO:0001972),0.30946665965578346,0.6038049599113106,0.8871650211565585,1.0,1.0,1/12,10.32%,NR2F2
prerank,voltage-gated calcium channel activity (GO:0005245),0.2632110020362178,0.6029785923396715,0.9322974472807991,1.0,1.0,8/37,21.18%,CACNA1I;CACNG5;ITGAV;CACNA1B;CACNG8;PKD2;CACHD1;CACNG4
prerank,gap junction channel activity (GO:0005243),-0.18596954516228797,-0.6011883543150552,0.9619565217391305,1.0,1.0,9/22,43.33%,GJA1;GJC2;GJB1;GJC1;GJD3;PANX2;PANX1;GJB2;GJD2
prerank,NF-kappaB binding (GO:0051059),0.2790437426329029,0.6009091474486171,0.905982905982906,1.0,1.0,6/24,19.03%,CDKN2A;FAF1;CDK5RAP3;GSK3B;COMMD6;HDAC1
prerank,phosphate ion binding (GO:0042301),0.3175725594692057,0.5997088526895724,0.8890469416785206,1.0,1.0,2/10,19.55%,PDE2A;PNP
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.30777187236856485,0.5983320836315189,0.8806818181818182,1.0,1.0,2/10,16.81%,ATM;PIK3CA
prerank,histone demethylase activity (GO:0032452),0.27659310910706564,0.5926715475768649,0.917936694021102,1.0,1.0,7/27,20.44%,RIOX1;KDM3B;PHF2;KDM4C;JARID2;KDM2B;KDM2A
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2965164516568842,0.5891519852441969,0.9135135135135135,1.0,1.0,3/13,25.17%,IDI1;SREBF2;MIF
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2501311179574051,0.5884482018476749,0.9481327800829875,1.0,1.0,6/70,9.85%,CSGALNACT2;HAS1;EXT1;GXYLT1;MFNG;B3GNT2
prerank,translation initiation factor activity (GO:0003743),0.2605482827449777,0.5875385177486986,0.9226519337016574,1.0,1.0,3/36,5.25%,EIF2S1;EIF2A;EIF3E
prerank,monocarboxylic acid binding (GO:0033293),0.28068986027467685,0.5809047778701703,0.9103896103896104,1.0,1.0,2/18,10.53%,NR2F2;NAPEPLD
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.2397530687638674,0.5793310419943096,0.9645748987854251,1.0,1.0,19/91,21.13%,STXBP6;SNX3;PHLDA3;CGAS;GSN;FLII;ACTN2;PLCB1;KCNJ2;RAB35;PLCD1;LDLRAP1;AMER2;KIF16B;MAPKAP1;MARK1;WDR45B;SVIL;MAPT
prerank,amyloid-beta binding (GO:0001540),0.24315717362024278,0.57728251479414,0.9710743801652892,1.0,1.0,13/79,17.65%,IAPP;HSPG2;CD74;VBP1;PFDN5;GRIA3;TM2D1;TLR6;TGFB2;GRIA2;LDLRAP1;CACNA1B;FCGR2B
prerank,N-acetyltransferase activity (GO:0008080),-0.18837844182930352,-0.5755899138877323,0.9797979797979798,1.0,1.0,10/19,36.48%,SAT1;NAT8L;ESCO1;GNPNAT1;NAA10;NAT2;SAT2;NAA80;EP300;NAT14
prerank,receptor tyrosine kinase binding (GO:0030971),0.2445504090699377,0.5750914982476936,0.9536354056902002,1.0,1.0,17/56,26.62%,LRP4;PCNA;TRADD;PTPN14;RACK1;IRS1;TP53;ELMO2;MAP3K7;GRB14;FIZ1;RNF41;FLT3LG;CPNE3;CBL;SHC3;GAS6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.24779483377030634,0.5750302980800928,0.9663512092534174,1.0,1.0,11/57,20.39%,NDUFS8;CYBRD1;NDUFB7;COX10;COX4I1;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5;UQCRH
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.26482599529338047,0.5749068114538336,0.9329268292682927,1.0,1.0,2/23,4.85%,SNX3;PHLDA3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.20948535698823167,-0.5745672997206729,0.9664179104477612,1.0,1.0,7/13,42.47%,PYCARD;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,lysine N-methyltransferase activity (GO:0016278),-0.1889192511169756,-0.573641758899831,0.9893617021276596,1.0,1.0,7/20,26.11%,SETD3;SETD4;METTL21A;EEF2KMT;ETFBKMT;EHMT2;ANTKMT
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.26361974735680244,0.5704019433158419,0.9346793349168646,1.0,1.0,4/26,18.42%,CSGALNACT2;B3GNT2;CHSY1;GBGT1
prerank,GTPase activity (GO:0003924),0.23583024233285643,0.5698040189584378,0.991,1.0,1.0,35/192,19.05%,RAB33B;GBP4;ATL2;ARHGDIB;RAB1B;RAB22A;RND3;GBP2;GNAI1;RAB8A;MTG2;GNAO1;RIT2;RHOU;RAB8B;GPN2;GFM2;RAB43;RAB11B;RAC2;RAB35;RAB2A;GNG11;EEF2;RAB5A;MMAA;RAC1;SEPTIN9;GSPT1;LRRK2;DRG1;GNB2;RAB6A;NKIRAS1;SAR1B
prerank,dynactin binding (GO:0034452),0.2958728509072196,0.5696642314099648,0.9298486932599724,1.0,1.0,4/12,21.13%,PAFAH1B1;BBS4;GSK3B;MAPT
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.2059718746503981,-0.5684440696295062,0.9850746268656716,1.0,1.0,2/15,11.29%,ALDH7A1;ALDH1A1
prerank,cell adhesion mediator activity (GO:0098631),0.26041189286390765,0.565916684632742,0.9302045728038508,1.0,1.0,4/24,17.12%,CD47;BSG;PALLD;EMB
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.25848842748925194,0.5639269700747098,0.9364705882352942,1.0,1.0,2/25,4.91%,PHLDA3;PLEKHA2
prerank,cation channel activity (GO:0005261),0.23744734193361466,0.5626667712953978,0.9736040609137055,1.0,1.0,13/94,17.56%,P2RX1;AQP1;ANO10;TRPM7;KCNA1;PSEN1;MCU;HVCN1;SLC24A4;SLC24A2;UNC80;TRPM4;ANO6
prerank,adenylyltransferase activity (GO:0070566),-0.18373147637944345,-0.562079240251073,0.9565217391304348,0.9997752123263786,1.0,8/21,27.57%,SELENOO;PAPOLG;NMNAT3;FLAD1;NMNAT1;MTPAP;NMNAT2;OASL
prerank,BMP receptor binding (GO:0070700),-0.20951200537226244,-0.5597795198109349,0.9703703703703703,0.9940596411243703,1.0,7/12,42.47%,PYCARD;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,enoyl-CoA hydratase activity (GO:0004300),0.29784691966105786,0.5596281261578187,0.9216524216524217,1.0,1.0,3/10,18.79%,AUH;HADHA;HADHB
prerank,mechanosensitive ion channel activity (GO:0008381),0.2844251639441373,0.5589868306785086,0.9257221458046767,1.0,1.0,1/12,5.29%,TMC4
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2392651386881727,0.553261686742474,0.9642470205850487,1.0,1.0,5/46,9.85%,EXT1;PIGA;MGAT2;MFNG;B3GNT2
prerank,voltage-gated chloride channel activity (GO:0005247),-0.22378230272589955,-0.54881757999097,0.9823943661971831,0.9917743557560169,1.0,4/10,29.53%,CLCN4;CLCN2;CLCN3;CLCN1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.2712494144382235,0.5456547000858126,0.9452247191011236,1.0,1.0,5/13,22.37%,EZR;GSK3B;PRKAR2A;SOX9;PKIA
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.253315668937749,0.5445445077441504,0.9502369668246445,1.0,1.0,5/24,18.99%,AK9;NME4;AK3;AK5;CMPK2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.22363199746501974,0.5433241310048972,0.978744939271255,1.0,1.0,19/100,21.13%,RACGAP1;SNX3;PHLDA3;OSBPL5;BTK;DENND1B;ARHGAP9;DENND1A;RUBCNL;ZFYVE26;ATG2B;IQGAP1;KIF16B;NCF4;MAPKAP1;GOLPH3;WDR45B;SNX13;MAPT
prerank,FAD binding (GO:0071949),0.2482085123598829,0.5419886046671695,0.9432799013563502,1.0,1.0,2/24,7.20%,KMO;PRODH
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.2803232141251783,0.5416991477016051,0.9277929155313351,1.0,1.0,3/11,14.09%,BAG3;GRPEL2;BAG1
prerank,adenyl nucleotide binding (GO:0030554),0.2803232141251783,0.5416991477016051,0.9277929155313351,1.0,1.0,3/11,14.09%,BAG3;GRPEL2;BAG1
prerank,myosin binding (GO:0017022),0.22933689245365113,0.5301908201302338,0.9743863393810032,1.0,1.0,16/55,23.06%,GSN;RAB8A;MYBPC1;SHROOM4;HAP1;RAB11B;LMTK2;TRIOBP;CALD1;CXCR4;RAB6A;TRAK2;SHROOM1;RAB27B;NCKIPSD;RAB10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.23952461854897772,0.5240871275957585,0.9637426900584796,1.0,1.0,3/29,9.09%,HPSE2;GBA2;ENGASE
prerank,amino acid binding (GO:0016597),0.23172406171003607,0.5223372155115157,0.9723820483314154,1.0,1.0,1/31,2.63%,DDAH2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.233381967970958,0.521575157344223,0.9655555555555555,1.0,1.0,7/34,19.11%,NDUFS8;NDUFB7;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.233381967970958,0.521575157344223,0.9655555555555555,1.0,1.0,7/34,19.11%,NDUFS8;NDUFB7;NDUFA1;NDUFA4;NDUFA5;NDUFS1;NDUFS5
prerank,5'-nucleotidase activity (GO:0008253),0.25905571671811456,0.5206501377021439,0.9521857923497268,1.0,1.0,2/13,12.73%,NT5C2;NT5C3A
prerank,voltage-gated cation channel activity (GO:0022843),0.21595843266250822,0.5184127587493388,0.9888211382113821,1.0,1.0,17/97,21.61%,CACNA1I;HCN3;CACNG5;ITGAV;KCNA1;KCNC2;KCNH7;HVCN1;CACNA1B;KCNQ5;CACNG8;PKD2;KCNC1;CACHD1;CACNG4;KCNH8;GRIN2D
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.19642397487416197,-0.513439276640022,0.9823321554770318,0.9954632306426784,1.0,2/13,11.29%,ALDH7A1;ALDH1A1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.25449133669777657,0.5075057379725035,0.9529569892473119,1.0,1.0,2/12,16.81%,ATM;PIK3CA
prerank,N-acyltransferase activity (GO:0016410),0.22890393987964386,0.5069431632251489,0.9745075318655851,1.0,1.0,7/32,20.80%,CERS4;SIRT7;CERS6;SIRT1;NAT10;CERS2;NMT2
prerank,ion channel inhibitor activity (GO:0008200),0.2185292742386762,0.4984731681390764,0.9806598407281001,1.0,1.0,3/35,13.14%,ITPR1;NEDD4L;RACK1
prerank,kinase inhibitor activity (GO:0019210),0.22132782996884356,0.4947985502484093,0.9738339021615472,1.0,1.0,12/33,28.67%,GMFG;PARVA;HEXIM1;SNCA;CDKN1A;DNAJC3;CDKN1B;NPM1;SH3BP5;SMCR8;MAPK8IP1;GSKIP
prerank,organic cation transmembrane transporter activity (GO:0015101),0.24130433860420367,0.4939522204052239,0.9715762273901809,1.0,1.0,3/16,20.66%,SLC44A1;SLC22A4;SLC44A2
prerank,ion gated channel activity (GO:0022839),0.23009765523032705,0.49310033377950074,0.9716981132075472,1.0,1.0,4/24,17.56%,ANO10;ANO3;TRPM4;ANO6
prerank,G protein-coupled receptor binding (GO:0001664),0.20026330293066344,0.48659628141148176,0.9959677419354839,1.0,1.0,10/132,13.07%,FLNA;GPRC5B;CCDC88C;GNAI1;INSL3;PICK1;GNAO1;ARRB2;S1PR2;GRK2
prerank,CXCR chemokine receptor binding (GO:0045236),0.2521498964283474,0.485383950946356,0.9833101529902643,1.0,1.0,11/11,74.80%,ITCH;CXCL13;CXCL2;PPBP;CXCL5;CXCL1;CXCL9;CXCL12;CXCL10;PF4;YARS1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.19155191741811367,-0.48473922877802406,0.996875,0.9942272940231578,1.0,4/11,34.17%,SLC2A9;SLC5A11;SLC23A1;SLC23A2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.23996591429933628,0.4694140031440757,0.9764216366158114,1.0,1.0,1/12,9.85%,B3GNT2
prerank,hexosyltransferase activity (GO:0016758),0.19580697112703,0.46695077805367063,0.9939455095862765,1.0,1.0,25/101,26.68%,CSGALNACT2;HAS1;EXT1;GBA2;MFNG;B3GNT2;TMTC2;GBE1;CHSY1;MTAP;POMT1;PIGM;B3GLCT;POFUT1;GCNT1;MGAT4C;FUT9;POMT2;TMTC4;B4GALT3;B3GALNT1;PIGV;LFNG;B3GALT1;DPY19L1
prerank,potassium channel regulator activity (GO:0015459),0.1969719490199328,0.458695506803317,0.9935414424111948,1.0,1.0,5/49,17.55%,FLNA;NEDD4L;SUMO1;SGK3;YWHAE
prerank,potassium channel activity (GO:0005267),0.19277029958042902,0.4559973914460519,0.9969325153374233,1.0,1.0,14/89,21.55%,AQP1;HCN3;KCNN4;KCNA1;KCNC2;KCNH7;KCNK12;KCNK2;KCNQ5;PKD2;KCNC1;GRIK5;GRIK3;KCNH8
prerank,NAD binding (GO:0051287),0.20979302802016184,0.4551941899482812,0.9939098660170523,1.0,1.0,8/26,26.13%,HPGD;UXS1;SIRT1;CRYL1;ZC3HAV1;ALDH2;QDPR;PARP9
prerank,voltage-gated potassium channel activity (GO:0005249),0.18558515897271402,0.4360333581432513,0.9989775051124744,1.0,1.0,13/80,22.22%,HCN3;KCNA1;KCNJ3;KCNC2;KCNH7;KCNJ2;KCNK2;KCNQ5;KCNJ10;PKD2;KCNC1;KCNH8;KCNN3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.2142045765506565,0.42485954110849095,0.988,1.0,1.0,3/14,20.87%,CAPN1;CAPN10;CAPN15
prerank,phosphatidylglycerol binding (GO:1901611),0.21182920067123445,0.41829391277340955,0.9917127071823204,1.0,1.0,2/13,19.95%,NME4;MME
prerank,ribonuclease P activity (GO:0004526),0.215500681037371,0.41624053883588363,0.9836512261580381,1.0,1.0,3/11,22.78%,PRORP;POP4;RPP30
prerank,phosphatidic acid binding (GO:0070300),0.17917701108032658,0.3786487562867089,0.9962732919254659,1.0,1.0,8/19,29.70%,PACSIN2;MAPKAP1;MARK1;RAPGEF6;RAPGEF2;SMPD3;OPA1;PITPNM1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.17782155701822386,0.36779889508786323,1.0,1.0,1.0,3/17,21.36%,EPHA3;EPHA7;EPHA10
prerank,ephrin receptor activity (GO:0005003),0.17782155701822386,0.36779889508786323,1.0,1.0,1.0,3/17,21.36%,EPHA3;EPHA7;EPHA10
prerank,delayed rectifier potassium channel activity (GO:0005251),0.16162675794866987,0.35569861035732203,1.0,1.0,1.0,4/32,20.02%,KCNA1;KCNC2;KCNQ5;KCNC1
prerank,P-type ion transporter activity (GO:0015662),0.16709701101958005,0.323729090956882,1.0,1.0,1.0,4/12,27.89%,ATP7A;ATP2B4;ATP2A2;ATP6V1E1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.16035311476159556,0.32262818054878906,1.0,0.9997585183526052,1.0,3/14,22.78%,PRORP;POP4;RPP30
